<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id>
<journal-title>Frontiers in Oncology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Oncol.</abbrev-journal-title>
<issn pub-type="epub">2234-943X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fonc.2019.00670</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Oncology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Association Between Simian Virus 40 and Human Tumors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Rotondo</surname> <given-names>John Charles</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/500174/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mazzoni</surname> <given-names>Elisa</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/418504/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Bononi</surname> <given-names>Ilaria</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Tognon</surname> <given-names>Mauro</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/31119/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Martini</surname> <given-names>Fernanda</given-names></name>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/418605/overview"/>
</contrib>
</contrib-group>
<aff><institution>Section of Pathology, Oncology and Experimental Biology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara</institution>, <addr-line>Ferrara</addr-line>, <country>Italy</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Markus A. N. Hartl, University of Innsbruck, Austria</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Ugo Moens, UiT the Arctic University of Norway, Norway; Abhik Saha, Presidency University, India</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Mauro Tognon <email>tgm&#x00040;unife.it</email></corresp>
<corresp id="c002">Fernanda Martini <email>mrf&#x00040;unife.it</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>07</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>9</volume>
<elocation-id>670</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>03</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>07</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2019 Rotondo, Mazzoni, Bononi, Tognon and Martini.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Rotondo, Mazzoni, Bononi, Tognon and Martini</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p>Simian virus 40 (SV40) is a small DNA tumor virus of monkey origin. This polyomavirus was administered to human populations mainly through contaminated polio vaccines, which were produced in naturally infected SV40 monkey cells. Previous molecular biology and recent immunological assays have indicated that SV40 is spreading in human populations, independently from earlier SV40-contaminated vaccines. SV40 DNA sequences have been detected at a higher prevalence in specific human cancer specimens, such as the brain and bone tumors, malignant pleural mesotheliomas, and lymphoproliferative disorders, compared to the corresponding normal tissues/specimens. However, other investigations, which reported negative data, did not confirm an association between SV40 and human tumors. To circumvent the controversies, which have arisen because of these molecular biology studies, immunological researches with newly developed indirect ELISA tests were carried out in serum samples from patients affected by the same kind of tumors as mentioned above. These innovative indirect ELISAs employ synthetic peptides as mimotopes/specific SV40 antigens. SV40 mimotopes do not cross-react with the homologous human polyomaviruses, BKPyV, and JCPyV. Immunological data obtained from indirect ELISAs, using SV40 mimotopes, employed to analyze serum samples from oncological patients, have indicated that these sera had a higher prevalence of antibodies against SV40 compared to healthy subjects. The main data on (i) the biology and genetics of SV40; (ii) the epidemiology of SV40 in the general population, (iii) the mechanisms of SV40 transformation; (iv) the putative role of SV40 in the onset/progression of specific human tumors, and (v) its association with other human diseases are reported in this review.</p></abstract>
<kwd-group>
<kwd>simian virus 40</kwd>
<kwd>polyomavirus</kwd>
<kwd>cancer</kwd>
<kwd>tumor</kwd>
<kwd>malignant pleura mesothelioma</kwd>
<kwd>osteosarcoma</kwd>
<kwd>healthy subjects</kwd>
<kwd>ELISA</kwd>
</kwd-group>
<contract-sponsor id="cn001">Universit&#x000E0; degli Studi di Ferrara<named-content content-type="fundref-id">10.13039/501100007109</named-content></contract-sponsor>
<contract-sponsor id="cn002">Associazione Italiana per la Ricerca sul Cancro<named-content content-type="fundref-id">10.13039/501100005010</named-content></contract-sponsor>
<contract-sponsor id="cn003">Fondazione Umberto Veronesi<named-content content-type="fundref-id">10.13039/501100004710</named-content></contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="287"/>
<page-count count="19"/>
<word-count count="17454"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>Simian virus 40 (SV40) is a monkey virus that was accidentally administered to human populations through SV40-contaminated vaccines, mainly polio vaccines, between 1955 and 1963 (<xref ref-type="bibr" rid="B1">1</xref>). SV40 has been assigned to the family of <italic>Polyomaviridae</italic>, Betapolyomavirus genus, which is closely related to human JC (JCPyV) and BK (BKPyV) polyomaviruses (HPyVs) (<xref ref-type="bibr" rid="B2">2</xref>). Many studies have reported on the transforming and tumorigenic properties of SV40, which have been experimentally proven in cell cultures and animal models, respectively (<xref ref-type="bibr" rid="B3">3</xref>&#x02013;<xref ref-type="bibr" rid="B7">7</xref>). These data have encouraged a significant amount of new researches aimed developed aimed at verifying if an association between SV40 and different human cancers exists.</p>
<p>This review provides a brief overview on the (i) biology and genetics of SV40; (ii) the epidemiology of SV40 in the general population, (iii) the mechanisms of SV40 transformation; (iv) the putative role of SV40 in the onset/progression of specific human tumors, and (v) its association with other human diseases.</p>
</sec>
<sec id="s2">
<title>SV40 Genomic Organization</title>
<p>The SV40 virion is formed by an unenveloped icosahedral protein structure with a diameter of 45&#x02013;50 nm and a density of 1.34&#x02013;1.35 g/cm<sup>3</sup> (<xref ref-type="bibr" rid="B8">8</xref>). Its viral genome is a circular double-stranded DNA molecule with &#x0007E;5.2 kb, depending on the SV40 strain (<xref ref-type="bibr" rid="B9">9</xref>). SV40 shares about 70&#x02013;75% genome homology with JCPyV (<xref ref-type="bibr" rid="B10">10</xref>&#x02013;<xref ref-type="bibr" rid="B12">12</xref>) and BKPyV (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>), whereas it has little homology with other HPyVs, including HPyV 6 and 7 (<xref ref-type="bibr" rid="B14">14</xref>), Malawi polyomavirus (MXPyV or HPyV 10) (<xref ref-type="bibr" rid="B15">15</xref>), Saint Louis polyomavirus (STPyV or HPyV 11) (<xref ref-type="bibr" rid="B16">16</xref>), and Merkel cell polyomavirus (MCPyV) (<xref ref-type="bibr" rid="B17">17</xref>&#x02013;<xref ref-type="bibr" rid="B19">19</xref>).</p>
<p>Three main regions have been identified in the SV40 genome: (i) a non-coding control region (NCCR), (ii) an early, and (iii) late coding regions (<xref ref-type="fig" rid="F1">Figure 1</xref>). NCCR includes the DNA replication origin (ori) and a gene promoter, whose nucleotide sequences are binding sites for transcription factors regulating early and late gene expressions. The terms &#x0201C;early&#x0201D; and &#x0201C;late&#x0201D; indicate the chronological order of gene transcriptions during the viral life cycle in the host cell. Both early and late genes are transcribed in opposing directions, i.e., anti-clockwise and clockwise, respectively, in relation to NCCR. The early region contains coding sequences for the large tumor antigen (Tag), small tumor antigen (tag), 17 kT and the early leader protein (<xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="table" rid="T1">Table 1</xref>). Both Tag and tag are transcribed with alternative splicing. Tag and tag are viral oncoproteins, which induce SV40 DNA replication, gene expression, as well as S-phase entry and DNA synthesis in the host cell, thereby triggering cycle progression (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref ref-type="bibr" rid="B9">9</xref>). In addition, these two oncoproteins own transformation potential <italic>in vitro</italic> and exert oncogenic activities <italic>in vivo</italic> (<xref ref-type="bibr" rid="B9">9</xref>). The 17 kT protein, which shares most of its amino acid (aa) sequence with the Tag N-terminal domain, promotes cell cycle progression in the presence of tag, as well as presenting tumorigenic potential (<xref ref-type="bibr" rid="B20">20</xref>). The early leader protein is a small protein of 23 aa whose function is unclear (<xref ref-type="bibr" rid="B21">21</xref>). The late region contains genes transcribed into two classes of late mRNAs: (i) 16S, which encodes the major capsid protein VP 1; (ii) 19S, coding for the VP 2, VP 3, VP 4 polypeptides, and the agnoprotein (<xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="table" rid="T1">Table 1</xref>). VP 1-2-3 are structural proteins that enable viral DNA to be packaged into the SV40 virion. A total of 360 VP 1 molecules form, with 72 pentamers, the virion (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>). The internal face of each pentamer binds a single copy of VP 2 or VP 3 (<xref ref-type="bibr" rid="B22">22</xref>). VP 4 seems to facilitate the lytic release of the SV40 virions (<xref ref-type="bibr" rid="B24">24</xref>), but a recent study demonstrated that VP4 is not required for this process (<xref ref-type="bibr" rid="B25">25</xref>). The agnoprotein controls the perinuclear localization of VP 1 during virion formation, which then triggers virion assembly (<xref ref-type="bibr" rid="B26">26</xref>). In total, SV40 translates for nine proteins. Recently, two SV40-encoded microRNAs (miRNAs) have been identified (<xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="table" rid="T1">Table 1</xref>) (<xref ref-type="bibr" rid="B27">27</xref>). More details are reported on this topic in the section &#x0201C;SV40 microRNAs and viral infection&#x0201D; (see below).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Schematic representation of the SV40 genome. SV40 DNA is made up of three regions: the regulatory region and the early and late regions. The regulatory region contains the origin of replication (<italic>ori</italic>) and regulates the viral gene expression. The early region contains coding sequences for early genes, including the large tumor T antigen (Tag), the small tumor t antigen (tag), 17 kT, and the early leader protein (ELP). The late region contains coding sequences for late genes, including the major capsid protein VP 1, the VP 2, VP 3, VP 4, and the agnoprotein (Agno). The two miRNAs maps within the Tag gene sequences.</p></caption>
<graphic xlink:href="fonc-09-00670-g0001.tif"/>
</fig>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>SV40 gene products.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th valign="top" align="left"><bold>SV40 expression products</bold></th>
<th valign="top" align="left"><bold>Main function(s)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Early</td>
<td valign="top" align="left">Large tumor T antigen (Tag)</td>
<td valign="top" align="left">Cell cycle progression, viral DNA replication</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Small tumor t antigen (tag)</td>
<td valign="top" align="left">Cell cycle progression, viral DNA replication</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">17 KT</td>
<td valign="top" align="left">Cell cycle progression</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Early leader protein</td>
<td valign="top" align="left">Unclear function</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Early polarity SVmiRNA</td>
<td valign="top" align="left">Tag regulation</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Late polarity SVmiRNA Tag regulation</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">Late</td>
<td valign="top" align="left">VP1</td>
<td valign="top" align="left">Capsid structure (external), viral attachment and entry</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">VP2</td>
<td valign="top" align="left">Capsid structure (internal)</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">VP3</td>
<td valign="top" align="left">Capsid structure (internal)</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">VP4</td>
<td valign="top" align="left">Cell lysis, viral particles release</td>
</tr>
<tr>
<td/>
<td valign="top" align="left">Agnoprotein</td>
<td valign="top" align="left">Virion assembly</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Main steps of the SV40 life cycle. The life cycle of SV40 starts with the attachment of the SV40 viral capsid to the target cell surface and proceeds through a lipid raft-mediated endocytosis. Then, the virion is transferred, by vesicular transport, toward the endoplasmic reticulum where it starts the uncoating process which continues in the cell cytosol. Uncoated SV40 genomes translocate inside the nucleus where the cellular RNA polymerase II mediates early viral transcription. Early transcription generates a precursor that is alternatively spliced into mRNAs, encoding the large T (Tag), and small t (tag) antigens. These mRNAs are translated in the cytosol into their corresponding proteins. Tag and tag migrate to the nucleus where they mediate several functions interfering with a number of host cellular pathways, thereby forcing the cells to proceed from the G1 to the S-phase. At the same time, Tag/tag starts the replication of the SV40 genome. The transition from early to late phase during the SV40 infection begins at the end of the viral DNA replication. After synthesis, late viral proteins are accumulated in the cytoplasm, migrates into the nucleus and then assemble with replicated viral DNA to form virions. Finally, a progeny virus is released through cell lysis.</p></caption>
<graphic xlink:href="fonc-09-00670-g0002.tif"/>
</fig>
</sec>
<sec id="s3">
<title>SV40 Life Cycle</title>
<p>Attachment of the SV40 viral capsid to the target cell surface is the first event to take place during the infection process in host cells. Binding is mediated by an interaction between VP 1, the cell surface receptor ganglioside GM1 (<xref ref-type="bibr" rid="B28">28</xref>), and the major histocompatibility complex (MHC) class I, that act as co-receptors (<xref ref-type="bibr" rid="B29">29</xref>). Afterwards, SV40 capsid enters the target cell via lipid raft-mediated endocytosis (<xref ref-type="bibr" rid="B30">30</xref>), which is triggered by the interaction between VP 1 and cell surface ganglioside GM1 (<xref ref-type="bibr" rid="B31">31</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). Then, SV40 capsid is transferred, by vesicular transport, in the endosomal compartment, toward the endoplasmic reticulum (ER). In atypical circumstances, SV40 enters the cells via a caveolae-mediated endocytic pathway by which the virus is directly translocated to the ER (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>), bypassing the endosomal compartment. The uncoating process begins in the ER, proceeds through ER absorption of Ca<sup>2&#x0002B;</sup> ions, thus inducing the loss of specific inter-pentamer connections provided by invading VP 1 C-terminal arms in the capsid. This process exposes the SV40 nuclear localization signal, thereby inducing the translocation of the viral genome in the nucleus via a mechanism mediated by the importin &#x003B1;<sub>2</sub>/&#x003B2; heterodimer and VP 3 (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). Both early viral transcription and DNA replication occur inside the nucleus. Transcription is NCCR regulated (<xref ref-type="bibr" rid="B36">36</xref>), whereas DNA replication starts from the ORI sequence contained in the same NCCR region. SV40 DNA replication occurs soon after transcription in the early region, whereas late region transcription initiates after replication of viral DNA (<xref ref-type="bibr" rid="B37">37</xref>). Both early and late promoters are recognized by cellular RNA polymerase II and host factors, thereby inducing viral gene transcription. Early transcription provides the generation of a precursor that is alternatively spliced into two mRNAs encoding Tag and tag (<xref ref-type="bibr" rid="B38">38</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). In this phase, SV40 late genes are maintained silenced by transcriptional repressors (<xref ref-type="bibr" rid="B39">39</xref>). In permissive cells, the role of Tag is essential for DNA replication. Tag is a multifunctional phosphoprotein that binds as a double hexamer to the SV40 viral replication ORI, where it unwinds viral DNA. This molecular process induces cellular protein recruitment required for viral DNA replication, including DNA polymerase-&#x003B1; and replication protein A (<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B41">41</xref>). Tag is also responsible for an ATPase activity that is required for viral DNA elongation (<xref ref-type="bibr" rid="B42">42</xref>). SV40 needs additional cellular co-factors for its DNA replication, mainly expressed during the S phase. For this reason, Tag is evolutionarily developed to modulate intracellular proteins involved in crucial signal transduction pathways that control cell cycle progression and apoptosis (<xref ref-type="bibr" rid="B43">43</xref>), such as hepatocyte growth factor receptor (HGFR/Met) (<xref ref-type="bibr" rid="B44">44</xref>), insulin-like growth factor 1 (IGF-1) (<xref ref-type="bibr" rid="B45">45</xref>), Notch-1 (<xref ref-type="bibr" rid="B46">46</xref>), and cdc2 (<xref ref-type="bibr" rid="B47">47</xref>). These molecules force SV40-infected cells to proceed from the G1 to the S-phase (<xref ref-type="bibr" rid="B48">48</xref>). In this mechanism, tag seems to play a cooperative role with Tag in both SV40 DNA replication and S-phase progression (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). The transition from the early to late phase, during the SV40 infection, begins at the end of the viral DNA replication. It seems that this early-to-late transcriptional switch depends on changes on Tag concentration. Initially, low Tag concentrations are sufficient for an interaction between high-affinity NCCR Tag-binding motifs and Tag and thus early transcription is positively regulated. Then, high Tag concentrations enable this protein to interact with low-affinity NCCR Tag-binding motifs. This interaction induces the repressing early transcription by blocking the RNA polymerase II complex. In addition, cellular repressors are titrated-off the late promoter allowing the expression of late genes. Indeed, since the number of SV40 genomes increases during viral DNA replication, the concentration of repressors is reduced in the late promoter. Tag, together with host transcription factors, interacts with the late promoter, thereby inducing late gene transcription (<xref ref-type="bibr" rid="B51">51</xref>). Late genes are transcribed in an opposite direction to the early gene-encoding strand. Late proteins are translated from two classes of late mRNAs: (i) 16S, which encodes the major capsid protein VP 1; (ii) 19S, coding for VP 2, VP 3, VP 4 polypeptides, and agnoprotein (<xref ref-type="bibr" rid="B52">52</xref>) (<xref ref-type="fig" rid="F2">Figure 2</xref>). After synthesis, late viral proteins are accumulated inside the cell via checkpoint kinase Chk1 activation by SV40, which negatively regulates cell mitosis (<xref ref-type="bibr" rid="B53">53</xref>). Then, structural proteins assemble with replicated viral DNA to form virions inside the nucleus (<xref ref-type="fig" rid="F2">Figure 2</xref>) (<xref ref-type="bibr" rid="B26">26</xref>). This mechanism is induced by the six tandem GC-boxes within the SV40 genome, which represent the capsid assembly signal. Viral assembly starts with GC-boxes interacting with cellular transcriptional factor SP1 recruiting VP 2 and VP 3, which in turn bind to VP 1 pentamers (<xref ref-type="bibr" rid="B54">54</xref>). During this process, the number of capsomers surrounding the viral DNA increases until virion assembly has ended (<xref ref-type="bibr" rid="B9">9</xref>). At the same time, the agnoprotein controls perinuclear VP 1 localization (<xref ref-type="bibr" rid="B26">26</xref>). Then, the viral particle releasing (<xref ref-type="fig" rid="F2">Figure 2</xref>) leads to cell lysis and necrosis. However, the release of SV40 without displaying a cytopathic effect (CPE) has been reported in specific cell types, such as human mesothelial, epithelial, fibroblasts, and/or embryonic kidney cells (HEK) (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B55">55</xref>&#x02013;<xref ref-type="bibr" rid="B57">57</xref>).</p>
</sec>
<sec id="s4">
<title>SV40-Mediated Cell Immortalization and Transformation</title>
<p>Mammalian cells of different histotypes behave toward SV40 infection in different ways, depending on the ability of this oncogenic polyomavirus (PyV) to complete the viral cycle and produce a mature viral progeny. SV40-infected cells can be (i) permissive, (ii) non-permissive, or (iii) semi-permissive (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B58">58</xref>&#x02013;<xref ref-type="bibr" rid="B60">60</xref>). The main discriminant depends on viral DNA replication potential expressed in permissive and semi-permissive cells. In this case, viral progeny is produced, whereas SV40 infected cells lyse and die. CV-1 and fibroblast-like COS cell lines, both derived from monkey kidney tissue, are the prototype of permissive cells (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B61">61</xref>). In non-permissive cells, no productive viral cycle is established, whereas the infection occurs but is abortive. Indeed, these cells are transformed/immortalized by SV40. A typical example of non-permissive cells are rodent cells, that carry SV40 DNA integrated in their genome, while cells are transformed (<xref ref-type="bibr" rid="B62">62</xref>). Semi-permissive cells allow SV40 multiplication, but they produce a limited viral progeny (<xref ref-type="bibr" rid="B63">63</xref>). The majority of cells lyse and die upon infection, but a fraction of cells, which resist the SV40 infection, are transformed and immortalized, while producing a viral progeny at low titer. Several SV40 transformed/immortalized human fibroblasts have been described in the literature (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>). Cells differ in response to SV40 infection depending on the ability of Tag to stimulate late promoter transcription, which only occurs in permissive/semi-permissive cells. Human cells support SV40 replication less efficiently than monkey cells. Different <italic>in vitro</italic> cellular models have been established to demonstrate the replicative potential of SV40 in human cells (<xref ref-type="bibr" rid="B66">66</xref>). Early studies have shown that SV40 can replicate in human fetal neural cell lines (<xref ref-type="bibr" rid="B4">4</xref>), mesothelial cells (<xref ref-type="bibr" rid="B56">56</xref>), and B-/T-lymphocytes (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>, <xref ref-type="bibr" rid="B67">67</xref>). Although less efficiently, this PyV can also replicate in human HEK lymphoblastoid B-cell lines, as well as fibroblasts, such as WI-38 cells (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B68">68</xref>&#x02013;<xref ref-type="bibr" rid="B71">71</xref>). In addition, in rare cases (&#x0003C;1/10<sup>8</sup> cells), human fibroblasts may become transformed due to the viral DNA integration in the host cell genome (<xref ref-type="bibr" rid="B72">72</xref>). Early works have shown that one out of seven human astrocytes could become transformed (<xref ref-type="bibr" rid="B73">73</xref>) establishing continuous cell lines (<xref ref-type="bibr" rid="B74">74</xref>). In addition, several SV40 infected human cells produce a viral progeny at low titer without displaying CPE (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). An example is provided by normal human mesothelial cells (HMC), which seem to be persistently infected by SV40 for a long period of time, while releasing viral progeny (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). The molecular mechanism behind the capacity of SV40 to enter into a true persistent/latent state remains to be fully elucidated. It has been reported that SV40 is able to establish a persistent infection in long-term immortalized human fibroblasts, resulting in the production of infectious viral progeny, which is able to infect both monkey and human cells (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>).</p>
<p>As for other DNA tumor viruses (<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>), several <italic>in vitro</italic> cellular models have been developed to study SV40 transformation potentials. Tag and tag expression both cause high cell transformation efficiently (<xref ref-type="bibr" rid="B3">3</xref>). Indeed, Tag blocks the activities of many different cellular factors involved in cell growth, differentiation and the cell cycle, such as p130, p300, and p400 (<xref ref-type="fig" rid="F3">Figure 3</xref>) (<xref ref-type="bibr" rid="B9">9</xref>). In addition, both Tag and tag can inhibit the activities of p53 and pRb, which are two key tumor suppressor proteins of animal and human cells (<xref ref-type="bibr" rid="B9">9</xref>). These interactions are mandatory in order to achieve full human cell transformation (<xref ref-type="bibr" rid="B9">9</xref>). Similarly, the transformation potential of Tag belonging to another PyV, MCPyV, has been demonstrated. Indeed, MCPyV Tag or LT has been detected to be overexpressed on MCPyV-positive tumor tissues (<xref ref-type="bibr" rid="B17">17</xref>) and several <italic>in vitro</italic> studies evaluated its transforming activity (<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B78">78</xref>). However, it is important to point out that many studies, while reporting the presence of SV40 sequences in human tumors, did not show the Tag expression. On the other hand, in investigations based on IHC staining of human tumor tissues, the Tag expression was revealed in SV40-positive cells (<xref ref-type="bibr" rid="B79">79</xref>&#x02013;<xref ref-type="bibr" rid="B85">85</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Oncogenic activities of Tag and tag. During SV40 infection, Tag inhibits both the pRB and p53 tumor suppressor pathways. The main downstream effects of these interactions are the blocking of p53-mediated apoptosis and pRb-mediated cell cycle arrest. Furthermore, the interaction between Tag and pRB, p53 and other factors transactivates genes such as IGF-1 and Met, thereby triggering the transition from the G1 to the S-phase and the proliferation of SV40-infected cells. By inhibiting PP2A, tag activates pathways facilitating cell proliferation and transformation.</p></caption>
<graphic xlink:href="fonc-09-00670-g0003.tif"/>
</fig>
<p>Interestingly, p53 was discovered for the first time when detected bound to Tag in SV40-transformed cells during immunoprecipitation experiments (<xref ref-type="bibr" rid="B86">86</xref>). Both Tag and tag can interfere with many other host cellular pathways (<xref ref-type="bibr" rid="B38">38</xref>, <xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>). For instance, Tag has been found to be associated with many cellular factors, such as Hsc70, Cul7, Bub1, TEF-1, Nbs1, and Fbw7 (<xref ref-type="bibr" rid="B59">59</xref>). It has also been reported that the Tag-p53 complexes bind and activate IGF-1 promoter stimulating cell growth (<xref ref-type="bibr" rid="B45">45</xref>). The expression of other growth factors may be potentially influenced by Tag (<xref ref-type="bibr" rid="B9">9</xref>). Another cellular factor that interacts with Tag during SV40 infection is the hepatocyte growth factor receptor (HGFR or Met) (<xref ref-type="bibr" rid="B44">44</xref>). Furthermore, Tag is capable of inducing cell immortalization and transformation by increasing CBP/p300 and specific histone acetylation levels (<xref ref-type="bibr" rid="B89">89</xref>).</p>
<p>Upon interaction with the cellular genome and cell factors, SV40 Tag induces different molecular changes in the host cell. SV40 Tag possesses clastogenic and mutagenic activities, which are shown by the appearance of chromosome aberrations and point mutations in the host genome (<xref ref-type="bibr" rid="B90">90</xref>&#x02013;<xref ref-type="bibr" rid="B93">93</xref>). These molecular/chromosome changes have not been investigated/reported in human tumors presumably caused by SV40. Specific genome alterations are characterized by numerical and structural chromosomal aberrations, such as gaps, breaks, dicentric and ring chromosomes, chromatid changes, deletions, duplications, and translocations (<xref ref-type="bibr" rid="B91">91</xref>&#x02013;<xref ref-type="bibr" rid="B93">93</xref>). SV40 Tag favors the accumulation of point mutations, interfering with host DNA repairs pathway (<xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B95">95</xref>). Indeed, SV40 Tag binds p53 protein thereby inhibiting p53-induced apoptosis and allowing DNA-mutated cells to survive (<xref ref-type="bibr" rid="B90">90</xref>, <xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B95">95</xref>). It is well-established that specific chromosomal aberrations can be detected in human tumors of different histotypes, as reported in: (<ext-link ext-link-type="uri" xlink:href="http://atlasgeneticsoncology.org/Deep/CancerCytogenet2005ID20050.html">http://atlasgeneticsoncology.org/Deep/CancerCytogenet2005ID20050.html</ext-link>). In SV40-driven/positive human tumors, a similar panel of chromosome alterations could be displayed (<xref ref-type="bibr" rid="B90">90</xref>&#x02013;<xref ref-type="bibr" rid="B93">93</xref>). Occasionally, SV40 DNA integrates into the host cellular genome. This event can occur randomly in the cellular DNA, while the viral DNA breaks randomly, as well (<xref ref-type="bibr" rid="B96">96</xref>). In cases where SV40 DNA integration occurs, while maintaining Tag and tag expression, these two viral oncoproteins support the cell transformation phenotype (<xref ref-type="bibr" rid="B9">9</xref>). In addition, Liu and collaborators demonstrated that the disruption of the human chromosomal interval at 1q21.1 by SV40 integration, in the human bronchial epithelial cell line, immortalized with a cloned Ori&#x02013; SV40, CRL-2504 cell line, can be an essential step for cellular immortalization, altering the expression of genes involved in senescence/apoptosis, which are located in the proximity of viral integration sites (<xref ref-type="bibr" rid="B97">97</xref>). Integration of SV40 DNA within the human genome has been reported in osteosarcoma samples, thus suggesting that the viral DNA integration is involved the tumorigenic process (<xref ref-type="bibr" rid="B98">98</xref>). Altogether these SV40-driven alterations represent the genetic background, which drives the phenotypical changes that lead to the SV40-induced transformation process of the host cell.</p>
<p>The small tag viral oncoprotein interacts with the protein phosphatase 2A (PP2A), thereby triggering several pathways related to cellular transformation (<xref ref-type="fig" rid="F3">Figure 3</xref>). The complex tag-PP2A induces the entry on the cell cycle S-phase through CDK inhibitor p27 degradation and cyclin A/CDK2 and cyclin E/CDK2 promotion (<xref ref-type="bibr" rid="B99">99</xref>&#x02013;<xref ref-type="bibr" rid="B101">101</xref>). Furthermore, tag-PP2A induces MAPK cascade activation, thereby triggering the transforming process <italic>in vitro</italic> (<xref ref-type="bibr" rid="B102">102</xref>). The third SV40 early protein, 17kT, also transactivates the cyclin A/CDK2 (<xref ref-type="bibr" rid="B100">100</xref>). Although many factors responsible for SV40 transformation have been discovered, the total number of proteins involved in this activity is yet to be determined.</p>
<p>An association between SV40 infection and DNA methylation of different cellular genes has been reported. Indeed, improper DNA methylation is involved in different diseases (<xref ref-type="bibr" rid="B103">103</xref>, <xref ref-type="bibr" rid="B104">104</xref>), including cancer (<xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B106">106</xref>). DNA methylation is induced by DNA tumor viruses in order to evade antiviral immunity, which contributes to the immunosuppressive microenvironment during cancer development (<xref ref-type="bibr" rid="B107">107</xref>). This process facilitates viral multiplication/activity (<xref ref-type="bibr" rid="B107">107</xref>).</p>
<p>In early studies, SV40 transforming potential was largely employed in developing different <italic>in vitro</italic> cellular models. SV40-immortalized cells have been established and used to study a large number of different molecular mechanisms, including cell proliferation and transformation (<xref ref-type="bibr" rid="B108">108</xref>&#x02013;<xref ref-type="bibr" rid="B110">110</xref>), cytokine-production (<xref ref-type="bibr" rid="B111">111</xref>), and angiogenesis (<xref ref-type="bibr" rid="B112">112</xref>), as well as mesenchymal stem cell differentiation (<xref ref-type="bibr" rid="B113">113</xref>) and neuronal differentiation and neuroregeneration (<xref ref-type="bibr" rid="B114">114</xref>). Moreover, different diseases, such as autoimmune disorders (<xref ref-type="bibr" rid="B115">115</xref>), male infertility (<xref ref-type="bibr" rid="B116">116</xref>), fibrosarcoma (<xref ref-type="bibr" rid="B108">108</xref>), and corneal dystrophy (<xref ref-type="bibr" rid="B117">117</xref>) have been studied employing SV40-immortalized cell models. Other applications of SV40-immortalized cell <italic>in vitro</italic> models are represented by cellular co-culturing (<xref ref-type="bibr" rid="B118">118</xref>) and suicide gene therapy (<xref ref-type="bibr" rid="B119">119</xref>).</p>
</sec>
<sec id="s5">
<title>SV40 MICRORNAs and Viral Infection</title>
<p>MicroRNAs (miRNAs) are small non-coding RNAs [18&#x02013;22 nucleotides (nt)] that are involved in the post-transcriptional negative regulation of gene expression in eukaryotes (<xref ref-type="bibr" rid="B120">120</xref>). These small molecules and their regulatory effect have been described in both eukaryote cells and viruses, including PyVs (<xref ref-type="bibr" rid="B120">120</xref>). In the SV40 the early region maps a gene encoding for two miRNAs (<xref ref-type="fig" rid="F1">Figure 1</xref>), which are transcribed in opposite orientations. These two viral miRNAs negatively regulate early mRNAs inhibiting Tag translation through RNA-mediated interference (RNAi) machinery, during the late phase of the SV40 life cycle. These two miRNAs actively direct Tag mRNA cleavage at different nucleotide positions (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B121">121</xref>). However, the silencing potential of human genes by SV40 miRNAs cannot be ruled out (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B121">121</xref>). These findings indicate that SV40 is able to use human RNAi machinery to its own advantage. Since Tag is a target for host cytotoxic T lymphocyte (CTL), the viral miRNA-mediated down-regulation of Tag decreases the susceptibility of SV40-infected cells to CTLs activity (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B121">121</xref>). Similarly, JCPyV and BKPyV escape the innate and adaptive immune detection exploiting the human RNAi machinery. Indeed, these two HPyVs code for a miRNA identical in sequence between BKPyV and JCPyV, which targets a member of the UL16 binding protein (ULBP) family, the stress-induced ligand ULBP3 (<xref ref-type="bibr" rid="B122">122</xref>). Although a recent study indicates that another member of this gene family, ULBP1, is down-regulated following SV40 infection, it has been demonstrated that SV40 miRNAs do not mediate this molecular effect, thus suggesting the involvement of other mechanisms behind the SV40 immune evasion ability (<xref ref-type="bibr" rid="B123">123</xref>). Another report showed that the two SV40 miRNAs can negatively regulate the degree of viral effects on B-cells as demonstrated using SV40 miRNA-null mutants in experiments with infected B-lymphocytes and myeloid cell lines (<xref ref-type="bibr" rid="B124">124</xref>).</p>
</sec>
<sec id="s6">
<title>SV40 Oncogenicity in Animal Models</title>
<p>SV40 is a high oncogenic small DNA tumor virus. However, this PyV has not been reported in tumors of the rhesus macaque (Macaca mulatta), which is its natural host. Indeed, SV40 infection in permissive monkey cells derived from kidney tissues leads to cell lysis and death, without neoplastic transformation (<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B61">61</xref>). By contrast, SV40 experimentally inoculated in hamsters induces tumors of different histotypes, depending of the route of injection. Specifically, SV40 subcutaneously (s.c.) inoculated in hamsters induces sarcomas and osteosarcomas; whereas when injected intracerebrally (i.c.) it induces ependymomas and choroid plexus papillomas (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B38">38</xref>). Hematological malignancies, such as lymphocytic leukemia, histiocytic lymphomas, and B-cell lymphomas are induced when SV40 is inoculated intravenously (i.v.) (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). SV40 injected in the pleural space of hamsters induces MPM in 100% of animals (<xref ref-type="bibr" rid="B125">125</xref>).</p>
<p>SV40 oncogenic activity is shown in transgenic mice, where Tag/tag expression is under the control of its promoter (<xref ref-type="bibr" rid="B126">126</xref>) or tissue-specific promoters (<xref ref-type="bibr" rid="B127">127</xref>&#x02013;<xref ref-type="bibr" rid="B145">145</xref>). Exploiting the vast SV40 oncogenicity <italic>in vivo</italic>, SV40 transgenic animals provided good models for studying tumor initiation/progression and innovative anti-cancer therapies (<xref ref-type="bibr" rid="B146">146</xref>). Transgenic animals develop ependymomas, choroid plexus papillomas (<xref ref-type="bibr" rid="B147">147</xref>), hepatocellular carcinomas (<xref ref-type="bibr" rid="B139">139</xref>, <xref ref-type="bibr" rid="B144">144</xref>), brain (<xref ref-type="bibr" rid="B148">148</xref>), bladder (<xref ref-type="bibr" rid="B140">140</xref>), and bowel tumors (<xref ref-type="bibr" rid="B149">149</xref>), as well as eye tumors, including ocular and/or lens tumors (<xref ref-type="bibr" rid="B150">150</xref>). The multistage progression of prostate carcinoma has also been largely studied employing SV40-transgenic mice (<xref ref-type="bibr" rid="B128">128</xref>&#x02013;<xref ref-type="bibr" rid="B130">130</xref>, <xref ref-type="bibr" rid="B132">132</xref>, <xref ref-type="bibr" rid="B134">134</xref>&#x02013;<xref ref-type="bibr" rid="B136">136</xref>, <xref ref-type="bibr" rid="B151">151</xref>, <xref ref-type="bibr" rid="B152">152</xref>). Interestingly, transgenic mice generated with SV40 have also been employed to study rare cancers, such as brown adipose tumor (<xref ref-type="bibr" rid="B151">151</xref>), cardiac rhabdomyosarcoma (<xref ref-type="bibr" rid="B142">142</xref>) and adrenocortical carcinoma (<xref ref-type="bibr" rid="B151">151</xref>). Lung cancers and MPM have also been studied in these animal models (<xref ref-type="bibr" rid="B127">127</xref>, <xref ref-type="bibr" rid="B137">137</xref>, <xref ref-type="bibr" rid="B141">141</xref>). More recently, SV40-transgenic mice have been developed to study chronic lymphocytic leukemia (<xref ref-type="bibr" rid="B143">143</xref>). In addition, other SV40-transgenic mouse models have also been developed to study fibrosarcoma (<xref ref-type="bibr" rid="B108">108</xref>) and retinoblastoma (<xref ref-type="bibr" rid="B153">153</xref>) as well as breast (<xref ref-type="bibr" rid="B154">154</xref>, <xref ref-type="bibr" rid="B155">155</xref>) ovarian (<xref ref-type="bibr" rid="B131">131</xref>, <xref ref-type="bibr" rid="B156">156</xref>, <xref ref-type="bibr" rid="B157">157</xref>), pancreatic (<xref ref-type="bibr" rid="B158">158</xref>), and liver cancers (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B159">159</xref>).</p>
</sec>
<sec id="s7">
<title>Epidemiology of SV40 Infection in Human Populations</title>
<p>SV40 infection in human populations has been widely reported (<xref ref-type="bibr" rid="B160">160</xref>&#x02013;<xref ref-type="bibr" rid="B164">164</xref>). Since SV40 is a monkey virus and the macaque is its natural host, this viral infection in humans was considered a rare event, being restricted to subjects in close contact with monkeys. Indeed, inhabitants of Indian villages located near the jungle, which is the natural environment for monkeys, and workers attending to monkeys in zoos/animal facilities are prone to SV40 infection and develop antibodies against this PyV (<xref ref-type="bibr" rid="B165">165</xref>, <xref ref-type="bibr" rid="B166">166</xref>).</p>
<p>SV40 was inadvertently administered to humans between 1955 and 1963, when hundreds of millions of people in North and South America, Canada, Europe, Asia, and Africa were vaccinated with both inactivated and/or live polio vaccines, found to be contaminated by SV40. This accident occurred because these early polio vaccines were produced by growing polioviruses in naturally SV40-infected monkey cell cultures (<xref ref-type="bibr" rid="B167">167</xref>&#x02013;<xref ref-type="bibr" rid="B169">169</xref>). It has been reported that in the former USSR, SV40-contaminated polio vaccines were used until 1978 (<xref ref-type="bibr" rid="B170">170</xref>), whereas in Italy up to 1999, when the Italian Health Public Organization switched to SV40-free anti-polio vaccines as indicated by the World Health Organization (WHO) guidelines, following a note from the British National Institute for Biological Standards and Control (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B171">171</xref>). In other countries, the risk of SV40 contagion through polio vaccines is still a problem, as these vaccines are produced using SV40-positive monkey cells (<xref ref-type="bibr" rid="B170">170</xref>). The past literature indicates that SV40 infection in different geographic regions was influenced by the use of either SV40-contaminated or non-contaminated vaccines, as well as the number of years of vaccine administration. Sweet and colleagues quantified that about 10&#x02013;30% of polio vaccines were contaminated with SV40 (<xref ref-type="bibr" rid="B1">1</xref>). Furthermore, SV40 genotypes in polio vaccines overlap with those detected in humans, thus suggesting that this oncogenic PyV was introduced into the human population through contaminated polio vaccines (<xref ref-type="bibr" rid="B172">172</xref>). It has also been reported that shortly after SV40 infection, this PyV spread for weeks in the stools of children vaccinated with SV40-contaminated vaccines (<xref ref-type="bibr" rid="B173">173</xref>). This evidence indicates that SV40 replicates in some gastrointestinal cells, thus suggesting that this virus could spread in humans via horizontal infection, such as the fecal-oral route. To a lesser extent, other vaccines against adenoviruses (<xref ref-type="bibr" rid="B174">174</xref>) and hepatitis A (<xref ref-type="bibr" rid="B175">175</xref>), were SV40 contaminated. In addition, SV40-contamination was detected in the respiratory syncytial virus vaccine employed in infected-volunteers to whom the vaccine was given to via the respiratory route (<xref ref-type="bibr" rid="B176">176</xref>). About two out of three volunteers developed neutralizing antibodies against SV40 (<xref ref-type="bibr" rid="B176">176</xref>). Altogether these data indicate that SV40 infects and multiplies in humans.</p>
<p>Over the years, with the development of molecular biology techniques (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B177">177</xref>, <xref ref-type="bibr" rid="B178">178</xref>), SV40 DNA sequences have been investigated and detected in both normal and neoplastic tissues from individuals vaccinated with polio vaccines contaminated with SV40. DNA sequences from this PyV have been detected in pituitary tissues (<xref ref-type="bibr" rid="B179">179</xref>) as well as in leukocytes from organ (<xref ref-type="bibr" rid="B180">180</xref>) and blood (<xref ref-type="bibr" rid="B181">181</xref>) donors. Footprints from SV40 DNA have also been reported in lymphoblastoid cells (<xref ref-type="bibr" rid="B68">68</xref>), as well as blood sample specimens from normal individuals and oncologic patients (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B161">161</xref>, <xref ref-type="bibr" rid="B182">182</xref>&#x02013;<xref ref-type="bibr" rid="B186">186</xref>). In addition, SV40 DNA has been detected in blood samples from healthy individuals exposed to asbestos pollution (<xref ref-type="bibr" rid="B187">187</xref>). These data cumulatively demonstrate that SV40 is circulating in the human population. It is also possible that blood cells are the SV40 reservoir and vehicle of the virus spreading in humans. Genomic sequences from this PyV have also been found in stool samples and urine from children and adults, suggesting that SV40 can potentially be transmitted via different routes, such as sexual and fecal-oral routes which are responsible for viral horizontal infection in humans (<xref ref-type="bibr" rid="B164">164</xref>, <xref ref-type="bibr" rid="B183">183</xref>, <xref ref-type="bibr" rid="B188">188</xref>). These additional sources of exposure may lead to subclinical SV40 infections in the healthy population. However, it has been reported that the SV40 transmission in monkeys seems to occur in the environment rather than directly among animals (<xref ref-type="bibr" rid="B189">189</xref>). It is plausible that in humans, a contaminated environment or home setting is responsible for SV40 spreading, rather than person to person transmission (<xref ref-type="bibr" rid="B188">188</xref>). The site of SV40 latent infection in humans is yet to be elucidated. Since this PyV has been detected in human kidney and urine samples (<xref ref-type="bibr" rid="B183">183</xref>, <xref ref-type="bibr" rid="B184">184</xref>) it seems reasonable that kidneys might be the site of virus latency, as in monkey it occurs to be the natural host (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B189">189</xref>).</p>
<p>SV40 primary infection occurs early in life and its seroprevalence increases with age. Anti-SV40 antibodies in the serum of immunized individuals and SV40 antigens have been detected in normal subjects (<xref ref-type="bibr" rid="B190">190</xref>&#x02013;<xref ref-type="bibr" rid="B199">199</xref>). Lusting et al. reported a prevalence of serum anti SV40 antibodies in 7.6&#x02013;14% of Swedish children aged from 1 to 13 years old (<xref ref-type="bibr" rid="B198">198</xref>). In early studies, a low prevalence, 11%, was detected in healthy individuals from Africa (<xref ref-type="bibr" rid="B200">200</xref>) and the U.S (<xref ref-type="bibr" rid="B201">201</xref>). Similarly, a more recent study detected anti SV40 antibodies in sera from healthy adult blood donors with low rates, about 2% (<xref ref-type="bibr" rid="B202">202</xref>). Altogether these serological data indicate that SV40 is present in immunized healthy populations in the range of 1.3&#x02013;15.6%, suggesting that this PyV circulates in humans at low prevalence (<xref ref-type="bibr" rid="B200">200</xref>, <xref ref-type="bibr" rid="B201">201</xref>, <xref ref-type="bibr" rid="B203">203</xref>&#x02013;<xref ref-type="bibr" rid="B206">206</xref>). Interestingly, one study reported SV40 antibodies in human sera before the introduction of SV40-contaminated polio vaccines, suggesting that SV40 was probably circulating in humans independently from SV40-contaminated vaccines (<xref ref-type="bibr" rid="B207">207</xref>). However, this study was conducted before the identification of human PyVs, JCPyV, and BKPyV, which are highly homologous to SV40 (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B13">13</xref>). Indeed, the high homology among the three PyVs, BKPyV, JCPyV, and SV40, hampered serological data due to antigenic cross-reactivity. For many years, PyV cross-reactivity did not allow the verification of the real SV40 prevalence in humans (<xref ref-type="bibr" rid="B208">208</xref>). Different immunological assays based on the use of virions, soluble recombinant VP 1 protein and virus-like particles (VLPs), such as SV40 antigens, always gave cross-reactivity with BKPyV/JCPyV (<xref ref-type="bibr" rid="B208">208</xref>).</p>
<p>In order to circumvent this technical issue, in recent years specific and sensitive indirect ELISA tests with SV40 VPs/Tag mimotopes as antigens were set up to investigate the presence in healthy subjects of serum IgG/IgM antibodies reacting to SV40 VPs/Tag (<xref ref-type="bibr" rid="B191">191</xref>, <xref ref-type="bibr" rid="B192">192</xref>). Immunological data showed that healthy blood donors carry IgG antibodies reacting to SV40 VPs and Tag with a prevalence of 18 and 20%, respectively (<xref ref-type="bibr" rid="B191">191</xref>, <xref ref-type="bibr" rid="B192">192</xref>). Furthermore, immunological data from children may suggest that SV40 infection/seroconversion occurs early in life, i.e., at 6 months of age (<xref ref-type="bibr" rid="B190">190</xref>, <xref ref-type="bibr" rid="B193">193</xref>).</p>
<p>Antibodies against SV40 VPs in sera from multiple transfused patients affected by thalassemia major had a higher prevalence than healthy subjects of the same age (31 years old, both cohorts). These data indicate that this PyV could have been transmitted by blood transfusions, along with other natural sources (<xref ref-type="bibr" rid="B209">209</xref>). Furthermore, the increased prevalence of SV40 antibodies was significantly higher in the older age group of patients (41&#x02013;50 years old) than in age-matched controls (38 vs. 20%).</p>
<p>In a recent investigation, SV40 neutralizing antibodies with a prevalence in the range of 7 and 18% were revealed in sera from women in Huston, Texas, employing a plaque reduction SV40-neutralization assay. The authors identified ethnicity as a significant factor associated with high seroprevalence SV40 neutralizing antibodies reported in Hispanic groups, including subjects from Houston (<xref ref-type="bibr" rid="B210">210</xref>). It is worth recalling that SV40-contaminated live polio vaccines, as candidate vaccines, were tested during large field trials in some Latin American Countries, due to their potential for being na&#x000EF;ve vaccines.</p>
<p>Overall, immunological data indicate that SV40 is circulating in humans inducing IgM, IgG including neutralizing antibodies, which can be detected in sera with a mean prevalence of &#x0007E;20% in healthy individuals. Recent immunological data, despite being obtained with specific SV40 mimotopes, do not rule out the hypothesis that another polyomavirus, still unknown, closely related to SV40 is circulating in humans.</p>
</sec>
<sec id="s8">
<title>Association of SV40 With Human Tumors</title>
<p>The hypothesis that SV40 might be associated to human malignancies has been investigated with a large number of molecular, immunological, and epidemiological studies (<xref ref-type="table" rid="T2">Table 2</xref>). This oncogenic PyV was previously associated with a broad range of tumor types including, malignant pleural mesothelioma (MPM) (<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B227">227</xref>&#x02013;<xref ref-type="bibr" rid="B233">233</xref>, <xref ref-type="bibr" rid="B235">235</xref>, <xref ref-type="bibr" rid="B238">238</xref>, <xref ref-type="bibr" rid="B240">240</xref>&#x02013;<xref ref-type="bibr" rid="B243">243</xref>, <xref ref-type="bibr" rid="B256">256</xref>&#x02013;<xref ref-type="bibr" rid="B258">258</xref>), bone (<xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B215">215</xref>, <xref ref-type="bibr" rid="B224">224</xref>), brain (<xref ref-type="bibr" rid="B212">212</xref>&#x02013;<xref ref-type="bibr" rid="B214">214</xref>, <xref ref-type="bibr" rid="B217">217</xref>, <xref ref-type="bibr" rid="B219">219</xref>&#x02013;<xref ref-type="bibr" rid="B221">221</xref>, <xref ref-type="bibr" rid="B259">259</xref>, <xref ref-type="bibr" rid="B260">260</xref>), lung (<xref ref-type="bibr" rid="B227">227</xref>, <xref ref-type="bibr" rid="B234">234</xref>), thyroid (<xref ref-type="bibr" rid="B82">82</xref>, <xref ref-type="bibr" rid="B244">244</xref>), pituitary (<xref ref-type="bibr" rid="B179">179</xref>), and urothelial (<xref ref-type="bibr" rid="B245">245</xref>) tumors, pleomorphic adenomas of parotid glands (<xref ref-type="bibr" rid="B83">83</xref>), choroid plexus tumors, and ependymomas in children (<xref ref-type="bibr" rid="B160">160</xref>). In addition, footprints from SV40 DNA have been detected in breast (<xref ref-type="bibr" rid="B84">84</xref>) and colon cancer specimens (<xref ref-type="bibr" rid="B222">222</xref>). Interestingly, DNA sequences belonging to SV40 have also been found in an AIDS patient with a cerebral lesion (<xref ref-type="bibr" rid="B216">216</xref>). More recently, a study conducted with an innovative analysis, known as RNA sequencing (RNA-seq), identified SV40 mRNAs, in tumor samples from low-grade glioma affected patients (<xref ref-type="bibr" rid="B219">219</xref>). Different lympho-proliferative disorders (<xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B239">239</xref>, <xref ref-type="bibr" rid="B254">254</xref>, <xref ref-type="bibr" rid="B255">255</xref>), including non-Hodgkin&#x00027;s lymphoma (<xref ref-type="bibr" rid="B79">79</xref>, <xref ref-type="bibr" rid="B247">247</xref>&#x02013;<xref ref-type="bibr" rid="B251">251</xref>, <xref ref-type="bibr" rid="B260">260</xref>) have also been associated with SV40 infection. It has been reported that the homologous and autologous implantation of SV40-transformed cells in humans caused the growth of nodules, thus suggesting that this PyV presents oncogenic capacity in humans (<xref ref-type="bibr" rid="B261">261</xref>). These studies support an association of human cancers with SV40. These results, obtained mainly by PCR, Southern blot hybridization, DNA sequencing, and immunohistochemistry (IHC) were confirmed by a multi-institutional study (<xref ref-type="bibr" rid="B80">80</xref>), but confuted by another group of investigators (<xref ref-type="bibr" rid="B262">262</xref>). Among SV40-positive tumor types, MPM has been detected as SV40-positive in many investigations (<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B227">227</xref>&#x02013;<xref ref-type="bibr" rid="B233">233</xref>, <xref ref-type="bibr" rid="B235">235</xref>, <xref ref-type="bibr" rid="B238">238</xref>, <xref ref-type="bibr" rid="B240">240</xref>&#x02013;<xref ref-type="bibr" rid="B243">243</xref>, <xref ref-type="bibr" rid="B256">256</xref>&#x02013;<xref ref-type="bibr" rid="B258">258</xref>, <xref ref-type="bibr" rid="B263">263</xref>), while the mechanisms of SV40 oncogenesis have also been studied (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B258">258</xref>, <xref ref-type="bibr" rid="B264">264</xref>, <xref ref-type="bibr" rid="B265">265</xref>). Interestingly, when normal HMC were exposed to both SV40 and asbestos fibers, the transformation rate increased significantly compared to the controls (<xref ref-type="bibr" rid="B9">9</xref>). High exposition to asbestos fibers alone can cause progressive fibrosis (i.e., asbestosis) and in the worse cases, lung cancer (<xref ref-type="bibr" rid="B266">266</xref>) and MPM (<xref ref-type="bibr" rid="B9">9</xref>). Many studies reported the synergistic activities of SV40 and asbestos on MPM development in geographical areas with high levels of asbestos exposure and SV40-contaminated polio vaccines (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B187">187</xref>, <xref ref-type="bibr" rid="B232">232</xref>, <xref ref-type="bibr" rid="B236">236</xref>, <xref ref-type="bibr" rid="B239">239</xref>). High prevalence of SV40 DNA sequences in MPM tissues reflects that relation to SV40-contaminated polio vaccines (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B187">187</xref>, <xref ref-type="bibr" rid="B232">232</xref>, <xref ref-type="bibr" rid="B236">236</xref>, <xref ref-type="bibr" rid="B239">239</xref>). The majority of human cancers mentioned above correspond to tumors, which develop in rodents inoculated with SV40 and in SV40-transgenic mice.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>SV40-positive human tumors.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Tumor type</bold></th>
<th valign="top" align="center" colspan="4" style="border-bottom: thin solid #000000;"><bold>No. of positive samples/total samples analyzed (%)</bold></th>
<th valign="top" align="left"><bold>Technique(s)</bold></th>
<th valign="top" align="left"><bold>References</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>SV40 DNA</bold></th>
<th valign="top" align="center"><bold>SV40 RNA</bold></th>
<th valign="top" align="center"><bold>SV40 protein</bold></th>
<th valign="top" align="center"><bold>Human serum Anti-SV40 Abs</bold></th>
<th/>
<th/>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" colspan="7"><bold>Solid tumors</bold></td>
</tr>
<tr>
<td valign="top" align="left">Breast cancer</td>
<td valign="top" align="center">24/109 (22)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">24/109 (22)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B84">84</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Breast cancer</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">12/78 (15)</td>
<td valign="top" align="left">ELISA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B211">211</xref>)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="7"><bold>Brain tumors</bold></td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Astrocytoma</td>
<td valign="top" align="center">8/35 (23)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">RA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B212">212</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Astrocytoma</td>
<td valign="top" align="center">8/17 (47)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B161">161</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Astrocytoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">11/15 (73)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">IP, SS, WB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B213">213</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Astrocytoma</td>
<td valign="top" align="center">9/28 (32)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B214">214</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Choroid plexus</td>
<td valign="top" align="center">10/20 (50)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">4/5 (80)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB, RA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B160">160</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Choroid plexus</td>
<td valign="top" align="center">10/20 (50)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B215">215</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Choroid plexus</td>
<td valign="top" align="center">5/6 (83)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B161">161</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Choroid plexus</td>
<td valign="top" align="center">6/16 (38)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B214">214</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Cerebral lesion</td>
<td valign="top" align="center">1<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, filter</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B216">216</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Ependymoma</td>
<td valign="top" align="center">10/11 (91)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B215">215</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Ependymoma</td>
<td valign="top" align="center">4/13 (31)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td/>
<td valign="top" align="left">PCR, SB, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B217">217</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Ependymoma</td>
<td valign="top" align="center">8/11 (73)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B161">161</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Ependymoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">8/8 (100)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">IP, SS, WB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B213">213</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Ependymoma</td>
<td valign="top" align="center">10/11 (91)</td>
<td/>
<td valign="top" align="center">3/6 (50)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB, RA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B160">160</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Ependymoma</td>
<td valign="top" align="center">9/16 (56)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B214">214</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Glioma</td>
<td valign="top" align="center">3/20 (15)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td/>
<td valign="top" align="left">PCR, SB, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B217">217</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Glioblastoma</td>
<td valign="top" align="center">10/30 (33)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B161">161</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Glioblastoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">4/8 (50)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">IP, SS, WB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B213">213</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Glioblastoma</td>
<td valign="top" align="center">9/46 (20)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B214">214</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Glioblastoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">15/44 (34)</td>
<td valign="top" align="left">ELISA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B218">218</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Gliosarcoma</td>
<td valign="top" align="center">4/20 (20)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B214">214</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Low grade Astrocytoma</td>
<td valign="top" align="center">13/22 (58)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B214">214</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Low grade Glioma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">40/172 (23)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">RNA-seq</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B219">219</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Meningioma</td>
<td valign="top" align="center">1/7 (14)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B161">161</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Meningioma</td>
<td valign="top" align="center">1<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B220">220</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Various brain tumors<xref ref-type="table-fn" rid="TN2"><sup>&#x00394;</sup></xref></td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">11/32 (34)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left"><italic>In situ</italic> hybridization</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B221">221</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Colon cancer</td>
<td valign="top" align="center">6/94 (6)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, qPCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B222">222</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Nasopharyngeal carcinoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">16/64 (25)</td>
<td valign="top" align="left">ELISA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B223">223</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Osteosarcoma</td>
<td valign="top" align="center">5/10 (50)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B224">224</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Osteosarcoma</td>
<td valign="top" align="center">9/35 (26)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B98">98</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Osteosarcoma</td>
<td valign="top" align="center">54/160 (34)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B215">215</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Osteosarcoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">24/55 (44)</td>
<td valign="top" align="left">ELISA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B225">225</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Osteosarcoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">87/249 (35)</td>
<td valign="top" align="left">ELISA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B190">190</xref>, <xref ref-type="bibr" rid="B280">280</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Osteosarcoma</td>
<td valign="top" align="center">143/277 (52%)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B226">226</xref>)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="7"><bold>Thoracic tumors</bold></td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Adenocarcinoma</td>
<td valign="top" align="center">7/15 (47)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B227">227</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Bronchopulmonary carcinoma</td>
<td valign="top" align="center">18/63 (29)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">0/16 (0)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B227">227</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">10/21 (48)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">0/15 (0)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B227">227</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">3/30 (10)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B228">228</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">5/5 (100)</td>
<td valign="top" align="center">5/6 (83)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, qPCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B229">229</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">29/48 (60)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">13/16 (81)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B230">230</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">12/10 (83)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">12/10 (83)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B80">80</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">4&#x02013;26/26 (15&#x02013;100)<xref ref-type="table-fn" rid="TN3"><sup>&#x00023;</sup></xref></td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B231">231</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">3/19 (16)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">QPCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B232">232</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">15/25 (60)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">15/25 (60)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PRINS, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B233">233</xref>, <xref ref-type="bibr" rid="B234">234</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">4/11&#x02013;0/9 <xref ref-type="table-fn" rid="TN4"><sup>&#x003B3;</sup></xref></td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B235">235</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant mesothelioma</td>
<td valign="top" align="center">8/19 (42.1)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B236">236</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant pleural mesothelioma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">25/97 (26)</td>
<td valign="top" align="left">ELISA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B237">237</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant pleural mesothelioma</td>
<td valign="top" align="center">20/40 (50)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B238">238</xref>, <xref ref-type="bibr" rid="B239">239</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant pleural mesothelioma</td>
<td valign="top" align="center">2/35 (6)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">QPCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B240">240</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant pleural mesothelioma</td>
<td valign="top" align="center">8/18 (45)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">0/18 (0)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B241">241</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant pleural mesothelioma</td>
<td valign="top" align="center">4/9 (45)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B242">242</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Malignant pleural mesothelioma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">9/45 (20)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B81">81</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Pleural/peritoneal mesotheliomas</td>
<td valign="top" align="center">67/118 (57)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B243">243</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">&#x000A0;&#x000A0;Various lung cancers<xref ref-type="table-fn" rid="TN5"><sup>&#x003A3;</sup></xref></td>
<td valign="top" align="center">12/35 (34)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B227">227</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Thyroid tumor</td>
<td valign="top" align="center">3/69 (4)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B244">244</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Thyroid tumor</td>
<td valign="top" align="center">12&#x02013;19/19&#x02013;29 (66&#x02013;100)<xref ref-type="table-fn" rid="TN3"><sup>&#x00023;</sup></xref></td>
<td valign="top" align="center">17/24 (71)</td>
<td valign="top" align="center">11/17</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB, IHC, Sequencing, qPCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B82">82</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Pleomorphic adenoma</td>
<td valign="top" align="center">28/45 (62)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">26/28 (93%)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B83">83</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Pituitary tumor</td>
<td valign="top" align="center">26/30 (87)<xref ref-type="table-fn" rid="TN6"><sup>&#x000A7;</sup></xref></td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">0/18 (0)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B179">179</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Urothelial tumor</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">1<xref ref-type="table-fn" rid="TN1"><sup>&#x0002A;</sup></xref></td>
<td/>
<td valign="top" align="left">IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B245">245</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Urothelial tumor</td>
<td valign="top" align="center">6/18 (42.1)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B236">236</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Uveal Melanoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">16/48 (33)</td>
<td valign="top" align="left">ELISA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B246">246</xref>)</td>
</tr>
<tr>
<td valign="top" align="left" colspan="7"><bold>Liquid tumors</bold></td>
</tr>
<tr>
<td valign="top" align="left">Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">7/43 (16)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">2/7 (28)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B79">79</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">16/54 (30)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">Multiplex Nested PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B238">238</xref>, <xref ref-type="bibr" rid="B247">247</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">2/19 (10)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">2/2 (100)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB, IHC, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B85">85</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">8/58 (14)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B182">182</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">3/29 (10)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B172">172</xref>, <xref ref-type="bibr" rid="B248">248</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">17/42 (40)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B249">249</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">6/36 (17)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B247">247</xref>, <xref ref-type="bibr" rid="B250">250</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">12/55 (22)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">12/12 (100)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B251">251</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">11/79 (14)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">3/11 (27)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, sequencing, IHC</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B79">79</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">36/89&#x02013;26/61 (40,41,42,43)<xref ref-type="table-fn" rid="TN4"><sup>&#x003B3;</sup></xref></td>
<td valign="top" align="left">ELISA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B252">252</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">55/150&#x02013;37/104 (37&#x02013;36)<xref ref-type="table-fn" rid="TN4"><sup>&#x003B3;</sup></xref></td>
<td valign="top" align="left">ELISA</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B195">195</xref>, <xref ref-type="bibr" rid="B197">197</xref>, <xref ref-type="bibr" rid="B253">253</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">85/158 (54)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">Multiplex Nested PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B238">238</xref>, <xref ref-type="bibr" rid="B239">239</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">28/106 (26)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">28/28 (100)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, SB, IHC, sequencing</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B85">85</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">63/108 (56)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B254">254</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Non-Hodgkin&#x00027;s lymphoma</td>
<td valign="top" align="center">38/60 (63)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, qPCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B255">255</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Leukemia</td>
<td valign="top" align="center">22/54 (41)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">Multiplex Nested PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B238">238</xref>, <xref ref-type="bibr" rid="B239">239</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Leukemia</td>
<td valign="top" align="center">16/48 (30)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B249">249</xref>)</td>
</tr>
<tr>
<td valign="top" align="left">Various Leukemias<xref ref-type="table-fn" rid="TN7"><sup>&#x000A5;</sup></xref></td>
<td valign="top" align="center">16/19 (84)</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="center">&#x02013;</td>
<td valign="top" align="left">PCR, qPCR</td>
<td valign="top" align="left">(<xref ref-type="bibr" rid="B255">255</xref>)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>&#x0002A;</label>
<p><italic>Case reports;</italic></p>
</fn>
<fn id="TN2">
<label>&#x00394;</label>
<p><italic>Angiofibroma, astrocytoma, metastatic brain tumors, meningiomas, neurinomas, oligodendrogliomas;</italic></p>
</fn>
<fn id="TN3">
<label>&#x00023;</label>
<p><italic>Different primer set;</italic></p>
</fn>
<fn id="TN4">
<label>&#x003B3;</label>
<p><italic>Two different cohorts;</italic></p>
</fn>
<fn id="TN5">
<label>&#x003A3;</label>
<p><italic>Pleomorphic carcinoma, Neuroendocrine carcinoma, Squamous cell carcinoma, others not specified</italic></p>
</fn>
<fn id="TN6">
<label>&#x000A7;</label>
<p><italic>Polyomaviral primers that hybridized to SV40 and BKPyV internal probes;</italic></p>
</fn>
<fn id="TN7">
<label>&#x000A5;</label>
<p><italic>Bcell acute lymphoblastic leukemia, B-cell precursor acute lymphoblastic leukemia, T-cell acute lymphoblastic leukemia. IP, Immunoprecipitation; SS, Silver staining; WB, Western blot; PCR, Polymerase chain reaction; PRINS, Primed in situ assay (DNA detection); qPCR, real time quantitative PCR; IHC, Immunohistochemistry; RA, restriction analysis</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>It appears that in the same kind of tumor, prevalence of SV40 sequences differs in distinct geographical areas. For example, it has been reported that in the U.S. and Europe 20&#x02013;83% of MPM tested SV40-positive (<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B228">228</xref>, <xref ref-type="bibr" rid="B230">230</xref>, <xref ref-type="bibr" rid="B235">235</xref>, <xref ref-type="bibr" rid="B236">236</xref>, <xref ref-type="bibr" rid="B249">249</xref>), while sequences of this PyV in MPM from Turkey and Austria have never been detected (<xref ref-type="bibr" rid="B235">235</xref>, <xref ref-type="bibr" rid="B267">267</xref>), or detected with low frequency, as in Sweden (<xref ref-type="bibr" rid="B228">228</xref>). Similarly, the prevalence SV40 DNA detected in bone tumors is different for example in Hungary (74%) and Germany (24%) (<xref ref-type="bibr" rid="B226">226</xref>). In addition, SV40-positive MPMs were found in two different studies in Japan with a prevalence ranging between 6 and 44% (<xref ref-type="bibr" rid="B241">241</xref>, <xref ref-type="bibr" rid="B268">268</xref>), whereas another investigation conducted in a cohort of Vietnamese MPM patients detected 20% SV40-positive tumors (<xref ref-type="bibr" rid="B81">81</xref>).</p>
<p>The association between SV40 and human tumors is based on results obtained by many investigators (<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B213">213</xref>, <xref ref-type="bibr" rid="B218">218</xref>, <xref ref-type="bibr" rid="B220">220</xref>, <xref ref-type="bibr" rid="B225">225</xref>, <xref ref-type="bibr" rid="B227">227</xref>, <xref ref-type="bibr" rid="B230">230</xref>, <xref ref-type="bibr" rid="B234">234</xref>, <xref ref-type="bibr" rid="B255">255</xref>, <xref ref-type="bibr" rid="B256">256</xref>). Most of these studies detected SV40 DNA sequences, using qualitative PCR techniques, in tumor specimens. However, these assays do not provide the quantification of SV40 DNA as a copy number, nor investigated the physical state of the viral DNA, i.e., integrated and/or episomal (<xref ref-type="bibr" rid="B96">96</xref>, <xref ref-type="bibr" rid="B98">98</xref>). In other studies SV40 mRNA and/or Tag/tag oncoproteins were analyzed in tumors (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B160">160</xref>, <xref ref-type="bibr" rid="B219">219</xref>), or quantified the amount of SV40 DNA sequences via qPCR methods (<xref ref-type="bibr" rid="B240">240</xref>, <xref ref-type="bibr" rid="B268">268</xref>, <xref ref-type="bibr" rid="B269">269</xref>). The majority of these qualitative/quantitative assays (<xref ref-type="table" rid="T2">Table 2</xref>) were carried out targeting different SV40 Tag sequences. Together with these sequences, other SV40 regions were PCR analyzed, including the control region and late gene sequences (<xref ref-type="bibr" rid="B181">181</xref>, <xref ref-type="bibr" rid="B220">220</xref>). These data indicate that SV40 DNA regions detected in human tumors were not due to PCR contaminations with recombinant plasmids carrying SV40 Tag sequences. In addition, in studies based on IHC staining, the localization of the SV40 Tag in the SV40-infected cell is shown (<xref ref-type="bibr" rid="B79">79</xref>&#x02013;<xref ref-type="bibr" rid="B85">85</xref>). Studies carried out on SV40 Tag-positive cells demonstrated that the cell transformation is related to the activation of specific autocrine/paracrine loops. In this context, different growth factors and their receptors were analyzed, such as HGF and its receptor (HGFR or Met) (<xref ref-type="bibr" rid="B44">44</xref>), the vascular endothelial growth factor (VEGF) and its receptor (VEGFR) (<xref ref-type="bibr" rid="B270">270</xref>, <xref ref-type="bibr" rid="B271">271</xref>) as well as (IGF-1) and its receptor, in T-antigen-mediated growth (<xref ref-type="bibr" rid="B272">272</xref>, <xref ref-type="bibr" rid="B273">273</xref>). Concordant data were reported on the ability of the SV40 Tag to induce growth factor receptor/growth factor loops, which in turn stimulates cell-cycle progression into the S phase. These results suggest that a few cells, found to be SV40-positive, induce SV40-negative cells on the microenvironment toward the transformation. The SV40-infected cells have also been determined by several <italic>in vitro</italic> studies (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B58">58</xref>&#x02013;<xref ref-type="bibr" rid="B65">65</xref>). Different hypotheses have been formulated on the mechanisms of SV40 carcinogenesis in human, including the &#x0201C;hit and run mechanism&#x0201D; which has been investigated in transgenic mice (<xref ref-type="bibr" rid="B274">274</xref>). However, this hypothesis cannot be proven in humans. Most of the reports mentioned above are related to association studies in which the causative role of SV40 in inducing human tumors cannot be proven. It is plausible that this PyV may act as a co-factor during the tumorigenic process, either during the early phase of oncogenesis or in the late phase of tumor progression. Indeed, as for other viruses (<xref ref-type="bibr" rid="B17">17</xref>), in normal physiological conditions, the immune system counteracts the oncogenic potential of SV40 (<xref ref-type="bibr" rid="B194">194</xref>) whose infection could be acquired early in life (<xref ref-type="bibr" rid="B190">190</xref>, <xref ref-type="bibr" rid="B193">193</xref>). However, in certain host conditions, such as in immunocompromised individuals, SV40 may exert its oncogenic activities. It is also possible that SV40 acts in a late phase when the cell is already transformed. In these pre-neoplastic cells SV40 Tag/tag expression could favor full transformation. Further studies may clarify this important aspect.</p>
<p>Some studies have reported negative data on an association between human tumors and SV40 (<xref ref-type="bibr" rid="B235">235</xref>, <xref ref-type="bibr" rid="B263">263</xref>, <xref ref-type="bibr" rid="B274">274</xref>&#x02013;<xref ref-type="bibr" rid="B277">277</xref>). These investigations have shown neither viral DNA (or SV40 DNA at low prevalence) nor viral oncoproteins and miRNAs in the same tumor types found to be SV40-positive in other studies (<xref ref-type="bibr" rid="B240">240</xref>, <xref ref-type="bibr" rid="B248">248</xref>, <xref ref-type="bibr" rid="B275">275</xref>&#x02013;<xref ref-type="bibr" rid="B278">278</xref>). This is an important issue that has fueled the controversy about SV40 in humans and in human tumors (<xref ref-type="bibr" rid="B262">262</xref>). It is important to point out, however, that a SV40 prevalence of about 5% was shown in those studies, even if it was considered statistically no-significant in considering SV40 a risk factor for human cancers (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B240">240</xref>, <xref ref-type="bibr" rid="B262">262</xref>). Another relevant issue was highlighted by Lopez-Rios et al. who evidenced the risk of false-positive PCR results accountable by plasmids carrying SV40 sequences circulating in common laboratories, thereby creating overly-high positive rates (<xref ref-type="bibr" rid="B262">262</xref>). Negative results have also been published in another independent report from Aaronson and colleagues, reaching similar conclusions (<xref ref-type="bibr" rid="B279">279</xref>). Indeed, this study shows no evidence for Tag antigen expression in a series of MPM tumors and derived cell lines (<xref ref-type="bibr" rid="B279">279</xref>). For this reason, over time, molecular techniques/protocols have been used ever-more carefully in order to prevent false-positive results, while still revealing any case evidence of SV40 infection in humans and human cancers (<xref ref-type="bibr" rid="B270">270</xref>, <xref ref-type="bibr" rid="B276">276</xref>). The different assays employed to isolate DNA from tumor tissues affecting the results is also considered as an explanation for this discrepancy (<xref ref-type="bibr" rid="B79">79</xref>). Indeed, several commercial kits prevent the isolation of SV40 DNA that is lower than 5.2 kb in length, i.e., too small. Furthermore, SV40 DNA can be amplified with certain sets of primers but not with others (<xref ref-type="bibr" rid="B160">160</xref>, <xref ref-type="bibr" rid="B230">230</xref>). In summary, further studies with new approaches are needed to clarify these conflicting results and to address the role of SV40 in human cancers.</p>
<p>To better elucidate these controversies, novel indirect ELISA tests employing synthetic peptides as mimotopes/specific SV40 antigens were set up (<xref ref-type="bibr" rid="B191">191</xref>, <xref ref-type="bibr" rid="B192">192</xref>). These immunological and specific assays established that anti-SV40 antibodies can be revealed in human sera from patients affected by different tumors (<xref ref-type="bibr" rid="B211">211</xref>, <xref ref-type="bibr" rid="B218">218</xref>, <xref ref-type="bibr" rid="B223">223</xref>, <xref ref-type="bibr" rid="B225">225</xref>, <xref ref-type="bibr" rid="B237">237</xref>, <xref ref-type="bibr" rid="B246">246</xref>, <xref ref-type="bibr" rid="B252">252</xref>, <xref ref-type="bibr" rid="B253">253</xref>, <xref ref-type="bibr" rid="B280">280</xref>, <xref ref-type="bibr" rid="B281">281</xref>), of the same kind found to be SV40-positive by molecular biology techniques. A significantly higher SV40 antibody prevalence was detected in sera from MPM, glioblastoma multiforme, osteosarcoma, and non-Hodgkin&#x00027;s lymphoma patients compared to age-/gender-matched healthy subjects (<xref ref-type="bibr" rid="B218">218</xref>, <xref ref-type="bibr" rid="B225">225</xref>, <xref ref-type="bibr" rid="B237">237</xref>, <xref ref-type="bibr" rid="B252">252</xref>, <xref ref-type="bibr" rid="B253">253</xref>, <xref ref-type="bibr" rid="B280">280</xref>).</p>
</sec>
<sec id="s9">
<title>Association of SV40 With Human Non-Malignant Diseases</title>
<p>Many reports have suggested that the kidney could be the main site for SV40 latency in humans as it occurs in monkeys, that are the natural animal host (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B189">189</xref>). For this reason, an association between SV40 infection and kidney-related diseases was investigated. DNA sequences from this PyV were found in renal tubular epithelial cells nuclei, PBMCs and renal biopsies derived from patients affected by focal segmental glomerulosclerosis, thus suggesting the possible involvement of SV40 in kidney diseases (<xref ref-type="bibr" rid="B184">184</xref>). This assumption has been further strengthened through the isolation of SV40 virions in co-cultured urine sediment cells from a nephropathy-affected patient with CV-1 cells, which are SV40 permissive cells derived from monkeys (<xref ref-type="bibr" rid="B183">183</xref>). Furthermore, molecular evidence that SV40/BKPyV co-infection occurs in patients with post-transplantation interstitial nephritis has also been reported, suggesting that SV40 may contribute to this disease after the renal transplant in cooperation with BKPyV (<xref ref-type="bibr" rid="B183">183</xref>). Other studies indicate that SV40 seems to be associated with neurological diseases, including multiple sclerosis (<xref ref-type="bibr" rid="B281">281</xref>&#x02013;<xref ref-type="bibr" rid="B283">283</xref>). DNA sequences from SV40 have also been detected in allografts from immunocompromised pediatric renal transplant recipients and in the kidneys of young adult lung-transplant patients (<xref ref-type="bibr" rid="B162">162</xref>, <xref ref-type="bibr" rid="B284">284</xref>). Therefore, it is reasonable to propose that a weak immune system, typical of transplant recipients subjected to iatrogenic immunosuppression, could be a risk factor for SV40 infection, as for other PyVs (<xref ref-type="bibr" rid="B17">17</xref>).</p>
</sec>
<sec sec-type="conclusions" id="s10">
<title>Conclusions</title>
<p>SV40 infection in different human populations worldwide has been reported by many groups (<xref ref-type="bibr" rid="B160">160</xref>&#x02013;<xref ref-type="bibr" rid="B164">164</xref>). Indeed, SV40 DNA sequences were detected in normal tissues, such as PBMCs (<xref ref-type="bibr" rid="B161">161</xref>, <xref ref-type="bibr" rid="B182">182</xref>, <xref ref-type="bibr" rid="B187">187</xref>), leukocytes from organ and blood donors (<xref ref-type="bibr" rid="B180">180</xref>, <xref ref-type="bibr" rid="B181">181</xref>), and pituitary tissues (<xref ref-type="bibr" rid="B179">179</xref>). Specific immunological assays identified IgG and IgM antibodies against SV40 VPs and Tag in sera from normal children, adults and elderly subjects (<xref ref-type="bibr" rid="B190">190</xref>, <xref ref-type="bibr" rid="B191">191</xref>, <xref ref-type="bibr" rid="B193">193</xref>, <xref ref-type="bibr" rid="B194">194</xref>). In addition, SV40 neutralizing antibodies were detected, in different investigations, using the plaque reduction assay, which is a high specific test demonstrating that the SV40 infection occurred in subjects/patients (<xref ref-type="bibr" rid="B203">203</xref>, <xref ref-type="bibr" rid="B210">210</xref>, <xref ref-type="bibr" rid="B285">285</xref>). These data cumulatively indicate that SV40, or a closely related polyomavirus, is circulating in humans. Conflicting results have been published on the association between different human tumors and SV40. Although this oncogenic PyV was previously associated with a broad range of tumor types including brain (<xref ref-type="bibr" rid="B213">213</xref>, <xref ref-type="bibr" rid="B220">220</xref>, <xref ref-type="bibr" rid="B234">234</xref>) and bone tumors (<xref ref-type="bibr" rid="B98">98</xref>), MPMs (<xref ref-type="bibr" rid="B80">80</xref>, <xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B227">227</xref>, <xref ref-type="bibr" rid="B230">230</xref>), and different lymphoproliferative disorders (<xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B239">239</xref>, <xref ref-type="bibr" rid="B249">249</xref>, <xref ref-type="bibr" rid="B254">254</xref>), other investigators reported negative results when analyzing the same tumor types (<xref ref-type="bibr" rid="B238">238</xref>, <xref ref-type="bibr" rid="B275">275</xref>&#x02013;<xref ref-type="bibr" rid="B279">279</xref>). In addition, these studies are mainly based on the detection of viral DNA. Other works carried out in tumor specimens investigated, to a lesser extent, the viral DNA status (integrated or/and episomal), mRNA, and the expression of viral oncoproteins (<xref ref-type="bibr" rid="B84">84</xref>, <xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B213">213</xref>, <xref ref-type="bibr" rid="B219">219</xref>). Immunological studies detected specific antibodies against SV40 in sera from tumor affected patients (<xref ref-type="bibr" rid="B218">218</xref>, <xref ref-type="bibr" rid="B225">225</xref>, <xref ref-type="bibr" rid="B237">237</xref>, <xref ref-type="bibr" rid="B252">252</xref>, <xref ref-type="bibr" rid="B280">280</xref>).</p>
<p>The existence of an SV40-like human polyomavirus, which is still unknown, cannot be ruled out. Recently, a new lymphotropic polyomavirus (HPyV9) was identified in humans (<xref ref-type="bibr" rid="B286">286</xref>). It turned out that HPyV9 has great homology with the monkey LPyV, which has been known since the 1960s (<xref ref-type="bibr" rid="B287">287</xref>).</p>
<p>The role of SV40 in human tumors, if any, remains to be proven. This is an important issue and certainly deserves further attention with detailed and innovative investigations.</p>
</sec>
<sec id="s11">
<title>Author Contributions</title>
<p>JR: data collection from the literature, writing, and figure preparation. EM and IB: data collection from the literature and figure preparation. MT and FM: manuscript revision.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sweet</surname> <given-names>BH</given-names></name> <name><surname>Hilleman</surname> <given-names>MR</given-names></name></person-group>. <article-title>The vacuolating virus, S.V. 40</article-title>. <source>Proc Soc Exp Biol Med.</source> (<year>1960</year>) <volume>105</volume>:<fpage>420</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.3181/00379727-105-26128</pub-id><pub-id pub-id-type="pmid">13774265</pub-id></citation></ref>
<ref id="B2">
<label>2.</label>
<citation citation-type="journal"><person-group person-group-type="author"><collab>Polyomaviridae Study Group of the International Committee on Taxonomy of Viruses</collab> <name><surname>Calvignac-Spencer</surname> <given-names>S</given-names></name> <name><surname>Feltkamp</surname> <given-names>MCW</given-names></name> <name><surname>Daugherty</surname> <given-names>MD</given-names></name> <name><surname>Moens</surname> <given-names>U</given-names></name> <name><surname>Ramqvist</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>A taxonomy update for the family Polyomaviridae</article-title>. <source>Arch Virol.</source> (<year>2016</year>) <volume>161</volume>:<fpage>1739</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/s00705-016-2794-y</pub-id><pub-id pub-id-type="pmid">26923930</pub-id></citation></ref>
<ref id="B3">
<label>3.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalili</surname> <given-names>K</given-names></name> <name><surname>Sariyer</surname> <given-names>IK</given-names></name> <name><surname>Safak</surname> <given-names>M</given-names></name></person-group>. <article-title>Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation</article-title>. <source>J Cell Physiol</source>. (<year>2008</year>) <volume>215</volume>:<fpage>309</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.21326</pub-id><pub-id pub-id-type="pmid">18022798</pub-id></citation></ref>
<ref id="B4">
<label>4.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;Neill</surname> <given-names>FJ</given-names></name> <name><surname>Carroll</surname> <given-names>D</given-names></name></person-group>. <article-title>Amplification of papovavirus defectives during serial low multiplicity infections</article-title>. <source>Virology</source>. (<year>1981</year>) <volume>112</volume>:<fpage>800</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1016/0042-6822(81)90330-5</pub-id><pub-id pub-id-type="pmid">6266155</pub-id></citation></ref>
<ref id="B5">
<label>5.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diamandopoulos</surname> <given-names>GT</given-names></name></person-group>. <article-title>Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40</article-title>. <source>Science</source>. (<year>1972</year>) <volume>176</volume>:<fpage>173</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1126/science.176.4031.173</pub-id><pub-id pub-id-type="pmid">4335386</pub-id></citation></ref>
<ref id="B6">
<label>6.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Coe</surname> <given-names>JE</given-names></name> <name><surname>Green</surname> <given-names>I</given-names></name></person-group>. <article-title>B-cell origin of hamster lymphoid tumors induced by simian virus 40</article-title>. <source>J Natl Cancer Inst.</source> (<year>1975</year>) <volume>54</volume>:<fpage>269</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1093/jnci/54.1.269</pub-id><pub-id pub-id-type="pmid">163322</pub-id></citation></ref>
<ref id="B7">
<label>7.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cicala</surname> <given-names>C</given-names></name> <name><surname>Avantaggiati</surname> <given-names>ML</given-names></name> <name><surname>Graessmann</surname> <given-names>A</given-names></name> <name><surname>Rundell</surname> <given-names>K</given-names></name> <name><surname>Levine</surname> <given-names>AS</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name></person-group>. <article-title>Simian virus 40 small-t antigen stimulates viral DNA replication in permissive monkey cells</article-title>. <source>J Virol.</source> (<year>1994</year>) <volume>68</volume>:<fpage>3138</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="pmid">8151779</pub-id></citation></ref>
<ref id="B8">
<label>8.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname> <given-names>A</given-names></name> <name><surname>Itoh</surname> <given-names>N</given-names></name> <name><surname>Li</surname> <given-names>PP</given-names></name> <name><surname>Handa</surname> <given-names>H</given-names></name> <name><surname>Liddington</surname> <given-names>RC</given-names></name> <name><surname>Kasamatsu</surname> <given-names>H</given-names></name></person-group>. <article-title>Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome</article-title>. <source>J Virol.</source> (<year>2007</year>) <volume>81</volume>:<fpage>3778</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02664-06</pub-id><pub-id pub-id-type="pmid">17267496</pub-id></citation></ref>
<ref id="B9">
<label>9.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname> <given-names>F</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name> <name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Gaudino</surname> <given-names>G</given-names></name></person-group>. <article-title>Simian virus 40 transformation, malignant mesothelioma and brain tumors</article-title>. <source>Expert Rev Respir Med.</source> (<year>2011</year>) <volume>5</volume>:<fpage>683</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1586/ers.11.51</pub-id><pub-id pub-id-type="pmid">21955238</pub-id></citation></ref>
<ref id="B10">
<label>10.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Candian</surname> <given-names>T</given-names></name> <name><surname>Selvatici</surname> <given-names>R</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Bonaccorsi</surname> <given-names>G</given-names></name> <name><surname>Greco</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Tracing males from different continents by genotyping JC polyomavirus in DNA from semen samples</article-title>. <source>J Cell Physiol.</source> (<year>2017</year>) <volume>232</volume>:<fpage>982</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.25686</pub-id><pub-id pub-id-type="pmid">27859215</pub-id></citation></ref>
<ref id="B11">
<label>11.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frisque</surname> <given-names>RJ</given-names></name> <name><surname>Bream</surname> <given-names>GL</given-names></name> <name><surname>Cannella</surname> <given-names>MT</given-names></name></person-group>. <article-title>Human polyomavirus JC virus genome</article-title>. <source>J Virol.</source> (<year>1984</year>) <volume>51</volume>:<fpage>458</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="pmid">6086957</pub-id></citation></ref>
<ref id="B12">
<label>12.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tagliapietra</surname> <given-names>A</given-names></name> <name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Bononi</surname> <given-names>I</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Magagnoli</surname> <given-names>F</given-names></name> <name><surname>Maritati</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Footprints of BK and JC Polyomavirus in specimens from females affected by spontaneous abortion</article-title>. <source>Hum Reprod</source>. (<year>2018</year>) <volume>34</volume>:<fpage>433</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dey375</pub-id></citation></ref>
<ref id="B13">
<label>13.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>RC</given-names></name> <name><surname>Wu</surname> <given-names>R</given-names></name></person-group>. <article-title>BK virus DNA: complete nucleotide sequence of a human tumor virus</article-title>. <source>Science</source>. (<year>1979</year>) <volume>206</volume>:<fpage>456</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1126/science.228391</pub-id><pub-id pub-id-type="pmid">228391</pub-id></citation></ref>
<ref id="B14">
<label>14.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schowalter</surname> <given-names>RM</given-names></name> <name><surname>Pastrana</surname> <given-names>DV</given-names></name> <name><surname>Pumphrey</surname> <given-names>KA</given-names></name> <name><surname>Moyer</surname> <given-names>AL</given-names></name> <name><surname>Buck</surname> <given-names>CB</given-names></name></person-group>. <article-title>Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin</article-title>. <source>Cell Host Microbe</source>. (<year>2010</year>) <volume>7</volume>:<fpage>509</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2010.05.006</pub-id><pub-id pub-id-type="pmid">20542254</pub-id></citation></ref>
<ref id="B15">
<label>15.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siebrasse</surname> <given-names>EA</given-names></name> <name><surname>Reyes</surname> <given-names>A</given-names></name> <name><surname>Lim</surname> <given-names>ES</given-names></name> <name><surname>Zhao</surname> <given-names>G</given-names></name> <name><surname>Mkakosya</surname> <given-names>RS</given-names></name> <name><surname>Manary</surname> <given-names>MJ</given-names></name> <etal/></person-group>. <article-title>Identification of MW polyomavirus, a novel polyomavirus in human stool</article-title>. <source>J Virol.</source> (<year>2012</year>) <volume>86</volume>:<fpage>10321</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01210-12</pub-id><pub-id pub-id-type="pmid">22740408</pub-id></citation></ref>
<ref id="B16">
<label>16.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname> <given-names>ES</given-names></name> <name><surname>Reyes</surname> <given-names>A</given-names></name> <name><surname>Antonio</surname> <given-names>M</given-names></name> <name><surname>Saha</surname> <given-names>D</given-names></name> <name><surname>Ikumapayi</surname> <given-names>UN</given-names></name> <name><surname>Adeyemi</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing</article-title>. <source>Virology</source>. (<year>2013</year>) <volume>436</volume>:<fpage>295</fpage>&#x02013;<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2012.12.005</pub-id><pub-id pub-id-type="pmid">23276405</pub-id></citation></ref>
<ref id="B17">
<label>17.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Bononi</surname> <given-names>I</given-names></name> <name><surname>Puozzo</surname> <given-names>A</given-names></name> <name><surname>Govoni</surname> <given-names>M</given-names></name> <name><surname>Foschi</surname> <given-names>V</given-names></name> <name><surname>Lanza</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Merkel cell carcinomas arising in autoimmune disease affected patients treated with biologic drugs, including anti-TNF</article-title>. <source>Clin Cancer Res</source>. (<year>2017</year>) <volume>23</volume>:<fpage>3929</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-16-2899</pub-id><pub-id pub-id-type="pmid">28174236</pub-id></citation></ref>
<ref id="B18">
<label>18.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Marracino</surname> <given-names>L</given-names></name> <name><surname>Selvatici</surname> <given-names>R</given-names></name> <name><surname>Bononi</surname> <given-names>I</given-names></name> <name><surname>Torreggiani</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Detection of merkel cell polyomavirus DNA in serum samples of healthy blood donors</article-title>. <source>Front Oncol.</source> (<year>2017</year>) <volume>7</volume>:<fpage>294</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2017.00294</pub-id><pub-id pub-id-type="pmid">29238698</pub-id></citation></ref>
<ref id="B19">
<label>19.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>H</given-names></name> <name><surname>Shuda</surname> <given-names>M</given-names></name> <name><surname>Chang</surname> <given-names>Y</given-names></name> <name><surname>Moore</surname> <given-names>PS</given-names></name></person-group>. <article-title>Clonal integration of a polyomavirus in human Merkel cell carcinoma</article-title>. <source>Science</source>. (<year>2008</year>) <volume>319</volume>:<fpage>1096</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1126/science.1152586</pub-id><pub-id pub-id-type="pmid">18202256</pub-id></citation></ref>
<ref id="B20">
<label>20.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comerford</surname> <given-names>SA</given-names></name> <name><surname>Schultz</surname> <given-names>N</given-names></name> <name><surname>Hinnant</surname> <given-names>EA</given-names></name> <name><surname>Klapproth</surname> <given-names>S</given-names></name> <name><surname>Hammer</surname> <given-names>RE</given-names></name></person-group>. <article-title>Comparative analysis of SV40 17kT and LT function <italic>in vivo</italic> demonstrates that LT&#x00027;s C-terminus re-programs hepatic gene expression and is necessary for tumorigenesis in the liver</article-title>. <source>Oncogenesis</source>. (<year>2012</year>) <volume>1</volume>:<fpage>e28</fpage>. <pub-id pub-id-type="doi">10.1038/oncsis.2012.27</pub-id><pub-id pub-id-type="pmid">23552841</pub-id></citation></ref>
<ref id="B21">
<label>21.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalili</surname> <given-names>K</given-names></name> <name><surname>Brady</surname> <given-names>J</given-names></name> <name><surname>Khoury</surname> <given-names>G</given-names></name></person-group>. <article-title>Translational regulation of SV40 early mRNA defines a new viral protein</article-title>. <source>Cell</source>. (<year>1987</year>) <volume>48</volume>:<fpage>639</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(87)90242-X</pub-id><pub-id pub-id-type="pmid">3028644</pub-id></citation></ref>
<ref id="B22">
<label>22.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname> <given-names>JP</given-names></name> <name><surname>Griffith</surname> <given-names>DL</given-names></name> <name><surname>Rayment</surname> <given-names>I</given-names></name> <name><surname>Murakami</surname> <given-names>WT</given-names></name> <name><surname>Caspar</surname> <given-names>DL</given-names></name></person-group>. <article-title>Inside polyomavirus at 25-A resolution</article-title>. <source>Nature</source>. (<year>1992</year>) <volume>355</volume>:<fpage>652</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/355652a0</pub-id><pub-id pub-id-type="pmid">1311415</pub-id></citation></ref>
<ref id="B23">
<label>23.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawano</surname> <given-names>M</given-names></name> <name><surname>Doi</surname> <given-names>K</given-names></name> <name><surname>Fukuda</surname> <given-names>H</given-names></name> <name><surname>Kita</surname> <given-names>Y</given-names></name> <name><surname>Imai</surname> <given-names>K</given-names></name> <name><surname>Inoue</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>SV40 VP1 major capsid protein in its self-assembled form allows VP1 pentamers to coat various types of artificial beads <italic>in vitro</italic> regardless of their sizes and shapes</article-title>. <source>Biotechnol Rep</source>. (<year>2015</year>) <volume>5</volume>:<fpage>105</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.btre.2014.12.008</pub-id><pub-id pub-id-type="pmid">28435806</pub-id></citation></ref>
<ref id="B24">
<label>24.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daniels</surname> <given-names>R</given-names></name> <name><surname>Sadowicz</surname> <given-names>D</given-names></name> <name><surname>Hebert</surname> <given-names>DN</given-names></name></person-group>. <article-title>A very late viral protein triggers the lytic release of SV40</article-title>. <source>PLoS Pathog</source>. (<year>2007</year>) <volume>3</volume>:<fpage>e98</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.0030098</pub-id><pub-id pub-id-type="pmid">17658947</pub-id></citation></ref>
<ref id="B25">
<label>25.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henriksen</surname> <given-names>S</given-names></name> <name><surname>Hansen</surname> <given-names>T</given-names></name> <name><surname>Bruun</surname> <given-names>J-A</given-names></name> <name><surname>Rinaldo</surname> <given-names>CH</given-names></name></person-group>. <article-title>The presumed polyomavirus viroporin VP4 of simian virus 40 or human BK polyomavirus is not required for viral progeny release</article-title>. <source>J Virol.</source> (<year>2016</year>) <volume>90</volume>:<fpage>10398</fpage>&#x02013;<lpage>413</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01326-16</pub-id></citation></ref>
<ref id="B26">
<label>26.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saribas</surname> <given-names>AS</given-names></name> <name><surname>Coric</surname> <given-names>P</given-names></name> <name><surname>Bouaziz</surname> <given-names>S</given-names></name> <name><surname>Safak</surname> <given-names>M</given-names></name></person-group>. <article-title>Expression of novel proteins by polyomaviruses and recent advances in the structural and functional features of agnoprotein of JC virus, BK virus, and simian virus 40</article-title>. <source>J Cell Physiol</source>. (<year>2018</year>) <volume>234</volume>:<fpage>8295</fpage>&#x02013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.27715</pub-id><pub-id pub-id-type="pmid">30390301</pub-id></citation></ref>
<ref id="B27">
<label>27.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>CS</given-names></name> <name><surname>Grundhoff</surname> <given-names>AT</given-names></name> <name><surname>Tevethia</surname> <given-names>S</given-names></name> <name><surname>Pipas</surname> <given-names>JM</given-names></name> <name><surname>Ganem</surname> <given-names>D</given-names></name></person-group>. <article-title>SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells</article-title>. <source>Nature</source>. (<year>2005</year>) <volume>435</volume>:<fpage>682</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1038/nature03576</pub-id><pub-id pub-id-type="pmid">15931223</pub-id></citation></ref>
<ref id="B28">
<label>28.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campanero-Rhodes</surname> <given-names>MA</given-names></name> <name><surname>Smith</surname> <given-names>A</given-names></name> <name><surname>Chai</surname> <given-names>W</given-names></name> <name><surname>Sonnino</surname> <given-names>S</given-names></name> <name><surname>Mauri</surname> <given-names>L</given-names></name> <name><surname>Childs</surname> <given-names>RA</given-names></name> <etal/></person-group>. <article-title>N-glycolyl GM1 ganglioside as a receptor for simian virus 40</article-title>. <source>J Virol</source>. (<year>2007</year>) <volume>81</volume>:<fpage>12846</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01311-07</pub-id><pub-id pub-id-type="pmid">17855525</pub-id></citation></ref>
<ref id="B29">
<label>29.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atwood</surname> <given-names>WJ</given-names></name> <name><surname>Norkin</surname> <given-names>LC</given-names></name></person-group>. <article-title>Class I major histocompatibility proteins as cell surface receptors for simian virus 40</article-title>. <source>J Virol</source>. (<year>1989</year>) <volume>63</volume>:<fpage>4474</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="pmid">2476575</pub-id></citation></ref>
<ref id="B30">
<label>30.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>HA</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Norkin</surname> <given-names>LC</given-names></name></person-group>. <article-title>Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae</article-title>. <source>Mol Biol Cell</source>. (<year>1996</year>) <volume>7</volume>:<fpage>1825</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.7.11.1825</pub-id><pub-id pub-id-type="pmid">8930903</pub-id></citation></ref>
<ref id="B31">
<label>31.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname> <given-names>Y</given-names></name> <name><surname>Motamedi</surname> <given-names>N</given-names></name> <name><surname>Magaldi</surname> <given-names>TG</given-names></name> <name><surname>Gee</surname> <given-names>GV</given-names></name> <name><surname>Atwood</surname> <given-names>WJ</given-names></name> <name><surname>DiMaio</surname> <given-names>D</given-names></name></person-group>. <article-title>Interaction between simian virus 40 major capsid protein VP1 and cell surface ganglioside GM1 triggers vacuole formation</article-title>. <source>MBio</source>. (<year>2016</year>) <volume>7</volume>:<fpage>e00297</fpage>. <pub-id pub-id-type="doi">10.1128/mBio.00297-16</pub-id><pub-id pub-id-type="pmid">27006465</pub-id></citation></ref>
<ref id="B32">
<label>32.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pelkmans</surname> <given-names>L</given-names></name> <name><surname>Kartenbeck</surname> <given-names>J</given-names></name> <name><surname>Helenius</surname> <given-names>A</given-names></name></person-group>. <article-title>Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER</article-title>. <source>Nat Cell Biol</source>. (<year>2001</year>) <volume>3</volume>:<fpage>473</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1038/35074539</pub-id><pub-id pub-id-type="pmid">11331875</pub-id></citation></ref>
<ref id="B33">
<label>33.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engel</surname> <given-names>S</given-names></name> <name><surname>Heger</surname> <given-names>T</given-names></name> <name><surname>Mancini</surname> <given-names>R</given-names></name> <name><surname>Herzog</surname> <given-names>F</given-names></name> <name><surname>Kartenbeck</surname> <given-names>J</given-names></name> <name><surname>Hayer</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Role of endosomes in simian virus 40 entry and infection</article-title>. <source>J Virol.</source> (<year>2011</year>) <volume>85</volume>:<fpage>4198</fpage>&#x02013;<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02179-10</pub-id><pub-id pub-id-type="pmid">21345959</pub-id></citation></ref>
<ref id="B34">
<label>34.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname> <given-names>A</given-names></name> <name><surname>Shum</surname> <given-names>D</given-names></name> <name><surname>Morioka</surname> <given-names>H</given-names></name> <name><surname>Otsuka</surname> <given-names>E</given-names></name> <name><surname>Kasamatsu</surname> <given-names>H</given-names></name></person-group>. <article-title>Interaction of the Vp3 nuclear localization signal with the importin alpha 2/beta heterodimer directs nuclear entry of infecting simian virus 40</article-title>. <source>J Virol</source>. (<year>2002</year>) <volume>76</volume>:<fpage>9368</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.76.18.9368-9377.2002</pub-id><pub-id pub-id-type="pmid">12186919</pub-id></citation></ref>
<ref id="B35">
<label>35.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname> <given-names>A</given-names></name> <name><surname>Clever</surname> <given-names>J</given-names></name> <name><surname>Yamada</surname> <given-names>M</given-names></name> <name><surname>Li</surname> <given-names>PP</given-names></name> <name><surname>Kasamatsu</surname> <given-names>H</given-names></name></person-group>. <article-title>Association with capsid proteins promotes nuclear targeting of simian virus 40 DNA</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1996</year>) <volume>93</volume>:<fpage>96</fpage>&#x02013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.93.1.96</pub-id><pub-id pub-id-type="pmid">8552683</pub-id></citation></ref>
<ref id="B36">
<label>36.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname> <given-names>K</given-names></name> <name><surname>Keiser</surname> <given-names>S</given-names></name> <name><surname>G&#x000FC;nther</surname> <given-names>V</given-names></name> <name><surname>Georgiev</surname> <given-names>O</given-names></name> <name><surname>Hirsch</surname> <given-names>HH</given-names></name> <name><surname>Schaffner</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Transcription enhancers as major determinants of SV40 polyomavirus growth efficiency and host cell tropism</article-title>. <source>J Gen Virol</source>. (<year>2016</year>) <volume>97</volume>:<fpage>1597</fpage>&#x02013;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1099/jgv.0.000487</pub-id><pub-id pub-id-type="pmid">27100458</pub-id></citation></ref>
<ref id="B37">
<label>37.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeCaprio</surname> <given-names>JA</given-names></name> <name><surname>Garcea</surname> <given-names>RL</given-names></name></person-group>. <article-title>A cornucopia of human polyomaviruses</article-title>. <source>Nat Rev Microbiol</source>. (<year>2013</year>) <volume>11</volume>:<fpage>264</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2992</pub-id><pub-id pub-id-type="pmid">23474680</pub-id></citation></ref>
<ref id="B38">
<label>38.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gazdar</surname> <given-names>AF</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name></person-group>. <article-title>SV40 and human tumours: myth, association or causality?</article-title> <source>Nat Rev Cancer</source>. (<year>2002</year>) <volume>2</volume>:<fpage>957</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1038/nrc947</pub-id></citation></ref>
<ref id="B39">
<label>39.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiley</surname> <given-names>SR</given-names></name> <name><surname>Kraus</surname> <given-names>RJ</given-names></name> <name><surname>Zuo</surname> <given-names>F</given-names></name> <name><surname>Murray</surname> <given-names>EE</given-names></name> <name><surname>Loritz</surname> <given-names>K</given-names></name> <name><surname>Mertz</surname> <given-names>JE</given-names></name></person-group>. <article-title>SV40 early-to-late switch involves titration of cellular transcriptional repressors</article-title>. <source>Genes Dev</source>. (<year>1993</year>) <volume>7</volume>:<fpage>2206</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1101/gad.7.11.2206</pub-id><pub-id pub-id-type="pmid">8224847</pub-id></citation></ref>
<ref id="B40">
<label>40.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dornreiter</surname> <given-names>I</given-names></name> <name><surname>H&#x000F6;ss</surname> <given-names>A</given-names></name> <name><surname>Arthur</surname> <given-names>AK</given-names></name> <name><surname>Fanning</surname> <given-names>E</given-names></name></person-group>. <article-title>SV40 T antigen binds directly to the large subunit of purified DNA polymerase alpha</article-title>. <source>EMBO J</source>. (<year>1990</year>) <volume>9</volume>:<fpage>3329</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1002/j.1460-2075.1990.tb07533.x</pub-id><pub-id pub-id-type="pmid">1698613</pub-id></citation></ref>
<ref id="B41">
<label>41.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melendy</surname> <given-names>T</given-names></name> <name><surname>Stillman</surname> <given-names>B</given-names></name></person-group>. <article-title>An interaction between replication protein A and SV40 T antigen appears essential for primosome assembly during SV40 DNA replication</article-title>. <source>J Biol Chem</source>. (<year>1993</year>) <volume>268</volume>:<fpage>3389</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="pmid">8381428</pub-id></citation></ref>
<ref id="B42">
<label>42.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>An</surname> <given-names>P</given-names></name> <name><surname>S&#x000E1;enz Robles</surname> <given-names>MT</given-names></name> <name><surname>Pipas</surname> <given-names>JM</given-names></name></person-group>. <article-title>Large T antigens of polyomaviruses: amazing molecular machines</article-title>. <source>Annu Rev Microbiol</source>. (<year>2012</year>) <volume>66</volume>:<fpage>213</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-micro-092611-150154</pub-id><pub-id pub-id-type="pmid">22994493</pub-id></citation></ref>
<ref id="B43">
<label>43.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barbanti-Brodano</surname> <given-names>G</given-names></name> <name><surname>Sabbioni</surname> <given-names>S</given-names></name> <name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Negrini</surname> <given-names>M</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name></person-group>. <article-title>Simian virus 40 infection in humans and association with human diseases: results and hypotheses</article-title>. <source>Virology</source>. (<year>2004</year>) <volume>318</volume>:<fpage>1</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2003.09.004</pub-id><pub-id pub-id-type="pmid">15015494</pub-id></citation></ref>
<ref id="B44">
<label>44.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cacciotti</surname> <given-names>P</given-names></name> <name><surname>Libener</surname> <given-names>R</given-names></name> <name><surname>Betta</surname> <given-names>P</given-names></name> <name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Porta</surname> <given-names>C</given-names></name> <name><surname>Procopio</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2001</year>) <volume>98</volume>:<fpage>12032</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.211026798</pub-id><pub-id pub-id-type="pmid">11572935</pub-id></citation></ref>
<ref id="B45">
<label>45.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bocchetta</surname> <given-names>M</given-names></name> <name><surname>Eliasz</surname> <given-names>S</given-names></name> <name><surname>De Marco</surname> <given-names>MA</given-names></name> <name><surname>Rudzinski</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name></person-group>. <article-title>The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth</article-title>. <source>Cancer Res</source>. (<year>2008</year>) <volume>68</volume>:<fpage>1022</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-5203</pub-id><pub-id pub-id-type="pmid">18281476</pub-id></citation></ref>
<ref id="B46">
<label>46.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bocchetta</surname> <given-names>M</given-names></name> <name><surname>Miele</surname> <given-names>L</given-names></name> <name><surname>Pass</surname> <given-names>HI</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name></person-group>. <article-title>Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells</article-title>. <source>Oncogene</source>. (<year>2003</year>) <volume>22</volume>:<fpage>81</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1206097</pub-id><pub-id pub-id-type="pmid">12527910</pub-id></citation></ref>
<ref id="B47">
<label>47.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>H</given-names></name> <name><surname>Campisi</surname> <given-names>J</given-names></name> <name><surname>Padmanabhan</surname> <given-names>R</given-names></name></person-group>. <article-title>SV40 large T antigen transactivates the human cdc2 promoter by inducing a CCAAT box binding factor</article-title>. <source>J Biol Chem</source>. (<year>1996</year>) <volume>271</volume>:<fpage>13959</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.24.13959</pub-id><pub-id pub-id-type="pmid">8662914</pub-id></citation></ref>
<ref id="B48">
<label>48.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname> <given-names>DA</given-names></name> <name><surname>Yellen</surname> <given-names>P</given-names></name> <name><surname>Xu</surname> <given-names>L</given-names></name> <name><surname>Saqcena</surname> <given-names>M</given-names></name></person-group>. <article-title>Regulation of G1 cell cycle progression: distinguishing the restriction point from a nutrient-sensing cell growth checkpoint(s)</article-title>. <source>Genes Cancer</source>. (<year>2010</year>) <volume>1</volume>:<fpage>1124</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1177/1947601910392989</pub-id><pub-id pub-id-type="pmid">21779436</pub-id></citation></ref>
<ref id="B49">
<label>49.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bikel</surname> <given-names>I</given-names></name> <name><surname>Loeken</surname> <given-names>MR</given-names></name></person-group>. <article-title>Involvement of simian virus 40 (SV40) small t antigen in trans activation of SV40 early and late promoters</article-title>. <source>J Virol</source>. (<year>1992</year>) <volume>66</volume>:<fpage>1489</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="pmid">1310761</pub-id></citation></ref>
<ref id="B50">
<label>50.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porr&#x000E1;s</surname> <given-names>A</given-names></name> <name><surname>Gaillard</surname> <given-names>S</given-names></name> <name><surname>Rundell</surname> <given-names>K</given-names></name></person-group>. <article-title>The simian virus 40 small-t and large-T antigens jointly regulate cell cycle reentry in human fibroblasts</article-title>. <source>J Virol</source>. (<year>1999</year>) <volume>73</volume>:<fpage>3102</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="pmid">10074161</pub-id></citation></ref>
<ref id="B51">
<label>51.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gruda</surname> <given-names>MC</given-names></name> <name><surname>Zabolotny</surname> <given-names>JM</given-names></name> <name><surname>Xiao</surname> <given-names>JH</given-names></name> <name><surname>Davidson</surname> <given-names>I</given-names></name> <name><surname>Alwine</surname> <given-names>JC</given-names></name></person-group>. <article-title>Transcriptional activation by simian virus 40 large T antigen: interactions with multiple components of the transcription complex</article-title>. <source>Mol Cell Biol</source>. (<year>1993</year>) <volume>13</volume>:<fpage>961</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.13.2.961</pub-id><pub-id pub-id-type="pmid">8423815</pub-id></citation></ref>
<ref id="B52">
<label>52.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Good</surname> <given-names>PJ</given-names></name> <name><surname>Welch</surname> <given-names>RC</given-names></name> <name><surname>Barkan</surname> <given-names>A</given-names></name> <name><surname>Somasekhar</surname> <given-names>MB</given-names></name> <name><surname>Mertz</surname> <given-names>JE</given-names></name></person-group>. <article-title>Both VP2 and VP3 are synthesized from each of the alternative spliced late 19S RNA species of simian virus 40</article-title>. <source>J Virol</source>. (<year>1988</year>) <volume>62</volume>:<fpage>944</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="pmid">2828689</pub-id></citation></ref>
<ref id="B53">
<label>53.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Okubo</surname> <given-names>E</given-names></name> <name><surname>Lehman</surname> <given-names>JM</given-names></name> <name><surname>Friedrich</surname> <given-names>TD</given-names></name></person-group>. <article-title>Negative regulation of mitotic promoting factor by the checkpoint kinase chk1 in simian virus 40 lytic infection</article-title>. <source>J Virol</source>. (<year>2003</year>) <volume>77</volume>:<fpage>1257</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.77.2.1257-1267.2003</pub-id><pub-id pub-id-type="pmid">12502843</pub-id></citation></ref>
<ref id="B54">
<label>54.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gordon-Shaag</surname> <given-names>A</given-names></name> <name><surname>Ben-Nun-Shaul</surname> <given-names>O</given-names></name> <name><surname>Roitman</surname> <given-names>V</given-names></name> <name><surname>Yosef</surname> <given-names>Y</given-names></name> <name><surname>Oppenheim</surname> <given-names>A</given-names></name></person-group>. <article-title>Cellular transcription factor Sp1 recruits simian virus 40 capsid proteins to the viral packaging signal, ses</article-title>. <source>J Virol</source>. (<year>2002</year>) <volume>76</volume>:<fpage>5915</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.76.12.5915-5924.2002</pub-id><pub-id pub-id-type="pmid">12021324</pub-id></citation></ref>
<ref id="B55">
<label>55.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clayson</surname> <given-names>ET</given-names></name> <name><surname>Brando</surname> <given-names>LV</given-names></name> <name><surname>Compans</surname> <given-names>RW</given-names></name></person-group>. <article-title>Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis</article-title>. <source>J Virol</source>. (<year>1989</year>) <volume>63</volume>:<fpage>2278</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="pmid">2539518</pub-id></citation></ref>
<ref id="B56">
<label>56.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bocchetta</surname> <given-names>M</given-names></name> <name><surname>Di Resta</surname> <given-names>I</given-names></name> <name><surname>Powers</surname> <given-names>A</given-names></name> <name><surname>Fresco</surname> <given-names>R</given-names></name> <name><surname>Tosolini</surname> <given-names>A</given-names></name> <name><surname>Testa</surname> <given-names>JR</given-names></name> <etal/></person-group>. <article-title>Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2000</year>) <volume>97</volume>:<fpage>10214</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.170207097</pub-id><pub-id pub-id-type="pmid">10954737</pub-id></citation></ref>
<ref id="B57">
<label>57.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;Neill</surname> <given-names>FJ</given-names></name> <name><surname>Xu</surname> <given-names>XL</given-names></name> <name><surname>Miller</surname> <given-names>TH</given-names></name></person-group>. <article-title>Host range determinant in the late region of SV40 and RF virus affecting growth in human cells</article-title>. <source>Intervirology</source>. (<year>1990</year>) <volume>31</volume>:<fpage>175</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1159/000150152</pub-id><pub-id pub-id-type="pmid">2165043</pub-id></citation></ref>
<ref id="B58">
<label>58.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katzman</surname> <given-names>RB</given-names></name> <name><surname>Seeger</surname> <given-names>M</given-names></name> <name><surname>Rundell</surname> <given-names>K</given-names></name></person-group>. <article-title>SV40 reporter viruses</article-title>. <source>J Virol Methods</source>. (<year>2008</year>) <volume>150</volume>:<fpage>7</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.jviromet.2008.02.013</pub-id><pub-id pub-id-type="pmid">18403028</pub-id></citation></ref>
<ref id="B59">
<label>59.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atkin</surname> <given-names>SJL</given-names></name> <name><surname>Griffin</surname> <given-names>BE</given-names></name> <name><surname>Dilworth</surname> <given-names>SM</given-names></name></person-group>. <article-title>Polyoma virus and simian virus 40 as cancer models: history and perspectives</article-title>. <source>Semin Cancer Biol</source>. (<year>2009</year>) <volume>19</volume>:<fpage>211</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2009.03.001</pub-id><pub-id pub-id-type="pmid">19505648</pub-id></citation></ref>
<ref id="B60">
<label>60.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Small</surname> <given-names>MB</given-names></name> <name><surname>Gluzman</surname> <given-names>Y</given-names></name> <name><surname>Ozer</surname> <given-names>HL</given-names></name></person-group>. <article-title>Enhanced transformation of human fibroblasts by origin-defective simian virus 40</article-title>. <source>Nature</source>. (<year>1982</year>) <volume>296</volume>:<fpage>671</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1038/296671a0</pub-id><pub-id pub-id-type="pmid">6280060</pub-id></citation></ref>
<ref id="B61">
<label>61.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gluzman</surname> <given-names>Y</given-names></name></person-group>. <article-title>SV40-transformed simian cells support the replication of early SV40 mutants</article-title>. <source>Cell</source>. (<year>1981</year>) <volume>23</volume>:<fpage>175</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(81)90282-8</pub-id><pub-id pub-id-type="pmid">6260373</pub-id></citation></ref>
<ref id="B62">
<label>62.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirai</surname> <given-names>K</given-names></name> <name><surname>Lehman</surname> <given-names>J</given-names></name> <name><surname>Defendi</surname> <given-names>V</given-names></name></person-group>. <article-title>Integration of simian virus 40 deoxyribonucleic acid into the deoxyribonucleic acid of primary infected Chinese hamster cells</article-title>. <source>J Virol</source>. (<year>1971</year>) <volume>8</volume>:<fpage>708</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="pmid">4332141</pub-id></citation></ref>
<ref id="B63">
<label>63.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su&#x000E1;rez</surname> <given-names>HG</given-names></name> <name><surname>Morris</surname> <given-names>AG</given-names></name> <name><surname>Lavialle</surname> <given-names>C</given-names></name> <name><surname>Cassingena</surname> <given-names>R</given-names></name></person-group>. <article-title>Enhanced SV 40-virus replication in Chinese hamster kidney cells pretreated with 5-iodo-2&#x00027;-deoxyuridine</article-title>. <source>Arch Virol</source>. (<year>1976</year>) <volume>50</volume>:<fpage>249</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1007/BF01320580</pub-id><pub-id pub-id-type="pmid">176975</pub-id></citation></ref>
<ref id="B64">
<label>64.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morelli</surname> <given-names>C</given-names></name> <name><surname>Barbisan</surname> <given-names>F</given-names></name> <name><surname>Iaccheri</surname> <given-names>L</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name></person-group>. <article-title>SV40-immortalized human fibroblasts as a source of SV40 infectious virions</article-title>. <source>Mol Med</source>. (<year>2004</year>) <volume>10</volume>:<fpage>112</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.2119/2004-00037</pub-id><pub-id pub-id-type="pmid">15702218</pub-id></citation></ref>
<ref id="B65">
<label>65.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morelli</surname> <given-names>C</given-names></name> <name><surname>Barbisan</surname> <given-names>F</given-names></name> <name><surname>Iaccheri</surname> <given-names>L</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name></person-group>. <article-title>Simian virus 40 persistent infection in long-term immortalized human fibroblast cell lines</article-title>. <source>J Neurovirol</source>. (<year>2004</year>) <volume>10</volume>:<fpage>250</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1080/13550280490441185</pub-id><pub-id pub-id-type="pmid">15371155</pub-id></citation></ref>
<ref id="B66">
<label>66.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Balatti</surname> <given-names>V</given-names></name> <name><surname>Sabbioni</surname> <given-names>S</given-names></name> <name><surname>Pancaldi</surname> <given-names>C</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name></person-group>. <article-title>Simian virus 40 in humans</article-title>. <source>Infect Agents Cancer</source>. (<year>2007</year>) <volume>2</volume>:<fpage>13</fpage>. <pub-id pub-id-type="doi">10.1186/1750-9378-2-13</pub-id><pub-id pub-id-type="pmid">17620119</pub-id></citation></ref>
<ref id="B67">
<label>67.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Rigolin</surname> <given-names>GM</given-names></name> <name><surname>Alaribe</surname> <given-names>FN</given-names></name> <name><surname>Pancaldi</surname> <given-names>C</given-names></name> <name><surname>Maniero</surname> <given-names>S</given-names></name> <name><surname>Comar</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Simian virus 40 efficiently infects human T lymphocytes and extends their lifespan</article-title>. <source>Exp Hematol.</source> (<year>2012</year>) <volume>40</volume>:<fpage>466</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.exphem.2012.02.008</pub-id><pub-id pub-id-type="pmid">22421183</pub-id></citation></ref>
<ref id="B68">
<label>68.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dolcetti</surname> <given-names>R</given-names></name> <name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Quaia</surname> <given-names>M</given-names></name> <name><surname>Gloghini</surname> <given-names>A</given-names></name> <name><surname>Vignocchi</surname> <given-names>B</given-names></name> <name><surname>Cariati</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Simian virus 40 sequences in human lymphoblastoid B-cell lines</article-title>. <source>J Virol</source>. (<year>2003</year>) <volume>77</volume>:<fpage>1595</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.77.2.1595-1597.2003</pub-id><pub-id pub-id-type="pmid">12502874</pub-id></citation></ref>
<ref id="B69">
<label>69.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x00027;Neill</surname> <given-names>FJ</given-names></name> <name><surname>Carney</surname> <given-names>H</given-names></name> <name><surname>Hu</surname> <given-names>Y</given-names></name></person-group>. <article-title>Host range analysis of simian virus 40, BK virus and chimaeric SV40/BKV: relative expression of large T-antigen and Vp1 in infected and transformed cells</article-title>. <source>Dev Biol Stand</source>. (<year>1998</year>) <volume>94</volume>:<fpage>191</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="pmid">9776240</pub-id></citation></ref>
<ref id="B70">
<label>70.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname> <given-names>ED</given-names></name> <name><surname>Manley</surname> <given-names>JL</given-names></name></person-group>. <article-title>Repression of simian virus 40 early transcription by viral DNA replication in human 293 cells</article-title>. <source>Nature</source>. (<year>1985</year>) <volume>317</volume>:<fpage>172</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/317172a0</pub-id><pub-id pub-id-type="pmid">2993922</pub-id></citation></ref>
<ref id="B71">
<label>71.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lebkowski</surname> <given-names>JS</given-names></name> <name><surname>Clancy</surname> <given-names>S</given-names></name> <name><surname>Calos</surname> <given-names>MP</given-names></name></person-group>. <article-title>Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression</article-title>. <source>Nature</source>. (<year>1985</year>) <volume>317</volume>:<fpage>169</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1038/317169a0</pub-id><pub-id pub-id-type="pmid">2993921</pub-id></citation></ref>
<ref id="B72">
<label>72.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>F</given-names></name> <name><surname>Koprowski</surname> <given-names>H</given-names></name> <name><surname>Ponten</surname> <given-names>JA</given-names></name></person-group>. <article-title>Rapid transformation of human fibroblast cultures by simian virus</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1963</year>) <volume>50</volume>:<fpage>343</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.50.2.343</pub-id><pub-id pub-id-type="pmid">14060654</pub-id></citation></ref>
<ref id="B73">
<label>73.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shein</surname> <given-names>HM</given-names></name></person-group>. <article-title>Transformation of astrocytes and destruction of spongioblasts induced by a simian tumor virus (SV40) in cultures of human fetal neuroglia</article-title>. <source>J Neuropathol Exp Neurol</source>. (<year>1967</year>) <volume>26</volume>:<fpage>60</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-196701000-00005</pub-id><pub-id pub-id-type="pmid">4164452</pub-id></citation></ref>
<ref id="B74">
<label>74.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Qi</surname> <given-names>F</given-names></name> <name><surname>Gaudino</surname> <given-names>G</given-names></name> <name><surname>Strianese</surname> <given-names>O</given-names></name> <name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Morris</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Tissue tropism of SV40 transformation of human cells: role of the viral regulatory region and of cellular oncogenes</article-title>. <source>Genes Cancer.</source> (<year>2010</year>) <volume>1</volume>:<fpage>1008</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1177/1947601910395580</pub-id><pub-id pub-id-type="pmid">21779427</pub-id></citation></ref>
<ref id="B75">
<label>75.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Bosi</surname> <given-names>S</given-names></name> <name><surname>Bassi</surname> <given-names>C</given-names></name> <name><surname>Ferracin</surname> <given-names>M</given-names></name> <name><surname>Lanza</surname> <given-names>G</given-names></name> <name><surname>Gaf&#x000E0;</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Gene expression changes in progression of cervical neoplasia revealed by microarray analysis of cervical neoplastic keratinocytes</article-title>. <source>J Cell Physiol</source>. (<year>2015</year>) <volume>230</volume>:<fpage>806</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.24808</pub-id><pub-id pub-id-type="pmid">25205602</pub-id></citation></ref>
<ref id="B76">
<label>76.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torreggiani</surname> <given-names>E</given-names></name> <name><surname>Rossini</surname> <given-names>M</given-names></name> <name><surname>Bononi</surname> <given-names>I</given-names></name> <name><surname>Pietrobon</surname> <given-names>S</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Iaquinta</surname> <given-names>MR</given-names></name> <etal/></person-group>. <article-title>Protocol for the long-term culture of human primary keratinocytes from the normal colorectal mucosa</article-title>. <source>J Cell Physiol</source>. (<year>2019</year>) <volume>234</volume>:<fpage>9895</fpage>&#x02013;<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.28300</pub-id><pub-id pub-id-type="pmid">30740692</pub-id></citation></ref>
<ref id="B77">
<label>77.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <name><surname>Diaz</surname> <given-names>J</given-names></name> <name><surname>Tsang</surname> <given-names>SH</given-names></name> <name><surname>Buck</surname> <given-names>CB</given-names></name> <name><surname>You</surname> <given-names>J</given-names></name></person-group>. <article-title>Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation</article-title>. <source>J Virol</source>. (<year>2013</year>) <volume>87</volume>:<fpage>9173</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01216-13</pub-id><pub-id pub-id-type="pmid">23760247</pub-id></citation></ref>
<ref id="B78">
<label>78.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>J</given-names></name> <name><surname>Rozenblatt-Rosen</surname> <given-names>O</given-names></name> <name><surname>Paulson</surname> <given-names>KG</given-names></name> <name><surname>Nghiem</surname> <given-names>P</given-names></name> <name><surname>DeCaprio</surname> <given-names>JA</given-names></name></person-group>. <article-title>Merkel cell polyomavirus large T antigen has growth-promoting and inhibitory activities</article-title>. <source>J Virol.</source> (<year>2013</year>) <volume>87</volume>:<fpage>6118</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00385-13</pub-id><pub-id pub-id-type="pmid">23514892</pub-id></citation></ref>
<ref id="B79">
<label>79.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Dolcetti</surname> <given-names>R</given-names></name> <name><surname>Gloghini</surname> <given-names>A</given-names></name> <name><surname>Iaccheri</surname> <given-names>L</given-names></name> <name><surname>Carbone</surname> <given-names>A</given-names></name> <name><surname>Boiocchi</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV&#x0002B; patients</article-title>. <source>Int J Cancer</source>. (<year>1998</year>) <volume>78</volume>:<fpage>669</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(19981209)78:6&#x0003C;669::AID-IJC1&#x0003E;3.0.CO;2-B</pub-id><pub-id pub-id-type="pmid">9833757</pub-id></citation></ref>
<ref id="B80">
<label>80.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Testa</surname> <given-names>JR</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name> <name><surname>Hirvonen</surname> <given-names>A</given-names></name> <name><surname>Khalili</surname> <given-names>K</given-names></name> <name><surname>Krynska</surname> <given-names>B</given-names></name> <name><surname>Linnainmaa</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas</article-title>. <source>Cancer Res</source>. (<year>1998</year>) <volume>58</volume>:<fpage>4505</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="pmid">9788590</pub-id></citation></ref>
<ref id="B81">
<label>81.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thanh</surname> <given-names>TD</given-names></name> <name><surname>Tho</surname> <given-names>NV</given-names></name> <name><surname>Lam</surname> <given-names>NS</given-names></name> <name><surname>Dung</surname> <given-names>NH</given-names></name> <name><surname>Tabata</surname> <given-names>C</given-names></name> <name><surname>Nakano</surname> <given-names>Y</given-names></name></person-group>. <article-title>Simian virus 40 may be associated with developing malignant pleural mesothelioma</article-title>. <source>Oncol Lett</source>. (<year>2016</year>) <volume>11</volume>:<fpage>2051</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.3892/ol.2016.4174</pub-id><pub-id pub-id-type="pmid">26998120</pub-id></citation></ref>
<ref id="B82">
<label>82.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vivaldi</surname> <given-names>A</given-names></name> <name><surname>Pacini</surname> <given-names>F</given-names></name> <name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Iaccheri</surname> <given-names>L</given-names></name> <name><surname>Pezzetti</surname> <given-names>F</given-names></name> <name><surname>Elisei</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Simian virus 40-like sequences from early and late regions in human thyroid tumors of different histotypes</article-title>. <source>J Clin Endocrinol Metab</source>. (<year>2003</year>) <volume>88</volume>:<fpage>892</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2002-020436</pub-id><pub-id pub-id-type="pmid">12574230</pub-id></citation></ref>
<ref id="B83">
<label>83.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinelli</surname> <given-names>M</given-names></name> <name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Rinaldi</surname> <given-names>E</given-names></name> <name><surname>Caramanico</surname> <given-names>L</given-names></name> <name><surname>Magri</surname> <given-names>E</given-names></name> <name><surname>Grandi</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Simian virus 40 sequences and expression of the viral large T antigen oncoprotein in human pleomorphic adenomas of parotid glands</article-title>. <source>Am J Pathol</source>. (<year>2002</year>) <volume>161</volume>:<fpage>1127</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64389-1</pub-id><pub-id pub-id-type="pmid">12368186</pub-id></citation></ref>
<ref id="B84">
<label>84.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hachana</surname> <given-names>M</given-names></name> <name><surname>Trimeche</surname> <given-names>M</given-names></name> <name><surname>Ziadi</surname> <given-names>S</given-names></name> <name><surname>Amara</surname> <given-names>K</given-names></name> <name><surname>Korbi</surname> <given-names>S</given-names></name></person-group>. <article-title>Evidence for a role of the Simian virus 40 in human breast carcinomas</article-title>. <source>Breast Cancer Res Treat</source>. (<year>2009</year>) <volume>113</volume>:<fpage>43</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1007/s10549-008-9901-z</pub-id><pub-id pub-id-type="pmid">18205041</pub-id></citation></ref>
<ref id="B85">
<label>85.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meneses</surname> <given-names>A</given-names></name> <name><surname>Lopez-Terrada</surname> <given-names>D</given-names></name> <name><surname>Zanwar</surname> <given-names>P</given-names></name> <name><surname>Killen</surname> <given-names>DE</given-names></name> <name><surname>Monterroso</surname> <given-names>V</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name> <etal/></person-group>. <article-title>Lymphoproliferative disorders in Costa Rica and simian virus 40</article-title>. <source>Haematologica</source>. (<year>2005</year>) <volume>90</volume>:<fpage>1635</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="pmid">16330436</pub-id></citation></ref>
<ref id="B86">
<label>86.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname> <given-names>DP</given-names></name> <name><surname>Crawford</surname> <given-names>LV</given-names></name></person-group>. <article-title>T antigen is bound to a host protein in SV40-transformed cells</article-title>. <source>Nature</source>. (<year>1979</year>) <volume>278</volume>:<fpage>261</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1038/278261a0</pub-id><pub-id pub-id-type="pmid">218111</pub-id></citation></ref>
<ref id="B87">
<label>87.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname> <given-names>T</given-names></name> <name><surname>Xu</surname> <given-names>X</given-names></name> <name><surname>Kronast</surname> <given-names>M</given-names></name> <name><surname>Muehlich</surname> <given-names>S</given-names></name> <name><surname>Meyer</surname> <given-names>K</given-names></name> <name><surname>Zimmermann</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Inhibition of Cullin-RING E3 ubiquitin ligase 7 by simian virus 40 large T antigen</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2014</year>) <volume>111</volume>:<fpage>3371</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1401556111</pub-id><pub-id pub-id-type="pmid">24550499</pub-id></citation></ref>
<ref id="B88">
<label>88.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baez</surname> <given-names>CF</given-names></name> <name><surname>Brand&#x000E3;o Varella</surname> <given-names>R</given-names></name> <name><surname>Villani</surname> <given-names>S</given-names></name> <name><surname>Delbue</surname> <given-names>S</given-names></name></person-group>. <article-title>Human polyomaviruses: the battle of large and small tumor antigens</article-title>. <source>Virology</source>. (<year>2017</year>) <volume>8</volume>:<fpage>1178122X17744785</fpage>. <pub-id pub-id-type="doi">10.1177/1178122X17744785</pub-id><pub-id pub-id-type="pmid">29238174</pub-id></citation></ref>
<ref id="B89">
<label>89.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x000E1;enz Robles</surname> <given-names>MT</given-names></name> <name><surname>Pipas</surname> <given-names>JM</given-names></name></person-group>. <article-title>T antigen transgenic mouse models</article-title>. <source>Semin Cancer Biol</source>. (<year>2009</year>) <volume>19</volume>:<fpage>229</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2009.02.002</pub-id><pub-id pub-id-type="pmid">19505650</pub-id></citation></ref>
<ref id="B90">
<label>90.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Theile</surname> <given-names>M</given-names></name> <name><surname>Strauss</surname> <given-names>M</given-names></name> <name><surname>Luebbe</surname> <given-names>L</given-names></name> <name><surname>Scherneck</surname> <given-names>S</given-names></name> <name><surname>Krause</surname> <given-names>H</given-names></name> <name><surname>Geissler</surname> <given-names>E</given-names></name></person-group>. <article-title>SV40-induced somatic mutations: possible relevance to viral transformation</article-title>. <source>Cold Spring Harb Symp Quant Biol</source>. (<year>1980</year>) <volume>44</volume>(<issue>Pt 1</issue>):<fpage>377</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1101/SQB.1980.044.01.042</pub-id><pub-id pub-id-type="pmid">6253150</pub-id></citation></ref>
<ref id="B91">
<label>91.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>N</given-names></name> <name><surname>Bacchetti</surname> <given-names>S</given-names></name></person-group>. <article-title>Expression of SV40 large T antigen, but not small T antigen, is required for the induction of chromosomal aberrations in transformed human cells</article-title>. <source>Virology</source>. (<year>1991</year>) <volume>180</volume>:<fpage>49</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/0042-6822(91)90008-Y</pub-id></citation></ref>
<ref id="B92">
<label>92.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname> <given-names>FA</given-names></name> <name><surname>Peabody</surname> <given-names>DS</given-names></name> <name><surname>Cooper</surname> <given-names>JL</given-names></name> <name><surname>Cram</surname> <given-names>LS</given-names></name> <name><surname>Kraemer</surname> <given-names>PM</given-names></name></person-group>. <article-title>SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts</article-title>. <source>J Cell Biochem</source>. (<year>1990</year>) <volume>42</volume>:<fpage>13</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.240420103</pub-id><pub-id pub-id-type="pmid">2153691</pub-id></citation></ref>
<ref id="B93">
<label>93.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname> <given-names>FA</given-names></name> <name><surname>Meyne</surname> <given-names>J</given-names></name> <name><surname>Kraemer</surname> <given-names>PM</given-names></name></person-group>. <article-title>SV40 T antigen induced chromosomal changes reflect a process that is both clastogenic and aneuploidogenic and is ongoing throughout neoplastic progression of human fibroblasts</article-title>. <source>Mutat Res</source>. (<year>1992</year>) <volume>284</volume>:<fpage>265</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/0027-5107(92)90011-P</pub-id><pub-id pub-id-type="pmid">1281278</pub-id></citation></ref>
<ref id="B94">
<label>94.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname> <given-names>K</given-names></name> <name><surname>Sobol</surname> <given-names>RW</given-names></name></person-group>. <article-title>Mutation research/fundamental and molecular mechanisms of mutagenesis: special issue: DNA repair and genetic instability</article-title>. <source>Mutat Res</source>. (<year>2013</year>) <fpage>743&#x02013;744</fpage>:<lpage>1&#x02013;3</lpage>. <pub-id pub-id-type="doi">10.1016/j.mrfmmm.2013.04.009</pub-id><pub-id pub-id-type="pmid">23688353</pub-id></citation></ref>
<ref id="B95">
<label>95.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boichuk</surname> <given-names>S</given-names></name> <name><surname>Hu</surname> <given-names>L</given-names></name> <name><surname>Hein</surname> <given-names>J</given-names></name> <name><surname>Gjoerup</surname> <given-names>OV</given-names></name></person-group>. <article-title>Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen</article-title>. <source>J Virol</source>. (<year>2010</year>) <volume>84</volume>:<fpage>8007</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00334-10</pub-id><pub-id pub-id-type="pmid">20519379</pub-id></citation></ref>
<ref id="B96">
<label>96.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shera</surname> <given-names>KA</given-names></name> <name><surname>Shera</surname> <given-names>CA</given-names></name> <name><surname>McDougall</surname> <given-names>JK</given-names></name></person-group>. <article-title>Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells</article-title>. <source>J Virol</source>. (<year>2001</year>) <volume>75</volume>:<fpage>12339</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.75.24.12339-12346.2001</pub-id><pub-id pub-id-type="pmid">11711624</pub-id></citation></ref>
<ref id="B97">
<label>97.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Kaur</surname> <given-names>G</given-names></name> <name><surname>Zhawar</surname> <given-names>VK</given-names></name> <name><surname>Zimonjic</surname> <given-names>DB</given-names></name> <name><surname>Popescu</surname> <given-names>NC</given-names></name> <name><surname>Kandpal</surname> <given-names>RP</given-names></name> <etal/></person-group>. <article-title>Role of SV40 integration site at chromosomal interval 1q21.1 in immortalized CRL2504 cells</article-title>. <source>Cancer Res</source>. (<year>2009</year>) <volume>69</volume>:<fpage>7819</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-1003</pub-id><pub-id pub-id-type="pmid">19789346</pub-id></citation></ref>
<ref id="B98">
<label>98.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname> <given-names>SM</given-names></name> <name><surname>Konishi</surname> <given-names>T</given-names></name> <name><surname>Miller</surname> <given-names>CW</given-names></name></person-group>. <article-title>Integration of SV40 in human osteosarcoma DNA</article-title>. <source>Oncogene</source>. (<year>1998</year>) <volume>17</volume>:<fpage>2457</fpage>&#x02013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1202179</pub-id><pub-id pub-id-type="pmid">9824156</pub-id></citation></ref>
<ref id="B99">
<label>99.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000FC;chner</surname> <given-names>S</given-names></name> <name><surname>Wintersberger</surname> <given-names>E</given-names></name></person-group>. <article-title>Binding of polyomavirus small T antigen to protein phosphatase 2A is required for elimination of p27 and support of S-phase induction in concert with large T antigen</article-title>. <source>J Virol</source>. (<year>1999</year>) <volume>73</volume>:<fpage>9266</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="pmid">10516035</pub-id></citation></ref>
<ref id="B100">
<label>100.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skoczylas</surname> <given-names>C</given-names></name> <name><surname>Henglein</surname> <given-names>B</given-names></name> <name><surname>Rundell</surname> <given-names>K</given-names></name></person-group>. <article-title>PP2A-dependent transactivation of the cyclin A promoter by SV40 ST is mediated by a cell cycle-regulated E2F site</article-title>. <source>Virology</source>. (<year>2005</year>) <volume>332</volume>:<fpage>596</fpage>&#x02013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2004.12.017</pub-id><pub-id pub-id-type="pmid">15680424</pub-id></citation></ref>
<ref id="B101">
<label>101.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sotillo</surname> <given-names>E</given-names></name> <name><surname>Garriga</surname> <given-names>J</given-names></name> <name><surname>Kurimchak</surname> <given-names>A</given-names></name> <name><surname>Gra&#x000F1;a</surname> <given-names>X</given-names></name></person-group>. <article-title>Cyclin E and SV40 small T antigen cooperate to bypass quiescence and contribute to transformation by activating CDK2 in human fibroblasts</article-title>. <source>J Biol Chem</source>. (<year>2008</year>) <volume>283</volume>:<fpage>11280</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M709055200</pub-id><pub-id pub-id-type="pmid">18276582</pub-id></citation></ref>
<ref id="B102">
<label>102.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frost</surname> <given-names>JA</given-names></name> <name><surname>Alberts</surname> <given-names>AS</given-names></name> <name><surname>Sontag</surname> <given-names>E</given-names></name> <name><surname>Guan</surname> <given-names>K</given-names></name> <name><surname>Mumby</surname> <given-names>MC</given-names></name> <name><surname>Feramisco</surname> <given-names>JR</given-names></name></person-group>. <article-title>Simian virus 40 small t antigen cooperates with mitogen-activated kinases to stimulate AP-1 activity</article-title>. <source>Mol Cell Biol.</source> (<year>1994</year>) <volume>14</volume>:<fpage>6244</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.14.9.6244</pub-id><pub-id pub-id-type="pmid">8065356</pub-id></citation></ref>
<ref id="B103">
<label>103.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Bosi</surname> <given-names>S</given-names></name> <name><surname>Bazzan</surname> <given-names>E</given-names></name> <name><surname>Di Domenico</surname> <given-names>M</given-names></name> <name><surname>De Mattei</surname> <given-names>M</given-names></name> <name><surname>Selvatici</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Methylenetetrahydrofolate reductase gene promoter hypermethylation in semen samples of infertile couples correlates with recurrent spontaneous abortion</article-title>. <source>Hum Reprod</source>. (<year>2012</year>) <volume>27</volume>:<fpage>3632</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/des319</pub-id><pub-id pub-id-type="pmid">23010533</pub-id></citation></ref>
<ref id="B104">
<label>104.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Selvatici</surname> <given-names>R</given-names></name> <name><surname>Di Domenico</surname> <given-names>M</given-names></name> <name><surname>Marci</surname> <given-names>R</given-names></name> <name><surname>Vesce</surname> <given-names>F</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Methylation loss at H19 imprinted gene correlates with methylenetetrahydrofolate reductase gene promoter hypermethylation in semen samples from infertile males</article-title>. <source>Epigenetics</source>. (<year>2013</year>) <volume>8</volume>:<fpage>990</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.4161/epi.25798</pub-id><pub-id pub-id-type="pmid">23975186</pub-id></citation></ref>
<ref id="B105">
<label>105.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Borghi</surname> <given-names>A</given-names></name> <name><surname>Selvatici</surname> <given-names>R</given-names></name> <name><surname>Magri</surname> <given-names>E</given-names></name> <name><surname>Bianchini</surname> <given-names>E</given-names></name> <name><surname>Montinari</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Hypermethylation-induced inactivation of the IRF6 gene as a possible early event in progression of vulvar squamous cell carcinoma associated with lichen sclerosus</article-title>. <source>JAMA Dermatol.</source> (<year>2016</year>) <volume>152</volume>:<fpage>928</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1001/jamadermatol.2016.1336</pub-id><pub-id pub-id-type="pmid">27223861</pub-id></citation></ref>
<ref id="B106">
<label>106.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Borghi</surname> <given-names>A</given-names></name> <name><surname>Selvatici</surname> <given-names>R</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Bononi</surname> <given-names>I</given-names></name> <name><surname>Corazza</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Association of retinoic acid receptor &#x003B2; gene with onset and progression of lichen sclerosus-associated vulvar squamous cell carcinoma</article-title>. <source>JAMA Dermatol</source>. (<year>2018</year>) <volume>154</volume>:<fpage>819</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1001/jamadermatol.2018.1373</pub-id><pub-id pub-id-type="pmid">29898214</pub-id></citation></ref>
<ref id="B107">
<label>107.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuss-Duerkop</surname> <given-names>SK</given-names></name> <name><surname>Westrich</surname> <given-names>JA</given-names></name> <name><surname>Pyeon</surname> <given-names>D</given-names></name></person-group>. <article-title>DNA tumor virus regulation of host DNA methylation and its implications for immune evasion and oncogenesis</article-title>. <source>Viruses</source>. (<year>2018</year>) <volume>10</volume>:<fpage>E82</fpage>. <pub-id pub-id-type="doi">10.3390/v10020082</pub-id><pub-id pub-id-type="pmid">29438328</pub-id></citation></ref>
<ref id="B108">
<label>108.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Q</given-names></name> <name><surname>Zhang</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Ma</surname> <given-names>Y</given-names></name> <name><surname>Hu</surname> <given-names>Y</given-names></name></person-group>. <article-title>Defective heat shock factor 1 inhibits the growth of fibrosarcoma derived from simian virus 40/T antigen-transformed MEF cells</article-title>. <source>Mol Med Rep</source>. (<year>2015</year>) <volume>12</volume>:<fpage>6517</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2015.4300</pub-id></citation></ref>
<ref id="B109">
<label>109.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>T</given-names></name> <name><surname>S&#x000E1;enz Robles</surname> <given-names>MT</given-names></name> <name><surname>Pipas</surname> <given-names>JM</given-names></name></person-group>. <article-title>Cellular transformation of mouse embryo fibroblasts in the absence of activator E2Fs</article-title>. <source>J Virol</source>. (<year>2015</year>) <volume>89</volume>:<fpage>5124</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.03578-14</pub-id><pub-id pub-id-type="pmid">25717106</pub-id></citation></ref>
<ref id="B110">
<label>110.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>N</given-names></name> <name><surname>Yang</surname> <given-names>R</given-names></name> <name><surname>Zhang</surname> <given-names>W</given-names></name> <name><surname>Dorfman</surname> <given-names>H</given-names></name> <name><surname>Rao</surname> <given-names>P</given-names></name> <name><surname>Gorlick</surname> <given-names>R</given-names></name></person-group>. <article-title>Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential</article-title>. <source>Cancer</source>. (<year>2009</year>) <volume>115</volume>:<fpage>4795</fpage>&#x02013;<lpage>806</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.24519</pub-id><pub-id pub-id-type="pmid">19593798</pub-id></citation></ref>
<ref id="B111">
<label>111.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z-Y</given-names></name> <name><surname>Burlak</surname> <given-names>C</given-names></name> <name><surname>Klaunig</surname> <given-names>JE</given-names></name> <name><surname>Kamendulis</surname> <given-names>LM</given-names></name></person-group>. <article-title>Development of a cytokine-producing immortalized murine Kupffer cell line</article-title>. <source>Cytokine</source>. (<year>2014</year>) <volume>70</volume>:<fpage>165</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2014.07.251</pub-id><pub-id pub-id-type="pmid">25138015</pub-id></citation></ref>
<ref id="B112">
<label>112.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Best</surname> <given-names>B</given-names></name> <name><surname>Moran</surname> <given-names>P</given-names></name> <name><surname>Ren</surname> <given-names>B</given-names></name></person-group>. <article-title>VEGF/PKD-1 signaling mediates arteriogenic gene expression and angiogenic responses in reversible human microvascular endothelial cells with extended lifespan</article-title>. <source>Mol Cell Biochem</source>. (<year>2018</year>) <volume>446</volume>:<fpage>199</fpage>&#x02013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-018-3286-z</pub-id><pub-id pub-id-type="pmid">29380239</pub-id></citation></ref>
<ref id="B113">
<label>113.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>C</given-names></name> <name><surname>Ji</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Bi</surname> <given-names>Y</given-names></name> <name><surname>Yang</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation</article-title>. <source>J Cell Biochem</source>. (<year>2018</year>) <volume>119</volume>:<fpage>8872</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.27140</pub-id><pub-id pub-id-type="pmid">30076626</pub-id></citation></ref>
<ref id="B114">
<label>114.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname> <given-names>M</given-names></name> <name><surname>Bi</surname> <given-names>Y</given-names></name> <name><surname>Jiang</surname> <given-names>W</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>Chen</surname> <given-names>L</given-names></name> <name><surname>Hou</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Immortalized mesenchymal stem cells: an alternative to primary mesenchymal stem cells in neuronal differentiation and neuroregeneration associated studies</article-title>. <source>J Biomed Sci</source>. (<year>2011</year>) <volume>18</volume>:<fpage>87</fpage>. <pub-id pub-id-type="doi">10.1186/1423-0127-18-87</pub-id><pub-id pub-id-type="pmid">22118013</pub-id></citation></ref>
<ref id="B115">
<label>115.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langert</surname> <given-names>KA</given-names></name> <name><surname>Von Zee</surname> <given-names>CL</given-names></name> <name><surname>Stubbs</surname> <given-names>EB</given-names></name></person-group>. <article-title>Tumour necrosis factor &#x003B1; enhances CCL2 and ICAM-1 expression in peripheral nerve microvascular endoneurial endothelial cells</article-title>. <source>ASN Neuro</source>. (<year>2013</year>) <volume>5</volume>:<fpage>e00104</fpage>. <pub-id pub-id-type="doi">10.1042/AN20120048</pub-id><pub-id pub-id-type="pmid">23293927</pub-id></citation></ref>
<ref id="B116">
<label>116.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rundell</surname> <given-names>K</given-names></name> <name><surname>Parakati</surname> <given-names>R</given-names></name></person-group>. <article-title>The role of the SV40 ST antigen in cell growth promotion and transformation</article-title>. <source>Semin Cancer Biol.</source> (<year>2001</year>) <volume>11</volume>:<fpage>5</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1006/scbi.2000.0341</pub-id><pub-id pub-id-type="pmid">11243894</pub-id></citation></ref>
<ref id="B117">
<label>117.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitazawa</surname> <given-names>K</given-names></name> <name><surname>Kawasaki</surname> <given-names>S</given-names></name> <name><surname>Shinomiya</surname> <given-names>K</given-names></name> <name><surname>Aoi</surname> <given-names>K</given-names></name> <name><surname>Matsuda</surname> <given-names>A</given-names></name> <name><surname>Funaki</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Establishment of a human corneal epithelial cell line lacking the functional TACSTD2 gene as an <italic>in vitro</italic> model for gelatinous drop-like dystrophy</article-title>. <source>Invest Ophthalmol Vis Sci</source>. (<year>2013</year>) <volume>54</volume>:<fpage>5701</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1167/iovs.12-11043</pub-id><pub-id pub-id-type="pmid">23868985</pub-id></citation></ref>
<ref id="B118">
<label>118.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Yu</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>J</given-names></name> <name><surname>Zhou</surname> <given-names>N</given-names></name> <name><surname>Du</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Establishment and characterization of an immortalized human hepatic stellate cell line for applications in co-culturing with immortalized human hepatocytes</article-title>. <source>Int J Med Sci</source>. (<year>2015</year>) <volume>12</volume>:<fpage>248</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.7150/ijms.11002</pub-id><pub-id pub-id-type="pmid">25678842</pub-id></citation></ref>
<ref id="B119">
<label>119.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>WYW</given-names></name> <name><surname>Zhang</surname> <given-names>T</given-names></name> <name><surname>Lau</surname> <given-names>CPY</given-names></name> <name><surname>Wang</surname> <given-names>CC</given-names></name> <name><surname>Chan</surname> <given-names>K-M</given-names></name> <name><surname>Li</surname> <given-names>G</given-names></name></person-group>. <article-title>Immortalized human fetal bone marrow-derived mesenchymal stromal cell expressing suicide gene for anti-tumor therapy <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>Cytotherapy</source>. (<year>2013</year>) <volume>15</volume>:<fpage>1484</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcyt.2013.06.010</pub-id><pub-id pub-id-type="pmid">24199592</pub-id></citation></ref>
<ref id="B120">
<label>120.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Plaisance-Bonstaff</surname> <given-names>K</given-names></name> <name><surname>Renne</surname> <given-names>R</given-names></name></person-group>. <article-title>Viral miRNAs</article-title>. <source>Methods Mol Biol</source>. (<year>2011</year>) <volume>721</volume>:<fpage>43</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-037-9_3</pub-id><pub-id pub-id-type="pmid">21431678</pub-id></citation></ref>
<ref id="B121">
<label>121.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>CS</given-names></name> <name><surname>Ganem</surname> <given-names>D</given-names></name></person-group>. <article-title>MicroRNAs and viral infection</article-title>. <source>Mol Cell</source>. (<year>2005</year>) <volume>20</volume>:<fpage>3</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2005.09.012</pub-id><pub-id pub-id-type="pmid">16209940</pub-id></citation></ref>
<ref id="B122">
<label>122.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauman</surname> <given-names>Y</given-names></name> <name><surname>Nachmani</surname> <given-names>D</given-names></name> <name><surname>Vitenshtein</surname> <given-names>A</given-names></name> <name><surname>Tsukerman</surname> <given-names>P</given-names></name> <name><surname>Drayman</surname> <given-names>N</given-names></name> <name><surname>Stern-Ginossar</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination</article-title>. <source>Cell Host Microbe</source>. (<year>2011</year>) <volume>9</volume>:<fpage>93</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/j.chom.2011.01.008</pub-id><pub-id pub-id-type="pmid">21320692</pub-id></citation></ref>
<ref id="B123">
<label>123.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bauman</surname> <given-names>Y</given-names></name> <name><surname>Drayman</surname> <given-names>N</given-names></name> <name><surname>Ben-Nun-Shaul</surname> <given-names>O</given-names></name> <name><surname>Vitenstein</surname> <given-names>A</given-names></name> <name><surname>Yamin</surname> <given-names>R</given-names></name> <name><surname>Ophir</surname> <given-names>Y</given-names></name> <etal/></person-group>. <article-title>Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity</article-title>. <source>Oncotarget</source>. (<year>2016</year>) <volume>7</volume>:<fpage>15369</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.8085</pub-id><pub-id pub-id-type="pmid">26992229</pub-id></citation></ref>
<ref id="B124">
<label>124.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McNees</surname> <given-names>AL</given-names></name> <name><surname>Harrigal</surname> <given-names>LJ</given-names></name> <name><surname>Kelly</surname> <given-names>A</given-names></name> <name><surname>Minard</surname> <given-names>CG</given-names></name> <name><surname>Wong</surname> <given-names>C</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>Viral microRNA effects on persistent infection of human lymphoid cells by polyomavirus SV40</article-title>. <source>PLoS ONE</source>. (<year>2018</year>) <volume>13</volume>:<fpage>e0192799</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0192799</pub-id><pub-id pub-id-type="pmid">29432481</pub-id></citation></ref>
<ref id="B125">
<label>125.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cicala</surname> <given-names>C</given-names></name> <name><surname>Pompetti</surname> <given-names>F</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name></person-group>. <article-title>SV40 induces mesotheliomas in hamsters</article-title>. <source>Am J Pathol</source>. (<year>1993</year>) <volume>142</volume>:<fpage>1524</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="pmid">8388174</pub-id></citation></ref>
<ref id="B126">
<label>126.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Dyke</surname> <given-names>TA</given-names></name> <name><surname>Finlay</surname> <given-names>C</given-names></name> <name><surname>Miller</surname> <given-names>D</given-names></name> <name><surname>Marks</surname> <given-names>J</given-names></name> <name><surname>Lozano</surname> <given-names>G</given-names></name> <name><surname>Levine</surname> <given-names>AJ</given-names></name></person-group>. <article-title>Relationship between simian virus 40 large tumor antigen expression and tumor formation in transgenic mice</article-title>. <source>J Virol</source>. (<year>1987</year>) <volume>61</volume>:<fpage>2029</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="pmid">3033329</pub-id></citation></ref>
<ref id="B127">
<label>127.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wikenheiser</surname> <given-names>KA</given-names></name> <name><surname>Clark</surname> <given-names>JC</given-names></name> <name><surname>Linnoila</surname> <given-names>RI</given-names></name> <name><surname>Stahlman</surname> <given-names>MT</given-names></name> <name><surname>Whitsett</surname> <given-names>JA</given-names></name></person-group>. <article-title>Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice</article-title>. <source>Cancer Res</source>. (<year>1992</year>) <volume>52</volume>:<fpage>5342</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="pmid">1394139</pub-id></citation></ref>
<ref id="B128">
<label>128.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maroulakou</surname> <given-names>IG</given-names></name> <name><surname>Anver</surname> <given-names>M</given-names></name> <name><surname>Garrett</surname> <given-names>L</given-names></name> <name><surname>Green</surname> <given-names>JE</given-names></name></person-group>. <article-title>Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1994</year>) <volume>91</volume>:<fpage>11236</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.91.23.11236</pub-id><pub-id pub-id-type="pmid">7972041</pub-id></citation></ref>
<ref id="B129">
<label>129.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname> <given-names>NM</given-names></name> <name><surname>DeMayo</surname> <given-names>F</given-names></name> <name><surname>Finegold</surname> <given-names>MJ</given-names></name> <name><surname>Medina</surname> <given-names>D</given-names></name> <name><surname>Tilley</surname> <given-names>WD</given-names></name> <name><surname>Aspinall</surname> <given-names>JO</given-names></name> <etal/></person-group>. <article-title>Prostate cancer in a transgenic mouse</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>1995</year>) <volume>92</volume>:<fpage>3439</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.92.8.3439</pub-id></citation></ref>
<ref id="B130">
<label>130.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hurwitz</surname> <given-names>AA</given-names></name> <name><surname>Foster</surname> <given-names>BA</given-names></name> <name><surname>Allison</surname> <given-names>JP</given-names></name> <name><surname>Greenberg</surname> <given-names>NM</given-names></name> <name><surname>Kwon</surname> <given-names>ED</given-names></name></person-group>. <article-title>The TRAMP mouse as a model for prostate cancer</article-title>. <source>Curr Protoc Immunol.</source> (<year>2001</year>) Chapter 20:Unit 20.5. <pub-id pub-id-type="doi">10.1002/0471142735.im2005s45</pub-id><pub-id pub-id-type="pmid">18432778</pub-id></citation></ref>
<ref id="B131">
<label>131.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santarelli</surname> <given-names>R</given-names></name> <name><surname>Tzeng</surname> <given-names>YJ</given-names></name> <name><surname>Zimmermann</surname> <given-names>C</given-names></name> <name><surname>Guhl</surname> <given-names>E</given-names></name> <name><surname>Graessmann</surname> <given-names>A</given-names></name></person-group>. <article-title>SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals</article-title>. <source>Oncogene</source>. (<year>1996</year>) <volume>12</volume>:<fpage>495</fpage>&#x02013;<lpage>505</lpage>. <pub-id pub-id-type="pmid">8637705</pub-id></citation></ref>
<ref id="B132">
<label>132.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garabedian</surname> <given-names>EM</given-names></name> <name><surname>Roberts</surname> <given-names>LJ</given-names></name> <name><surname>McNevin</surname> <given-names>MS</given-names></name> <name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group>. <article-title>Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice</article-title>. <source>J Biol Chem.</source> (<year>1997</year>) <volume>272</volume>:<fpage>23729</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.272.38.23729</pub-id><pub-id pub-id-type="pmid">9295317</pub-id></citation></ref>
<ref id="B133">
<label>133.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garabedian</surname> <given-names>EM</given-names></name> <name><surname>Humphrey</surname> <given-names>PA</given-names></name> <name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group>. <article-title>A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>1998</year>) <volume>95</volume>:<fpage>15382</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.26.15382</pub-id><pub-id pub-id-type="pmid">9860977</pub-id></citation></ref>
<ref id="B134">
<label>134.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asamoto</surname> <given-names>M</given-names></name> <name><surname>Hokaiwado</surname> <given-names>N</given-names></name> <name><surname>Cho</surname> <given-names>YM</given-names></name> <name><surname>Takahashi</surname> <given-names>S</given-names></name> <name><surname>Ikeda</surname> <given-names>Y</given-names></name> <name><surname>Imaida</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent</article-title>. <source>Cancer Res.</source> (<year>2001</year>) <volume>61</volume>:<fpage>4693</fpage>&#x02013;<lpage>700</lpage>. <pub-id pub-id-type="pmid">11406539</pub-id></citation></ref>
<ref id="B135">
<label>135.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Masumori</surname> <given-names>N</given-names></name> <name><surname>Thomas</surname> <given-names>TZ</given-names></name> <name><surname>Chaurand</surname> <given-names>P</given-names></name> <name><surname>Case</surname> <given-names>T</given-names></name> <name><surname>Paul</surname> <given-names>M</given-names></name> <name><surname>Kasper</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential</article-title>. <source>Cancer Res</source>. (<year>2001</year>) <volume>61</volume>:<fpage>2239</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="pmid">11280793</pub-id></citation></ref>
<ref id="B136">
<label>136.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gabril</surname> <given-names>MY</given-names></name> <name><surname>Onita</surname> <given-names>T</given-names></name> <name><surname>Ji</surname> <given-names>PG</given-names></name> <name><surname>Sakai</surname> <given-names>H</given-names></name> <name><surname>Chan</surname> <given-names>FL</given-names></name> <name><surname>Koropatnick</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model</article-title>. <source>Gene Ther</source>. (<year>2002</year>) <volume>9</volume>:<fpage>1589</fpage>&#x02013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1038/sj.gt.3301895</pub-id><pub-id pub-id-type="pmid">12424611</pub-id></citation></ref>
<ref id="B137">
<label>137.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hicks</surname> <given-names>SM</given-names></name> <name><surname>Vassallo</surname> <given-names>JD</given-names></name> <name><surname>Dieter</surname> <given-names>MZ</given-names></name> <name><surname>Lewis</surname> <given-names>CL</given-names></name> <name><surname>Whiteley</surname> <given-names>LO</given-names></name> <name><surname>Fix</surname> <given-names>AS</given-names></name> <etal/></person-group>. <article-title>Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis</article-title>. <source>Toxicology</source>. (<year>2003</year>) <volume>187</volume>:<fpage>217</fpage>&#x02013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/S0300-483X(03)00060-X</pub-id><pub-id pub-id-type="pmid">12699910</pub-id></citation></ref>
<ref id="B138">
<label>138.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garson</surname> <given-names>K</given-names></name> <name><surname>Macdonald</surname> <given-names>E</given-names></name> <name><surname>Dub&#x000E9;</surname> <given-names>M</given-names></name> <name><surname>Bao</surname> <given-names>R</given-names></name> <name><surname>Hamilton</surname> <given-names>TC</given-names></name> <name><surname>Vanderhyden</surname> <given-names>BC</given-names></name></person-group>. <article-title>Generation of tumors in transgenic mice expressing the SV40 T antigen under the control of ovarian-specific promoter 1</article-title>. <source>J Soc Gynecol Investig</source>. (<year>2003</year>) <volume>10</volume>:<fpage>244</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/S1071-55760300073-X</pub-id><pub-id pub-id-type="pmid">12759154</pub-id></citation></ref>
<ref id="B139">
<label>139.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lou</surname> <given-names>D-Q</given-names></name> <name><surname>Molina</surname> <given-names>T</given-names></name> <name><surname>Bennoun</surname> <given-names>M</given-names></name> <name><surname>Porteu</surname> <given-names>A</given-names></name> <name><surname>Briand</surname> <given-names>P</given-names></name> <name><surname>Joulin</surname> <given-names>V</given-names></name> <etal/></person-group>. <article-title>Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences</article-title>. <source>Cancer Lett</source>. (<year>2005</year>) <volume>229</volume>:<fpage>107</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2004.12.032</pub-id><pub-id pub-id-type="pmid">16157222</pub-id></citation></ref>
<ref id="B140">
<label>140.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grippo</surname> <given-names>PJ</given-names></name> <name><surname>Sandgren</surname> <given-names>EP</given-names></name></person-group>. <article-title>Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model</article-title>. <source>Am J Pathol</source>. (<year>2000</year>) <volume>157</volume>:<fpage>805</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64594-4</pub-id><pub-id pub-id-type="pmid">10980120</pub-id></citation></ref>
<ref id="B141">
<label>141.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname> <given-names>C</given-names></name> <name><surname>van Bruggen</surname> <given-names>I</given-names></name> <name><surname>Segal</surname> <given-names>A</given-names></name> <name><surname>Dunham</surname> <given-names>M</given-names></name> <name><surname>Sherwood</surname> <given-names>A</given-names></name> <name><surname>Koentgen</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent</article-title>. <source>Cancer Res.</source> (<year>2006</year>) <volume>66</volume>:<fpage>10786</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-4668</pub-id><pub-id pub-id-type="pmid">17108115</pub-id></citation></ref>
<ref id="B142">
<label>142.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x000F6;bbert</surname> <given-names>C</given-names></name> <name><surname>M&#x000F6;llmann</surname> <given-names>C</given-names></name> <name><surname>Sch&#x000E4;fers</surname> <given-names>M</given-names></name> <name><surname>Hermann</surname> <given-names>S</given-names></name> <name><surname>Baba</surname> <given-names>HA</given-names></name> <name><surname>Hoffmeier</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Transgenic model of cardiac rhabdomyosarcoma formation</article-title>. <source>J Thorac Cardiovasc Surg.</source> (<year>2008</year>) <volume>136</volume>:<fpage>1178</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtcvs.2008.04.022</pub-id><pub-id pub-id-type="pmid">19026800</pub-id></citation></ref>
<ref id="B143">
<label>143.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>ter Brugge</surname> <given-names>PJ</given-names></name> <name><surname>Ta</surname> <given-names>VBT</given-names></name> <name><surname>de Bruijn</surname> <given-names>MJW</given-names></name> <name><surname>Keijzers</surname> <given-names>G</given-names></name> <name><surname>Maas</surname> <given-names>A</given-names></name> <name><surname>van Gent</surname> <given-names>DC</given-names></name> <etal/></person-group>. <article-title>A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen</article-title>. <source>Blood</source>. (<year>2009</year>) <volume>114</volume>:<fpage>119</fpage>&#x02013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2009-01-198937</pub-id><pub-id pub-id-type="pmid">19332766</pub-id></citation></ref>
<ref id="B144">
<label>144.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stahl</surname> <given-names>S</given-names></name> <name><surname>Sacher</surname> <given-names>T</given-names></name> <name><surname>Bechtold</surname> <given-names>A</given-names></name> <name><surname>Protzer</surname> <given-names>U</given-names></name> <name><surname>Ganss</surname> <given-names>R</given-names></name> <name><surname>H&#x000E4;mmerling</surname> <given-names>GJ</given-names></name> <etal/></person-group>. <article-title>Tumor agonist peptides break tolerance and elicit effective CTL responses in an inducible mouse model of hepatocellular carcinoma</article-title>. <source>Immunol Lett</source>. (<year>2009</year>) <volume>123</volume>:<fpage>31</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.imlet.2009.01.011</pub-id><pub-id pub-id-type="pmid">19428549</pub-id></citation></ref>
<ref id="B145">
<label>145.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iwakura</surname> <given-names>H</given-names></name> <name><surname>Ariyasu</surname> <given-names>H</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Kanamoto</surname> <given-names>N</given-names></name> <name><surname>Bando</surname> <given-names>M</given-names></name> <name><surname>Yamada</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>A mouse model of ghrelinoma exhibited activated growth hormone-insulin-like growth factor I axis and glucose intolerance</article-title>. <source>Am J Physiol Endocrinol Metab</source>. (<year>2009</year>) <volume>297</volume>:<fpage>E802</fpage>&#x02013;<lpage>811</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00205.2009</pub-id><pub-id pub-id-type="pmid">19602582</pub-id></citation></ref>
<ref id="B146">
<label>146.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feigenbaum</surname> <given-names>L</given-names></name> <name><surname>Hinrichs</surname> <given-names>SH</given-names></name> <name><surname>Jay</surname> <given-names>G</given-names></name></person-group>. <article-title>JC virus and simian virus 40 enhancers and transforming proteins: role in determining tissue specificity and pathogenicity in transgenic mice</article-title>. <source>J Virol.</source> (<year>1992</year>) <volume>66</volume>:<fpage>1176</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="pmid">1309896</pub-id></citation></ref>
<ref id="B147">
<label>147.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palmiter</surname> <given-names>RD</given-names></name> <name><surname>Chen</surname> <given-names>HY</given-names></name> <name><surname>Messing</surname> <given-names>A</given-names></name> <name><surname>Brinster</surname> <given-names>RL</given-names></name></person-group>. <article-title>SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice</article-title>. <source>Nature</source>. (<year>1985</year>) <volume>316</volume>:<fpage>457</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1038/316457a0</pub-id><pub-id pub-id-type="pmid">2991771</pub-id></citation></ref>
<ref id="B148">
<label>148.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brinster</surname> <given-names>RL</given-names></name> <name><surname>Chen</surname> <given-names>HY</given-names></name> <name><surname>Messing</surname> <given-names>A</given-names></name> <name><surname>van Dyke</surname> <given-names>T</given-names></name> <name><surname>Levine</surname> <given-names>AJ</given-names></name> <name><surname>Palmiter</surname> <given-names>RD</given-names></name></person-group>. <article-title>Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors</article-title>. <source>Cell</source>. (<year>1984</year>) <volume>37</volume>:<fpage>367</fpage>&#x02013;<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(84)90367-2</pub-id><pub-id pub-id-type="pmid">6327063</pub-id></citation></ref>
<ref id="B149">
<label>149.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>YC</given-names></name> <name><surname>Asa</surname> <given-names>SL</given-names></name> <name><surname>Drucker</surname> <given-names>DJ</given-names></name></person-group>. <article-title>Glucagon gene 5&#x00027;-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice</article-title>. <source>J Biol Chem</source>. (<year>1992</year>) <volume>267</volume>:<fpage>10705</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">1587847</pub-id></citation></ref>
<ref id="B150">
<label>150.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname> <given-names>DM</given-names></name> <name><surname>Kumar</surname> <given-names>A</given-names></name> <name><surname>Strugnell</surname> <given-names>SA</given-names></name> <name><surname>Darjatmoko</surname> <given-names>SR</given-names></name> <name><surname>Lokken</surname> <given-names>JM</given-names></name> <name><surname>Lindstrom</surname> <given-names>MJ</given-names></name> <etal/></person-group>. <article-title>Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model</article-title>. <source>Arch Ophthalmol</source>. (<year>2004</year>) <volume>122</volume>:<fpage>1365</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1001/archopht.122.9.1365</pub-id><pub-id pub-id-type="pmid">15364717</pub-id></citation></ref>
<ref id="B151">
<label>151.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez-Stable</surname> <given-names>C</given-names></name> <name><surname>Altman</surname> <given-names>NH</given-names></name> <name><surname>Brown</surname> <given-names>J</given-names></name> <name><surname>Harbison</surname> <given-names>M</given-names></name> <name><surname>Cray</surname> <given-names>C</given-names></name> <name><surname>Roos</surname> <given-names>BA</given-names></name></person-group>. <article-title>Prostate, adrenocortical, and brown adipose tumors in fetal globin/T antigen transgenic mice</article-title>. <source>Lab Invest</source>. (<year>1996</year>) <volume>74</volume>:<fpage>363</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="pmid">8780156</pub-id></citation></ref>
<ref id="B152">
<label>152.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grabowska</surname> <given-names>MM</given-names></name> <name><surname>DeGraff</surname> <given-names>DJ</given-names></name> <name><surname>Yu</surname> <given-names>X</given-names></name> <name><surname>Jin</surname> <given-names>RJ</given-names></name> <name><surname>Chen</surname> <given-names>Z</given-names></name> <name><surname>Borowsky</surname> <given-names>AD</given-names></name> <etal/></person-group>. <article-title>Mouse models of prostate cancer: picking the best model for the question</article-title>. <source>Cancer Metastasis Rev</source>. (<year>2014</year>) <volume>33</volume>:<fpage>377</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1007/s10555-013-9487-8</pub-id><pub-id pub-id-type="pmid">24452759</pub-id></citation></ref>
<ref id="B153">
<label>153.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname> <given-names>AA</given-names></name> <name><surname>O&#x00027;Hare</surname> <given-names>MN</given-names></name> <name><surname>Shadmand</surname> <given-names>M</given-names></name> <name><surname>Corson</surname> <given-names>TW</given-names></name></person-group>. <article-title>Optical coherence tomography enables imaging of tumor initiation in the TAg-RB mouse model of retinoblastoma</article-title>. <source>Mol Vis</source>. (<year>2015</year>) <volume>21</volume>:<fpage>515</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="pmid">25999678</pub-id></citation></ref>
<ref id="B154">
<label>154.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruns</surname> <given-names>M</given-names></name> <name><surname>Wanger</surname> <given-names>J</given-names></name> <name><surname>Uterm&#x000F6;hlen</surname> <given-names>O</given-names></name> <name><surname>Deppert</surname> <given-names>W</given-names></name></person-group>. <article-title>An inducible transgenic mouse breast cancer model for the analysis of tumor antigen specific CD8&#x0002B; T-cell responses</article-title>. <source>Oncotarget</source>. (<year>2015</year>) <volume>6</volume>:<fpage>38487</fpage>&#x02013;<lpage>503</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.5750</pub-id><pub-id pub-id-type="pmid">26513294</pub-id></citation></ref>
<ref id="B155">
<label>155.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirner</surname> <given-names>H</given-names></name> <name><surname>G&#x000FC;nes</surname> <given-names>C</given-names></name> <name><surname>Bischof</surname> <given-names>J</given-names></name> <name><surname>Wolff</surname> <given-names>S</given-names></name> <name><surname>Grothey</surname> <given-names>A</given-names></name> <name><surname>K&#x000FC;hl</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Impaired CK1 delta activity attenuates SV40-induced cellular transformation <italic>in vitro</italic> and mouse mammary carcinogenesis <italic>in vivo</italic></article-title>. <source>PLoS ONE</source>. (<year>2012</year>) <volume>7</volume>:<fpage>e29709</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0029709</pub-id><pub-id pub-id-type="pmid">22235331</pub-id></citation></ref>
<ref id="B156">
<label>156.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laviolette</surname> <given-names>LA</given-names></name> <name><surname>Garson</surname> <given-names>K</given-names></name> <name><surname>Macdonald</surname> <given-names>EA</given-names></name> <name><surname>Senterman</surname> <given-names>MK</given-names></name> <name><surname>Courville</surname> <given-names>K</given-names></name> <name><surname>Crane</surname> <given-names>CA</given-names></name> <etal/></person-group>. <article-title>17beta-estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer</article-title>. <source>Endocrinology</source>. (<year>2010</year>) <volume>151</volume>:<fpage>929</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1210/en.2009-0602</pub-id><pub-id pub-id-type="pmid">20056833</pub-id></citation></ref>
<ref id="B157">
<label>157.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chrusciel</surname> <given-names>M</given-names></name> <name><surname>Doroszko</surname> <given-names>M</given-names></name> <name><surname>Stelmaszewska</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name> <name><surname>Ziecik</surname> <given-names>AJ</given-names></name> <name><surname>Coelingh-Bennink</surname> <given-names>HJT</given-names></name> <etal/></person-group>. <article-title>Transgenic mice expressing inhibin &#x003B1;-subunit promoter (inh&#x003B1;)/Simian Virus 40 T-antigen (Tag) transgene as a model for the therapy of granulosa cell-derived ovarian cancer</article-title>. <source>Reprod Biol</source>. (<year>2014</year>) <volume>14</volume>:<fpage>25</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.repbio.2013.11.005</pub-id><pub-id pub-id-type="pmid">24607252</pub-id></citation></ref>
<ref id="B158">
<label>158.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braum&#x000FC;ller</surname> <given-names>H</given-names></name> <name><surname>Wieder</surname> <given-names>T</given-names></name> <name><surname>Brenner</surname> <given-names>E</given-names></name> <name><surname>A&#x000DF;mann</surname> <given-names>S</given-names></name> <name><surname>Hahn</surname> <given-names>M</given-names></name> <name><surname>Alkhaled</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>T-helper-1-cell cytokines drive cancer into senescence</article-title>. <source>Nature</source>. (<year>2013</year>) <volume>494</volume>:<fpage>361</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/nature11824</pub-id><pub-id pub-id-type="pmid">23376950</pub-id></citation></ref>
<ref id="B159">
<label>159.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patil</surname> <given-names>PB</given-names></name> <name><surname>Begum</surname> <given-names>S</given-names></name> <name><surname>Joshi</surname> <given-names>M</given-names></name> <name><surname>Kleman</surname> <given-names>MI</given-names></name> <name><surname>Olausson</surname> <given-names>M</given-names></name> <name><surname>Sumitran-Holgersson</surname> <given-names>S</given-names></name></person-group>. <article-title>Phenotypic and <italic>in vivo</italic> functional characterization of immortalized human fetal liver cells</article-title>. <source>Scand J Gastroenterol</source>. (<year>2014</year>) <volume>49</volume>:<fpage>705</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.3109/00365521.2013.830328</pub-id><pub-id pub-id-type="pmid">24730442</pub-id></citation></ref>
<ref id="B160">
<label>160.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergsagel</surname> <given-names>DJ</given-names></name> <name><surname>Finegold</surname> <given-names>MJ</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name> <name><surname>Kupsky</surname> <given-names>WJ</given-names></name> <name><surname>Garcea</surname> <given-names>RL</given-names></name></person-group>. <article-title>DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood</article-title>. <source>N Engl J Med.</source> (<year>1992</year>) <volume>326</volume>:<fpage>988</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199204093261504</pub-id><pub-id pub-id-type="pmid">1312224</pub-id></citation></ref>
<ref id="B161">
<label>161.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Iaccheri</surname> <given-names>L</given-names></name> <name><surname>Lazzarin</surname> <given-names>L</given-names></name> <name><surname>Carinci</surname> <given-names>P</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Gerosa</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals</article-title>. <source>Cancer Res</source>. (<year>1996</year>) <volume>56</volume>:<fpage>4820</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="pmid">8841004</pub-id></citation></ref>
<ref id="B162">
<label>162.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butel</surname> <given-names>JS</given-names></name> <name><surname>Jafar</surname> <given-names>S</given-names></name> <name><surname>Wong</surname> <given-names>C</given-names></name> <name><surname>Arrington</surname> <given-names>AS</given-names></name> <name><surname>Opekun</surname> <given-names>AR</given-names></name> <name><surname>Finegold</surname> <given-names>MJ</given-names></name> <etal/></person-group>. <article-title>Evidence of SV40 infections in hospitalized children</article-title>. <source>Hum Pathol.</source> (<year>1999</year>) <volume>30</volume>:<fpage>1496</fpage>&#x02013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1016/S0046-8177(99)90173-9</pub-id><pub-id pub-id-type="pmid">10667429</pub-id></citation></ref>
<ref id="B163">
<label>163.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butel</surname> <given-names>JS</given-names></name> <name><surname>Arrington</surname> <given-names>AS</given-names></name> <name><surname>Wong</surname> <given-names>C</given-names></name> <name><surname>Lednicky</surname> <given-names>JA</given-names></name> <name><surname>Finegold</surname> <given-names>MJ</given-names></name></person-group>. <article-title>Molecular evidence of simian virus 40 infections in children</article-title>. <source>J Infect Dis.</source> (<year>1999</year>) <volume>180</volume>:<fpage>884</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1086/314915</pub-id><pub-id pub-id-type="pmid">10438386</pub-id></citation></ref>
<ref id="B164">
<label>164.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanchiere</surname> <given-names>JA</given-names></name> <name><surname>White</surname> <given-names>ZS</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>Detection of BK virus and simian virus 40 in the urine of healthy children</article-title>. <source>J Med Virol</source>. (<year>2005</year>) <volume>75</volume>:<fpage>447</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.20287</pub-id><pub-id pub-id-type="pmid">15648074</pub-id></citation></ref>
<ref id="B165">
<label>165.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horv&#x000E1;th</surname> <given-names>LB</given-names></name></person-group>. <article-title>Incidence of SV-40 virus neutralizing antibodies in sera of laboratory workers</article-title>. <source>Acta Microbiol Acad Sci Hung.</source> (<year>1965</year>) <volume>12</volume>:<fpage>201</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="pmid">4284273</pub-id></citation></ref>
<ref id="B166">
<label>166.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>KV</given-names></name> <name><surname>Goverdhan</surname> <given-names>MK</given-names></name> <name><surname>Ozer</surname> <given-names>H</given-names></name></person-group>. <article-title>Neutralizing antibodies to SV40 in human sera from South India: search for additional hosts of SV40</article-title>. <source>Am J Epidemiol.</source> (<year>1971</year>) <volume>93</volume>:<fpage>291</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a121260</pub-id><pub-id pub-id-type="pmid">4323767</pub-id></citation></ref>
<ref id="B167">
<label>167.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname> <given-names>M</given-names></name> <name><surname>Rizzo</surname> <given-names>P</given-names></name> <name><surname>Pass</surname> <given-names>HI</given-names></name></person-group>. <article-title>Simian virus 40, poliovaccines and human tumors: a review of recent developments</article-title>. <source>Oncogene</source>. (<year>1997</year>) <volume>15</volume>:<fpage>1877</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1201375</pub-id><pub-id pub-id-type="pmid">9365233</pub-id></citation></ref>
<ref id="B168">
<label>168.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elswood</surname> <given-names>BF</given-names></name> <name><surname>Stricker</surname> <given-names>RB</given-names></name></person-group>. <article-title>Polio vaccines and the origin of AIDS</article-title>. <source>Med Hypotheses.</source> (<year>1994</year>) <volume>42</volume>:<fpage>347</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/0306-9877(94)90151-1</pub-id><pub-id pub-id-type="pmid">7935079</pub-id></citation></ref>
<ref id="B169">
<label>169.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lapin</surname> <given-names>BA</given-names></name> <name><surname>Chikobava</surname> <given-names>MG</given-names></name></person-group>. <article-title>Detection of SV40 in blood samples from healthy subjects in the Russian Federation by RT-PCR</article-title>. <source>Vestn Akad Med Nauk SSSR</source>. (<year>2009</year>) <volume>2009</volume>:<fpage>7</fpage>&#x02013;<lpage>10</lpage>.</citation></ref>
<ref id="B170">
<label>170.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cutrone</surname> <given-names>R</given-names></name> <name><surname>Lednicky</surname> <given-names>J</given-names></name> <name><surname>Dunn</surname> <given-names>G</given-names></name> <name><surname>Rizzo</surname> <given-names>P</given-names></name> <name><surname>Bocchetta</surname> <given-names>M</given-names></name> <name><surname>Chumakov</surname> <given-names>K</given-names></name> <etal/></person-group>. <article-title>Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961</article-title>. <source>Cancer Res</source>. (<year>2005</year>) <volume>65</volume>:<fpage>10273</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-2028</pub-id><pub-id pub-id-type="pmid">16288015</pub-id></citation></ref>
<ref id="B171">
<label>171.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sangar</surname> <given-names>D</given-names></name> <name><surname>Pipkin</surname> <given-names>PA</given-names></name> <name><surname>Wood</surname> <given-names>DJ</given-names></name> <name><surname>Minor</surname> <given-names>PD</given-names></name></person-group>. <article-title>Examination of poliovirus vaccine preparations for SV40 sequences</article-title>. <source>Biologicals</source>. (<year>1999</year>) <volume>27</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1006/biol.1998.0170</pub-id><pub-id pub-id-type="pmid">10441397</pub-id></citation></ref>
<ref id="B172">
<label>172.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname> <given-names>P</given-names></name> <name><surname>Di Resta</surname> <given-names>I</given-names></name> <name><surname>Powers</surname> <given-names>A</given-names></name> <name><surname>Ratner</surname> <given-names>H</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name></person-group>. <article-title>Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection</article-title>. <source>Cancer Res</source>. (<year>1999</year>) <volume>59</volume>:<fpage>6103</fpage>&#x02013;<lpage>8</lpage>.</citation></ref>
<ref id="B173">
<label>173.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melnick</surname> <given-names>JL</given-names></name> <name><surname>Stinebaugh</surname> <given-names>S</given-names></name></person-group>. <article-title>Excretion of vacuolating SV-40 virus (papova virus group) after ingestion as a contaminant of oral poliovaccine</article-title>. <source>Proc Soc Exp Biol Med.</source> (<year>1962</year>) <volume>109</volume>:<fpage>965</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3181/00379727-109-27392</pub-id><pub-id pub-id-type="pmid">14472428</pub-id></citation></ref>
<ref id="B174">
<label>174.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rollison</surname> <given-names>DEM</given-names></name> <name><surname>Page</surname> <given-names>WF</given-names></name> <name><surname>Crawford</surname> <given-names>H</given-names></name> <name><surname>Gridley</surname> <given-names>G</given-names></name> <name><surname>Wacholder</surname> <given-names>S</given-names></name> <name><surname>Martin</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Case-control study of cancer among US Army veterans exposed to simian virus 40-contaminated adenovirus vaccine</article-title>. <source>Am J Epidemiol</source>. (<year>2004</year>) <volume>160</volume>:<fpage>317</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwh212</pub-id><pub-id pub-id-type="pmid">15286016</pub-id></citation></ref>
<ref id="B175">
<label>175.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richmond</surname> <given-names>JE</given-names></name> <name><surname>Parry</surname> <given-names>JV</given-names></name> <name><surname>Gardner</surname> <given-names>SD</given-names></name></person-group>. <article-title>Characterisation of a polyomavirus in two foetal rhesus monkey kidney cell lines used for the growth of hepatitis A virus</article-title>. <source>Arch Virol.</source> (<year>1984</year>) <volume>80</volume>:<fpage>131</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1007/BF01310654</pub-id><pub-id pub-id-type="pmid">6326710</pub-id></citation></ref>
<ref id="B176">
<label>176.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname> <given-names>JA</given-names></name> <name><surname>Johnson</surname> <given-names>KM</given-names></name> <name><surname>Aulisio</surname> <given-names>CG</given-names></name> <name><surname>Chanock</surname> <given-names>RM</given-names></name> <name><surname>Knight</surname> <given-names>V</given-names></name></person-group>. <article-title>Clinical and serologic responses in volunteers given vacuolating virus (SV-40) by respiratory route</article-title>. <source>Proc Soc Exp Biol Med.</source> (<year>1961</year>) <volume>108</volume>:<fpage>56</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3181/00379727-108-26843</pub-id><pub-id pub-id-type="pmid">14476249</pub-id></citation></ref>
<ref id="B177">
<label>177.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Giari</surname> <given-names>L</given-names></name> <name><surname>Guerranti</surname> <given-names>C</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name> <name><surname>Castaldelli</surname> <given-names>G</given-names></name> <name><surname>Fano</surname> <given-names>EA</given-names></name> <etal/></person-group>. <article-title>Environmental doses of perfluorooctanoic acid change the expression of genes in target tissues of common carp</article-title>. <source>Environ Toxicol Chem.</source> (<year>2018</year>) <volume>37</volume>:<fpage>942</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/etc.4029</pub-id><pub-id pub-id-type="pmid">29105837</pub-id></citation></ref>
<ref id="B178">
<label>178.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trentini</surname> <given-names>A</given-names></name> <name><surname>Manfrinato</surname> <given-names>MC</given-names></name> <name><surname>Castellazzi</surname> <given-names>M</given-names></name> <name><surname>Tamborino</surname> <given-names>C</given-names></name> <name><surname>Roversi</surname> <given-names>G</given-names></name> <name><surname>Volta</surname> <given-names>CA</given-names></name> <etal/></person-group>. <article-title>TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis</article-title>. <source>Mult Scler.</source> (<year>2015</year>) <volume>21</volume>:<fpage>1121</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1177/1352458514560925</pub-id><pub-id pub-id-type="pmid">25662349</pub-id></citation></ref>
<ref id="B179">
<label>179.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Woloschak</surname> <given-names>M</given-names></name> <name><surname>Yu</surname> <given-names>A</given-names></name> <name><surname>Post</surname> <given-names>KD</given-names></name></person-group>. <article-title>Detection of polyomaviral DNA sequences in normal and adenomatous human pituitary tissues using the polymerase chain reaction</article-title>. <source>Cancer</source>. (<year>1995</year>) <volume>76</volume>:<fpage>490</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/1097-0142(19950801)76:3&#x0003C;490::AID-CNCR2820760320&#x0003E;3.0.CO;2-%23</pub-id><pub-id pub-id-type="pmid">8625131</pub-id></citation></ref>
<ref id="B180">
<label>180.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paracchini</surname> <given-names>V</given-names></name> <name><surname>Garte</surname> <given-names>S</given-names></name> <name><surname>Pedotti</surname> <given-names>P</given-names></name> <name><surname>Poli</surname> <given-names>F</given-names></name> <name><surname>Frison</surname> <given-names>S</given-names></name> <name><surname>Taioli</surname> <given-names>E</given-names></name></person-group>. <article-title>Molecular identification of simian virus 40 infection in healthy Italian subjects by birth cohort</article-title>. <source>Mol Med</source>. (<year>2005</year>) <volume>11</volume>:<fpage>48</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.2119/2005-00007</pub-id><pub-id pub-id-type="pmid">16032367</pub-id></citation></ref>
<ref id="B181">
<label>181.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Lazzarin</surname> <given-names>L</given-names></name> <name><surname>Iaccheri</surname> <given-names>L</given-names></name> <name><surname>Vignocchi</surname> <given-names>B</given-names></name> <name><surname>Finocchiaro</surname> <given-names>G</given-names></name> <name><surname>Magnani</surname> <given-names>I</given-names></name> <etal/></person-group>. <article-title>Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors</article-title>. <source>Cancer</source>. (<year>2002</year>) <volume>94</volume>:<fpage>1037</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.10272</pub-id><pub-id pub-id-type="pmid">11920474</pub-id></citation></ref>
<ref id="B182">
<label>182.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>David</surname> <given-names>H</given-names></name> <name><surname>Mendoza</surname> <given-names>S</given-names></name> <name><surname>Konishi</surname> <given-names>T</given-names></name> <name><surname>Miller</surname> <given-names>CW</given-names></name></person-group>. <article-title>Simian virus 40 is present in human lymphomas and normal blood</article-title>. <source>Cancer Lett.</source> (<year>2001</year>) <volume>162</volume>:<fpage>57</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3835(00)00628-5</pub-id><pub-id pub-id-type="pmid">11121863</pub-id></citation></ref>
<ref id="B183">
<label>183.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>R-M</given-names></name> <name><surname>Mannon</surname> <given-names>RB</given-names></name> <name><surname>Kleiner</surname> <given-names>D</given-names></name> <name><surname>Tsokos</surname> <given-names>M</given-names></name> <name><surname>Bynum</surname> <given-names>M</given-names></name> <name><surname>Kirk</surname> <given-names>AD</given-names></name> <etal/></person-group>. <article-title>BK virus and SV40 co-infection in polyomavirus nephropathy</article-title>. <source>Transplantation.</source> (<year>2002</year>) <volume>74</volume>:<fpage>1497</fpage>&#x02013;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1097/00007890-200212150-00004</pub-id><pub-id pub-id-type="pmid">12490781</pub-id></citation></ref>
<ref id="B184">
<label>184.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>R-M</given-names></name> <name><surname>Branton</surname> <given-names>MH</given-names></name> <name><surname>Tanawattanacharoen</surname> <given-names>S</given-names></name> <name><surname>Falk</surname> <given-names>RA</given-names></name> <name><surname>Jennette</surname> <given-names>JC</given-names></name> <name><surname>Kopp</surname> <given-names>JB</given-names></name></person-group>. <article-title>Molecular identification of SV40 infection in human subjects and possible association with kidney disease</article-title>. <source>J Am Soc Nephrol.</source> (<year>2002</year>) <volume>13</volume>:<fpage>2320</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1097/01.ASN.0000028249.06596.CF</pub-id><pub-id pub-id-type="pmid">12191976</pub-id></citation></ref>
<ref id="B185">
<label>185.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>De Mattei</surname> <given-names>M</given-names></name> <name><surname>Iaccheri</surname> <given-names>L</given-names></name> <name><surname>Lazzarin</surname> <given-names>L</given-names></name> <name><surname>Barbanti-Brodano</surname> <given-names>G</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Human brain tumors and simian virus 40</article-title>. <source>J Natl Cancer Inst</source>. (<year>1995</year>) <volume>87</volume>:<fpage>1331</fpage>. <pub-id pub-id-type="doi">10.1093/jnci/87.17.1331</pub-id><pub-id pub-id-type="pmid">7658487</pub-id></citation></ref>
<ref id="B186">
<label>186.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname> <given-names>H</given-names></name> <name><surname>Nakayama</surname> <given-names>T</given-names></name> <name><surname>Murakami</surname> <given-names>H</given-names></name> <name><surname>Hosaka</surname> <given-names>T</given-names></name> <name><surname>Nakamata</surname> <given-names>T</given-names></name> <name><surname>Tsuboyama</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients</article-title>. <source>Br J Cancer.</source> (<year>2000</year>) <volume>82</volume>:<fpage>1677</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1054/bjoc.2000.1213</pub-id><pub-id pub-id-type="pmid">10817503</pub-id></citation></ref>
<ref id="B187">
<label>187.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pancaldi</surname> <given-names>C</given-names></name> <name><surname>Balatti</surname> <given-names>V</given-names></name> <name><surname>Guaschino</surname> <given-names>R</given-names></name> <name><surname>Vaniglia</surname> <given-names>F</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Martini</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Simian virus 40 sequences in blood specimens from healthy individuals of Casale Monferrato, an industrial town with a history of asbestos pollution</article-title>. <source>J Infect.</source> (<year>2009</year>) <volume>58</volume>:<fpage>53</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2008.10.014</pub-id><pub-id pub-id-type="pmid">19070904</pub-id></citation></ref>
<ref id="B188">
<label>188.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vanchiere</surname> <given-names>JA</given-names></name> <name><surname>Nicome</surname> <given-names>RK</given-names></name> <name><surname>Greer</surname> <given-names>JM</given-names></name> <name><surname>Demmler</surname> <given-names>GJ</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>Frequent detection of polyomaviruses in stool samples from hospitalized children</article-title>. <source>J Infect Dis</source>. (<year>2005</year>) <volume>192</volume>:<fpage>658</fpage>&#x02013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1086/432076</pub-id><pub-id pub-id-type="pmid">16028135</pub-id></citation></ref>
<ref id="B189">
<label>189.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minor</surname> <given-names>P</given-names></name> <name><surname>Pipkin</surname> <given-names>PA</given-names></name> <name><surname>Cutler</surname> <given-names>K</given-names></name> <name><surname>Dunn</surname> <given-names>G</given-names></name></person-group>. <article-title>Natural infection and transmission of SV40</article-title>. <source>Virology</source>. (<year>2003</year>) <volume>314</volume>:<fpage>403</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0042-6822(03)00435-5</pub-id><pub-id pub-id-type="pmid">14517092</pub-id></citation></ref>
<ref id="B190">
<label>190.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Frontini</surname> <given-names>F</given-names></name> <name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Zanotta</surname> <given-names>N</given-names></name> <name><surname>Fioravanti</surname> <given-names>A</given-names></name> <name><surname>Minelli</surname> <given-names>F</given-names></name> <etal/></person-group>. <article-title>Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children</article-title>. <source>J Cell Physiol.</source> (<year>2018</year>) <volume>234</volume>:<fpage>3170</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.27490</pub-id><pub-id pub-id-type="pmid">30362540</pub-id></citation></ref>
<ref id="B191">
<label>191.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Taronna</surname> <given-names>A</given-names></name> <name><surname>Manfrini</surname> <given-names>M</given-names></name> <name><surname>Carandina</surname> <given-names>G</given-names></name> <name><surname>Guerra</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Specific antibodies reacting with simian virus 40 capsid protein mimotopes in serum samples from healthy blood donors</article-title>. <source>Hum Immunol</source>. (<year>2012</year>) <volume>73</volume>:<fpage>502</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.humimm.2012.02.009</pub-id><pub-id pub-id-type="pmid">22387152</pub-id></citation></ref>
<ref id="B192">
<label>192.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tognon</surname> <given-names>M</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Manfrini</surname> <given-names>M</given-names></name> <name><surname>Taronna</surname> <given-names>A</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name> <name><surname>Pietrobon</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Specific antibodies reacting with SV40 large T antigen mimotopes in serum samples of healthy subjects</article-title>. <source>PLoS ONE</source>. (<year>2016</year>) <volume>11</volume>:<fpage>e0145720</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0145720</pub-id><pub-id pub-id-type="pmid">26731525</pub-id></citation></ref>
<ref id="B193">
<label>193.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taronna</surname> <given-names>A</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Bononi</surname> <given-names>I</given-names></name> <name><surname>Pietrobon</surname> <given-names>S</given-names></name> <name><surname>Guerra</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents</article-title>. <source>PLoS ONE.</source> (<year>2013</year>) <volume>8</volume>:<fpage>e61182</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0061182</pub-id><pub-id pub-id-type="pmid">23634207</pub-id></citation></ref>
<ref id="B194">
<label>194.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name> <name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Taronna</surname> <given-names>A</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Barbanti-Brodano</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Simian virus 40 (SV40) antibodies in elderly subjects</article-title>. <source>J Infect.</source> (<year>2013</year>) <volume>67</volume>:<fpage>356</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2013.06.002</pub-id><pub-id pub-id-type="pmid">23769838</pub-id></citation></ref>
<ref id="B195">
<label>195.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Guerra</surname> <given-names>G</given-names></name> <name><surname>Casali</surname> <given-names>MV</given-names></name> <name><surname>Pietrobon</surname> <given-names>S</given-names></name> <name><surname>Bononi</surname> <given-names>I</given-names></name> <name><surname>Puozzo</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Antibodies against mimotopes of simian virus 40 large T antigen, the oncoprotein, in serum samples from elderly healthy subjects</article-title>. <source>J Cell Physiol.</source> (<year>2017</year>) <volume>232</volume>:<fpage>176</fpage>&#x02013;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.25405</pub-id><pub-id pub-id-type="pmid">27064510</pub-id></citation></ref>
<ref id="B196">
<label>196.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comar</surname> <given-names>M</given-names></name> <name><surname>Wong</surname> <given-names>C</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>Neutralizing and IgG antibodies against simian virus 40 in healthy pregnant women in Italy</article-title>. <source>PLoS ONE.</source> (<year>2014</year>) <volume>9</volume>:<fpage>e110700</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0110700</pub-id><pub-id pub-id-type="pmid">25335106</pub-id></citation></ref>
<ref id="B197">
<label>197.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Di Stefano</surname> <given-names>M</given-names></name> <name><surname>Fiore</surname> <given-names>JR</given-names></name> <name><surname>Destro</surname> <given-names>F</given-names></name> <name><surname>Manfrini</surname> <given-names>M</given-names></name> <name><surname>Rotondo</surname> <given-names>JC</given-names></name> <etal/></person-group>. <article-title>Serum IgG antibodies from pregnant women reacting to mimotopes of simian virus 40 large T antigen, the viral oncoprotein</article-title>. <source>Front Immunol.</source> (<year>2017</year>) <volume>8</volume>:<fpage>411</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00411</pub-id><pub-id pub-id-type="pmid">28443094</pub-id></citation></ref>
<ref id="B198">
<label>198.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lundstig</surname> <given-names>A</given-names></name> <name><surname>Eliasson</surname> <given-names>L</given-names></name> <name><surname>Lehtinen</surname> <given-names>M</given-names></name> <name><surname>Sasnauskas</surname> <given-names>K</given-names></name> <name><surname>Koskela</surname> <given-names>P</given-names></name> <name><surname>Dillner</surname> <given-names>J</given-names></name></person-group>. <article-title>Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles</article-title>. <source>J Gen Virol.</source> (<year>2005</year>) <volume>86</volume>(<issue>Pt 6</issue>):<fpage>1703</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1099/vir.0.80783-0</pub-id><pub-id pub-id-type="pmid">15914848</pub-id></citation></ref>
<ref id="B199">
<label>199.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stolt</surname> <given-names>A</given-names></name> <name><surname>Sasnauskas</surname> <given-names>K</given-names></name> <name><surname>Koskela</surname> <given-names>P</given-names></name> <name><surname>Lehtinen</surname> <given-names>M</given-names></name> <name><surname>Dillner</surname> <given-names>J</given-names></name></person-group>. <article-title>Seroepidemiology of the human polyomaviruses</article-title>. <source>J Gen Virol.</source> (<year>2003</year>) <volume>84</volume>(<issue>Pt 6</issue>):<fpage>1499</fpage>&#x02013;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1099/vir.0.18842-0</pub-id><pub-id pub-id-type="pmid">12771419</pub-id></citation></ref>
<ref id="B200">
<label>200.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basetse</surname> <given-names>HR</given-names></name> <name><surname>Lecatsas</surname> <given-names>G</given-names></name> <name><surname>Gerber</surname> <given-names>LJ</given-names></name></person-group>. <article-title>An investigation of the occurrence of SV40 antibodies in South Africa</article-title>. <source>S Afr Med J</source>. (<year>2002</year>) <volume>92</volume>:<fpage>825</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">12432810</pub-id></citation></ref>
<ref id="B201">
<label>201.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rollison</surname> <given-names>DEM</given-names></name> <name><surname>Helzlsouer</surname> <given-names>KJ</given-names></name> <name><surname>Alberg</surname> <given-names>AJ</given-names></name> <name><surname>Hoffman</surname> <given-names>S</given-names></name> <name><surname>Hou</surname> <given-names>J</given-names></name> <name><surname>Daniel</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. (<year>2003</year>) <volume>12</volume>:<fpage>460</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="pmid">12750243</pub-id></citation></ref>
<ref id="B202">
<label>202.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kean</surname> <given-names>JM</given-names></name> <name><surname>Rao</surname> <given-names>S</given-names></name> <name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Garcea</surname> <given-names>RL</given-names></name></person-group>. <article-title>Seroepidemiology of human polyomaviruses</article-title>. <source>PLoS Pathog</source>. (<year>2009</year>) <volume>5</volume>:<fpage>e1000363</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1000363</pub-id><pub-id pub-id-type="pmid">19325891</pub-id></citation></ref>
<ref id="B203">
<label>203.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butel</surname> <given-names>JS</given-names></name> <name><surname>Wong</surname> <given-names>C</given-names></name> <name><surname>Vilchez</surname> <given-names>RA</given-names></name> <name><surname>Sz&#x000FC;cs</surname> <given-names>G</given-names></name> <name><surname>D&#x000F6;m&#x000F6;k</surname> <given-names>I</given-names></name> <name><surname>Kr&#x000ED;z</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Detection of antibodies to polyomavirus SV40 in two central European countries</article-title>. <source>Cent Eur J Public Health</source>. (<year>2003</year>) <volume>11</volume>:<fpage>3</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="pmid">12690795</pub-id></citation></ref>
<ref id="B204">
<label>204.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Sanjose</surname> <given-names>S</given-names></name> <name><surname>Shah</surname> <given-names>KV</given-names></name> <name><surname>Domingo-Domenech</surname> <given-names>E</given-names></name> <name><surname>Engels</surname> <given-names>EA</given-names></name> <name><surname>Fernandez de Sevilla</surname> <given-names>A</given-names></name> <name><surname>Alvaro</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Lack of serological evidence for an association between simian virus 40 and lymphoma</article-title>. <source>Int J Cancer</source>. (<year>2003</year>) <volume>104</volume>:<fpage>522</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.11326</pub-id><pub-id pub-id-type="pmid">12584752</pub-id></citation></ref>
<ref id="B205">
<label>205.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jafar</surname> <given-names>S</given-names></name> <name><surname>Rodriguez-Barradas</surname> <given-names>M</given-names></name> <name><surname>Graham</surname> <given-names>DY</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>Serological evidence of SV40 infections in HIV-infected and HIV-negative adults</article-title>. <source>J Med Virol</source>. (<year>1998</year>) <volume>54</volume>:<fpage>276</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9071(199804)54:4&#x0003C;276::AID-JMV7&#x0003E;3.0.CO;2-1</pub-id><pub-id pub-id-type="pmid">9557293</pub-id></citation></ref>
<ref id="B206">
<label>206.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname> <given-names>KV</given-names></name> <name><surname>Ozer</surname> <given-names>HL</given-names></name> <name><surname>Pond</surname> <given-names>HS</given-names></name> <name><surname>Palma</surname> <given-names>LD</given-names></name> <name><surname>Murphy</surname> <given-names>GP</given-names></name></person-group>. <article-title>SV40 neutralizing antibodies in sera of US residents without history of polio immunization</article-title>. <source>Nature</source>. (<year>1971</year>) <volume>231</volume>:<fpage>448</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/231448a0</pub-id><pub-id pub-id-type="pmid">4325516</pub-id></citation></ref>
<ref id="B207">
<label>207.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geissler</surname> <given-names>E</given-names></name> <name><surname>Konzer</surname> <given-names>P</given-names></name> <name><surname>Scherneck</surname> <given-names>S</given-names></name> <name><surname>Zimmermann</surname> <given-names>W</given-names></name></person-group>. <article-title>Sera collected before introduction of contaminated polio vaccine contain antibodies against SV40</article-title>. <source>Acta Virol</source>. (<year>1985</year>) <volume>29</volume>:<fpage>420</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="pmid">2866697</pub-id></citation></ref>
<ref id="B208">
<label>208.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Viscidi</surname> <given-names>RP</given-names></name> <name><surname>Rollison</surname> <given-names>DEM</given-names></name> <name><surname>Viscidi</surname> <given-names>E</given-names></name> <name><surname>Clayman</surname> <given-names>B</given-names></name> <name><surname>Rubalcaba</surname> <given-names>E</given-names></name> <name><surname>Daniel</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays</article-title>. <source>Clin Diagn Lab Immunol.</source> (<year>2003</year>) <volume>10</volume>:<fpage>278</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1128/CDLI.10.2.278-285.2003</pub-id><pub-id pub-id-type="pmid">12626455</pub-id></citation></ref>
<ref id="B209">
<label>209.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Borgna-Pignatti</surname> <given-names>C</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Felletti</surname> <given-names>M</given-names></name> <name><surname>Turl&#x000E0;</surname> <given-names>G</given-names></name> <name><surname>Malaventura</surname> <given-names>C</given-names></name> <name><surname>Cappellini</surname> <given-names>MD</given-names></name> <etal/></person-group>. <article-title>Antibodies reacting with Simian virus 40 mimotopes in serum samples from patients with thalassaemia major</article-title>. <source>Blood Transfus.</source> (<year>2014</year>) <volume>12</volume>:<fpage>464</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.2450/2013.0220-13</pub-id><pub-id pub-id-type="pmid">24887224</pub-id></citation></ref>
<ref id="B210">
<label>210.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>C</given-names></name> <name><surname>Vilchez</surname> <given-names>RA</given-names></name> <name><surname>Quiroz</surname> <given-names>J</given-names></name> <name><surname>Adam</surname> <given-names>E</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas</article-title>. <source>J Infect</source>. (<year>2013</year>) <volume>66</volume>:<fpage>67</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2012.08.014</pub-id><pub-id pub-id-type="pmid">22940252</pub-id></citation></ref>
<ref id="B211">
<label>211.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Taronna</surname> <given-names>A</given-names></name> <name><surname>Querzoli</surname> <given-names>P</given-names></name> <name><surname>Magri</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Breast cancer and simian virus 40 infection</article-title>. <source>Epidemiology</source>. (<year>2013</year>) <volume>24</volume>:<fpage>464</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1097/EDE.0b013e31828d3ae6</pub-id><pub-id pub-id-type="pmid">23549184</pub-id></citation></ref>
<ref id="B212">
<label>212.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krieg</surname> <given-names>P</given-names></name> <name><surname>Amtmann</surname> <given-names>E</given-names></name> <name><surname>Jonas</surname> <given-names>D</given-names></name> <name><surname>Fischer</surname> <given-names>H</given-names></name> <name><surname>Zang</surname> <given-names>K</given-names></name> <name><surname>Sauer</surname> <given-names>G</given-names></name></person-group>. <article-title>Episomal simian virus 40 genomes in human brain tumors</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>1981</year>) <volume>78</volume>:<fpage>6446</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.78.10.6446</pub-id><pub-id pub-id-type="pmid">6273871</pub-id></citation></ref>
<ref id="B213">
<label>213.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhen</surname> <given-names>HN</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <name><surname>Bu</surname> <given-names>XY</given-names></name> <name><surname>Zhang</surname> <given-names>ZW</given-names></name> <name><surname>Huang</surname> <given-names>WJ</given-names></name> <name><surname>Zhang</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors</article-title>. <source>Cancer.</source> (<year>1999</year>) <volume>86</volume>:<fpage>2124</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0142(19991115)86:10&#x0003C;2124::AID-CNCR34&#x0003E;3.0.CO;2-D</pub-id><pub-id pub-id-type="pmid">10570441</pub-id></citation></ref>
<ref id="B214">
<label>214.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>H</given-names></name> <name><surname>Reis</surname> <given-names>R</given-names></name> <name><surname>Yonekawa</surname> <given-names>Y</given-names></name> <name><surname>Lopes</surname> <given-names>JM</given-names></name> <name><surname>Kleihues</surname> <given-names>P</given-names></name> <name><surname>Ohgaki</surname> <given-names>H</given-names></name></person-group>. <article-title>Identification in human brain tumors of DNA sequences specific for SV40 large T antigen</article-title>. <source>Brain Pathol.</source> (<year>1999</year>) <volume>9</volume>:<fpage>33</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3639.1999.tb00207.x</pub-id><pub-id pub-id-type="pmid">9989448</pub-id></citation></ref>
<ref id="B215">
<label>215.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Garcea</surname> <given-names>RL</given-names></name></person-group>. <article-title>Simian virus 40 DNA sequences in human brain and bone tumours</article-title>. <source>Dev Biol Stand.</source> (<year>1998</year>) <volume>94</volume>:<fpage>13</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="pmid">9776221</pub-id></citation></ref>
<ref id="B216">
<label>216.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Cultrera</surname> <given-names>R</given-names></name> <name><surname>Contini</surname> <given-names>C</given-names></name> <name><surname>Tognon</surname> <given-names>M</given-names></name></person-group>. <article-title>Simian virus 40 sequences in an AIDS patient with a cerebral lesion: a case report</article-title>. <source>Scand J Infect Dis.</source> (<year>2006</year>) <volume>38</volume>:<fpage>731</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1080/00365540500372911</pub-id><pub-id pub-id-type="pmid">16857629</pub-id></citation></ref>
<ref id="B217">
<label>217.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname> <given-names>SO</given-names></name> <name><surname>Mizoguchi</surname> <given-names>M</given-names></name> <name><surname>Iwaki</surname> <given-names>T</given-names></name></person-group>. <article-title>Detection of SV40 T antigen genome in human gliomas</article-title>. <source>Brain Tumor Pathol.</source> (<year>1997</year>) <volume>14</volume>:<fpage>125</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/BF02478881</pub-id><pub-id pub-id-type="pmid">15726791</pub-id></citation></ref>
<ref id="B218">
<label>218.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Gerosa</surname> <given-names>M</given-names></name> <name><surname>Lupidi</surname> <given-names>F</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Taronna</surname> <given-names>AP</given-names></name> <name><surname>D&#x00027;Agostino</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Significant prevalence of antibodies reacting with simian virus 40 mimotopes in sera from patients affected by glioblastoma multiforme</article-title>. <source>Neuro Oncol</source>. (<year>2014</year>) <volume>16</volume>:<fpage>513</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/neuonc/not217</pub-id><pub-id pub-id-type="pmid">24305701</pub-id></citation></ref>
<ref id="B219">
<label>219.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Hao</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>C</given-names></name> <name><surname>Wang</surname> <given-names>Z</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Li</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>The landscape of viral expression reveals clinically relevant viruses with potential capability of promoting malignancy in lower-grade glioma</article-title>. <source>Clin Cancer Res</source>. (<year>2017</year>) <volume>23</volume>:<fpage>2177</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-16-1495</pub-id><pub-id pub-id-type="pmid">27864420</pub-id></citation></ref>
<ref id="B220">
<label>220.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arrington</surname> <given-names>AS</given-names></name> <name><surname>Moore</surname> <given-names>MS</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>SV40-positive brain tumor in scientist with risk of laboratory exposure to the virus</article-title>. <source>Oncogene</source>. (<year>2004</year>) <volume>23</volume>:<fpage>2231</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1207341</pub-id><pub-id pub-id-type="pmid">14676832</pub-id></citation></ref>
<ref id="B221">
<label>221.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ibelgaufts</surname> <given-names>H</given-names></name> <name><surname>Jones</surname> <given-names>KW</given-names></name></person-group>. <article-title>Papovavirus-related RNA sequences in human neurogenic tumours</article-title>. <source>Acta Neuropathol.</source> (<year>1982</year>) <volume>56</volume>:<fpage>118</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1007/BF00690582</pub-id><pub-id pub-id-type="pmid">6278814</pub-id></citation></ref>
<ref id="B222">
<label>222.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campello</surname> <given-names>C</given-names></name> <name><surname>Comar</surname> <given-names>M</given-names></name> <name><surname>Zanotta</surname> <given-names>N</given-names></name> <name><surname>Minicozzi</surname> <given-names>A</given-names></name> <name><surname>Rodella</surname> <given-names>L</given-names></name> <name><surname>Poli</surname> <given-names>A</given-names></name></person-group>. <article-title>Detection of SV40 in colon cancer: a molecular case-control study from northeast Italy</article-title>. <source>J Med Virol.</source> (<year>2010</year>) <volume>82</volume>:<fpage>1197</fpage>&#x02013;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.21798</pub-id><pub-id pub-id-type="pmid">20513084</pub-id></citation></ref>
<ref id="B223">
<label>223.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Taronna</surname> <given-names>A</given-names></name> <name><surname>Barbanti-Brodano</surname> <given-names>G</given-names></name> <name><surname>Querzoli</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Serologic investigation of undifferentiated nasopharyngeal carcinoma and simian virus 40 infection</article-title>. <source>Head Neck.</source> (<year>2016</year>) <volume>38</volume>:<fpage>232</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/hed.23879</pub-id><pub-id pub-id-type="pmid">25244358</pub-id></citation></ref>
<ref id="B224">
<label>224.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lednicky</surname> <given-names>JA</given-names></name> <name><surname>Stewart</surname> <given-names>AR</given-names></name> <name><surname>Jenkins</surname> <given-names>JJ</given-names></name> <name><surname>Finegold</surname> <given-names>MJ</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes</article-title>. <source>Int J Cancer</source>. (<year>1997</year>) <volume>72</volume>:<fpage>791</fpage>&#x02013;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0215(19970904)72:5&#x0003C;791::AID-IJC15&#x0003E;3.0.CO;2-C</pub-id><pub-id pub-id-type="pmid">9311596</pub-id></citation></ref>
<ref id="B225">
<label>225.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Benassi</surname> <given-names>MS</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Barbanti-Brodano</surname> <given-names>G</given-names></name> <name><surname>Taronna</surname> <given-names>A</given-names></name> <name><surname>Picci</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Significant association between human osteosarcoma and simian virus 40</article-title>. <source>Cancer</source>. (<year>2015</year>) <volume>121</volume>:<fpage>708</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.29137</pub-id><pub-id pub-id-type="pmid">25377935</pub-id></citation></ref>
<ref id="B226">
<label>226.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heinsohn</surname> <given-names>S</given-names></name> <name><surname>Szendroi</surname> <given-names>M</given-names></name> <name><surname>Bielack</surname> <given-names>S</given-names></name> <name><surname>Stadt</surname> <given-names>UZ</given-names></name> <name><surname>Kabisch</surname> <given-names>H</given-names></name></person-group>. <article-title>Evaluation of SV40 in osteosarcoma and healthy population: a Hungarian-German study</article-title>. <source>Oncol Rep</source>. (<year>2009</year>) <volume>21</volume>:<fpage>289</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.3892/or_00000220</pub-id><pub-id pub-id-type="pmid">19148498</pub-id></citation></ref>
<ref id="B227">
<label>227.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galateau-Salle</surname> <given-names>F</given-names></name> <name><surname>Bidet</surname> <given-names>P</given-names></name> <name><surname>Iwatsubo</surname> <given-names>Y</given-names></name> <name><surname>Gennetay</surname> <given-names>E</given-names></name> <name><surname>Renier</surname> <given-names>A</given-names></name> <name><surname>Letourneux</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Detection of SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma and other pulmonary diseases</article-title>. <source>Dev Biol Stand</source>. (<year>1998</year>) <volume>94</volume>:<fpage>147</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9896(199803)184:3&#x0003C;252::AID-PATH15&#x0003E;3.3.CO;2-I</pub-id><pub-id pub-id-type="pmid">9776236</pub-id></citation></ref>
<ref id="B228">
<label>228.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Priftakis</surname> <given-names>P</given-names></name> <name><surname>Bogdanovic</surname> <given-names>G</given-names></name> <name><surname>Hjerpe</surname> <given-names>A</given-names></name> <name><surname>Dalianis</surname> <given-names>T</given-names></name></person-group>. <article-title>Presence of simian virus 40 (SV40) is not frequent in Swedish malignant mesotheliomas</article-title>. <source>Anticancer Res</source>. (<year>2002</year>) <volume>22</volume>:<fpage>1357</fpage>&#x02013;<lpage>60</lpage>.</citation></ref>
<ref id="B229">
<label>229.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>McLaren</surname> <given-names>BR</given-names></name> <name><surname>Haenel</surname> <given-names>T</given-names></name> <name><surname>Stevenson</surname> <given-names>S</given-names></name> <name><surname>Mukherjee</surname> <given-names>S</given-names></name> <name><surname>Robinson</surname> <given-names>BW</given-names></name> <name><surname>Lake</surname> <given-names>RA</given-names></name></person-group>. <article-title>Simian virus (SV) 40 like sequences in cell lines and tumour biopsies from Australian malignant mesotheliomas</article-title>. <source>Aust N Z J Med</source>. (<year>2000</year>) <volume>30</volume>:<fpage>450</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/j.1445-5994.2000.tb02050.x</pub-id><pub-id pub-id-type="pmid">10985509</pub-id></citation></ref>
<ref id="B230">
<label>230.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carbone</surname> <given-names>M</given-names></name> <name><surname>Pass</surname> <given-names>HI</given-names></name> <name><surname>Rizzo</surname> <given-names>P</given-names></name> <name><surname>Marinetti</surname> <given-names>M</given-names></name> <name><surname>Di Muzio</surname> <given-names>M</given-names></name> <name><surname>Mew</surname> <given-names>DJ</given-names></name> <etal/></person-group>. <article-title>Simian virus 40-like DNA sequences in human pleural mesothelioma</article-title>. <source>Oncogene</source>. (<year>1994</year>) <volume>9</volume>:<fpage>1781</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="pmid">8183577</pub-id></citation></ref>
<ref id="B231">
<label>231.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname> <given-names>DJ</given-names></name> <name><surname>Nicholson</surname> <given-names>AG</given-names></name> <name><surname>Weiss</surname> <given-names>RA</given-names></name></person-group>. <article-title>Detection of SV40 sequences in human mesothelioma</article-title>. <source>Dev Biol Stand</source>. (<year>1998</year>) <volume>94</volume>:<fpage>127</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="pmid">9776233</pub-id></citation></ref>
<ref id="B232">
<label>232.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comar</surname> <given-names>M</given-names></name> <name><surname>Rizzardi</surname> <given-names>C</given-names></name> <name><surname>de Zotti</surname> <given-names>R</given-names></name> <name><surname>Melato</surname> <given-names>M</given-names></name> <name><surname>Bovenzi</surname> <given-names>M</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name> <etal/></person-group>. <article-title>SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma</article-title>. <source>Cancer Res.</source> (<year>2007</year>) <volume>67</volume>:<fpage>8456</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-2232</pub-id><pub-id pub-id-type="pmid">17875683</pub-id></citation></ref>
<ref id="B233">
<label>233.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramael</surname> <given-names>M</given-names></name> <name><surname>Nagels</surname> <given-names>J</given-names></name> <name><surname>Heylen</surname> <given-names>H</given-names></name> <name><surname>De Schepper</surname> <given-names>S</given-names></name> <name><surname>Paulussen</surname> <given-names>J</given-names></name> <name><surname>De Maeyer</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Detection of SV40 like viral DNA and viral antigens in malignant pleural mesothelioma</article-title>. <source>Eur Respir J.</source> (<year>1999</year>) <volume>14</volume>:<fpage>1381</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.99.14613819</pub-id><pub-id pub-id-type="pmid">10624771</pub-id></citation></ref>
<ref id="B234">
<label>234.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramael</surname> <given-names>M</given-names></name> <name><surname>Nagels</surname> <given-names>J</given-names></name></person-group>. <article-title>Re. SV40-like DNA sequences in pleural mesothelioma, bronchopulmonary carcinoma and non-malignant pulmonary disease</article-title>. <source>J Pathol.</source> (<year>1999</year>) <volume>189</volume>:<fpage>628</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1096-9896(199912)189:4&#x0003C;628::AID-PATH481&#x0003E;3.0.CO;2-5</pub-id><pub-id pub-id-type="pmid">10629569</pub-id></citation></ref>
<ref id="B235">
<label>235.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Rienzo</surname> <given-names>A</given-names></name> <name><surname>Tor</surname> <given-names>M</given-names></name> <name><surname>Sterman</surname> <given-names>DH</given-names></name> <name><surname>Aksoy</surname> <given-names>F</given-names></name> <name><surname>Albelda</surname> <given-names>SM</given-names></name> <name><surname>Testa</surname> <given-names>JR</given-names></name></person-group>. <article-title>Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey</article-title>. <source>J Cell Biochem</source>. (<year>2002</year>) <volume>84</volume>:<fpage>455</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.10058</pub-id></citation></ref>
<ref id="B236">
<label>236.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cristaudo</surname> <given-names>A</given-names></name> <name><surname>Foddis</surname> <given-names>R</given-names></name> <name><surname>Vivaldi</surname> <given-names>A</given-names></name> <name><surname>Buselli</surname> <given-names>R</given-names></name> <name><surname>Gattini</surname> <given-names>V</given-names></name> <name><surname>Guglielmi</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study</article-title>. <source>Cancer Res</source>. (<year>2005</year>) <volume>65</volume>:<fpage>3049</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-2219</pub-id><pub-id pub-id-type="pmid">15833832</pub-id></citation></ref>
<ref id="B237">
<label>237.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Cristaudo</surname> <given-names>A</given-names></name> <name><surname>Taronna</surname> <given-names>A</given-names></name> <name><surname>Tassi</surname> <given-names>G</given-names></name> <name><surname>Manfrini</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>High prevalence of serum antibodies reacting with simian virus 40 capsid protein mimotopes in patients affected by malignant pleural mesothelioma</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2012</year>) <volume>109</volume>:<fpage>18066</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1213238109</pub-id><pub-id pub-id-type="pmid">23071320</pub-id></citation></ref>
<ref id="B238">
<label>238.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zekri</surname> <given-names>A-RN</given-names></name> <name><surname>Bahnassy</surname> <given-names>AA</given-names></name> <name><surname>Mohamed</surname> <given-names>WS</given-names></name> <name><surname>Hassan</surname> <given-names>N</given-names></name> <name><surname>Abdel-Rahman</surname> <given-names>A-RM</given-names></name> <name><surname>El-Kassem</surname> <given-names>FA</given-names></name> <etal/></person-group>. <article-title>Evaluation of simian virus-40 as a biological prognostic factor in Egyptian patients with malignant pleural mesothelioma</article-title>. <source>Pathol Int.</source> (<year>2007</year>) <volume>57</volume>:<fpage>493</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1827.2007.02130.x</pub-id><pub-id pub-id-type="pmid">17610473</pub-id></citation></ref>
<ref id="B239">
<label>239.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zekri</surname> <given-names>A-R</given-names></name> <name><surname>Mohamed</surname> <given-names>W</given-names></name> <name><surname>Bahnassy</surname> <given-names>A</given-names></name> <name><surname>Refat</surname> <given-names>L</given-names></name> <name><surname>Khaled</surname> <given-names>M</given-names></name> <name><surname>Shalaby</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Detection of simian virus 40 DNA sequences in Egyptian patients with different hematological malignancies</article-title>. <source>Leuk Lymphoma.</source> (<year>2007</year>) <volume>48</volume>:<fpage>1828</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1080/10428190701534408</pub-id><pub-id pub-id-type="pmid">17786720</pub-id></citation></ref>
<ref id="B240">
<label>240.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname> <given-names>GJ</given-names></name> <name><surname>Chen</surname> <given-names>C-J</given-names></name> <name><surname>Jaklitsch</surname> <given-names>MT</given-names></name> <name><surname>Richards</surname> <given-names>WG</given-names></name> <name><surname>Sugarbaker</surname> <given-names>DJ</given-names></name> <name><surname>Bueno</surname> <given-names>R</given-names></name></person-group>. <article-title>Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines</article-title>. <source>Oncol Rep</source>. (<year>2002</year>) <volume>9</volume>:<fpage>631</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.3892/or.9.3.631</pub-id><pub-id pub-id-type="pmid">11956641</pub-id></citation></ref>
<ref id="B241">
<label>241.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>M</given-names></name> <name><surname>Sawa</surname> <given-names>H</given-names></name> <name><surname>Suzuki</surname> <given-names>T</given-names></name> <name><surname>Shimizu</surname> <given-names>K</given-names></name> <name><surname>Makino</surname> <given-names>Y</given-names></name> <name><surname>Tanaka</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Investigation of simian virus 40 large T antigen in 18 autopsied malignant mesothelioma patients in Japan</article-title>. <source>J Med Virol</source>. (<year>2004</year>) <volume>74</volume>:<fpage>668</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.20219</pub-id><pub-id pub-id-type="pmid">15484269</pub-id></citation></ref>
<ref id="B242">
<label>242.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pepper</surname> <given-names>C</given-names></name> <name><surname>Jasani</surname> <given-names>B</given-names></name> <name><surname>Navabi</surname> <given-names>H</given-names></name> <name><surname>Wynford-Thomas</surname> <given-names>D</given-names></name> <name><surname>Gibbs</surname> <given-names>AR</given-names></name></person-group>. <article-title>Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue</article-title>. <source>Thorax.</source> (<year>1996</year>) <volume>51</volume>:<fpage>1074</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1136/thx.51.11.1074</pub-id><pub-id pub-id-type="pmid">8958887</pub-id></citation></ref>
<ref id="B243">
<label>243.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shivapurkar</surname> <given-names>N</given-names></name> <name><surname>Wiethege</surname> <given-names>T</given-names></name> <name><surname>Wistuba</surname> <given-names>II</given-names></name> <name><surname>Salomon</surname> <given-names>E</given-names></name> <name><surname>Milchgrub</surname> <given-names>S</given-names></name> <name><surname>Muller</surname> <given-names>KM</given-names></name> <etal/></person-group>. <article-title>Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations</article-title>. <source>J Cell Biochem.</source> (<year>1999</year>) <volume>76</volume>:<fpage>181</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-4644(20000201)76:2&#x0003C;181::AID-JCB2&#x0003E;3.3.CO;2-0</pub-id><pub-id pub-id-type="pmid">10618635</pub-id></citation></ref>
<ref id="B244">
<label>244.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pacini</surname> <given-names>F</given-names></name> <name><surname>Vivaldi</surname> <given-names>A</given-names></name> <name><surname>Santoro</surname> <given-names>M</given-names></name> <name><surname>Fedele</surname> <given-names>M</given-names></name> <name><surname>Fusco</surname> <given-names>A</given-names></name> <name><surname>Romei</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Simian virus 40-like DNA sequences in human papillary thyroid carcinomas</article-title>. <source>Oncogene</source>. (<year>1998</year>) <volume>16</volume>:<fpage>665</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1201552</pub-id><pub-id pub-id-type="pmid">9482113</pub-id></citation></ref>
<ref id="B245">
<label>245.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loghavi</surname> <given-names>S</given-names></name> <name><surname>Bose</surname> <given-names>S</given-names></name></person-group>. <article-title>Polyomavirus infection and urothelial carcinoma</article-title>. <source>Diagn Cytopathol.</source> (<year>2011</year>) <volume>39</volume>:<fpage>531</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1002/dc.21490</pub-id><pub-id pub-id-type="pmid">20891007</pub-id></citation></ref>
<ref id="B246">
<label>246.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bononi</surname> <given-names>I</given-names></name> <name><surname>Perri</surname> <given-names>P</given-names></name> <name><surname>Begnardi</surname> <given-names>A</given-names></name> <name><surname>Martini</surname> <given-names>A</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Bosi</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Antibodies reacting with Simian Virus 40 capsid protein mimotopes in serum samples from patients affected by uveal melanoma</article-title>. <source>J Hematol Oncol</source>. (<year>2014</year>) <volume>7</volume>:<fpage>38</fpage>. <pub-id pub-id-type="doi">10.1186/1756-8722-7-38</pub-id><pub-id pub-id-type="pmid">24886631</pub-id></citation></ref>
<ref id="B247">
<label>247.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vilchez</surname> <given-names>RA</given-names></name> <name><surname>Lednicky</surname> <given-names>JA</given-names></name> <name><surname>Halvorson</surname> <given-names>SJ</given-names></name> <name><surname>White</surname> <given-names>ZS</given-names></name> <name><surname>Kozinetz</surname> <given-names>CA</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma</article-title>. <source>J Acquir Immune Defic Syndr.</source> (<year>2002</year>) <volume>29</volume>:<fpage>109</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1097/00042560-200202010-00001</pub-id><pub-id pub-id-type="pmid">11832678</pub-id></citation></ref>
<ref id="B248">
<label>248.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname> <given-names>P</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name> <name><surname>Fisher</surname> <given-names>SG</given-names></name> <name><surname>Matker</surname> <given-names>C</given-names></name> <name><surname>Swinnen</surname> <given-names>LJ</given-names></name> <name><surname>Powers</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin&#x00027;s lymphoma</article-title>. <source>Chest</source>. (<year>1999</year>) <volume>116</volume>(<supplement>6 Suppl.</supplement>):<fpage>470S</fpage>&#x02212;<lpage>473S</lpage>. <pub-id pub-id-type="doi">10.1378/chest.116.suppl_3.470S</pub-id><pub-id pub-id-type="pmid">10619511</pub-id></citation></ref>
<ref id="B249">
<label>249.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shivapurkar</surname> <given-names>N</given-names></name> <name><surname>Harada</surname> <given-names>K</given-names></name> <name><surname>Reddy</surname> <given-names>J</given-names></name> <name><surname>Scheuermann</surname> <given-names>RH</given-names></name> <name><surname>Xu</surname> <given-names>Y</given-names></name> <name><surname>McKenna</surname> <given-names>RW</given-names></name> <etal/></person-group>. <article-title>Presence of simian virus 40 DNA sequences in human lymphomas</article-title>. <source>Lancet</source>. (<year>2002</year>) <volume>359</volume>:<fpage>851</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(02)07921-7</pub-id><pub-id pub-id-type="pmid">11897287</pub-id></citation></ref>
<ref id="B250">
<label>250.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vilchez</surname> <given-names>RA</given-names></name> <name><surname>Madden</surname> <given-names>CR</given-names></name> <name><surname>Kozinetz</surname> <given-names>CA</given-names></name> <name><surname>Halvorson</surname> <given-names>SJ</given-names></name> <name><surname>White</surname> <given-names>ZS</given-names></name> <name><surname>Jorgensen</surname> <given-names>JL</given-names></name> <etal/></person-group>. <article-title>Association between simian virus 40 and non-Hodgkin lymphoma</article-title>. <source>Lancet</source>. (<year>2002</year>) <volume>359</volume>:<fpage>817</fpage>&#x02013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(02)07950-3</pub-id><pub-id pub-id-type="pmid">11897278</pub-id></citation></ref>
<ref id="B251">
<label>251.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vilchez</surname> <given-names>RA</given-names></name> <name><surname>Lopez-Terrada</surname> <given-names>D</given-names></name> <name><surname>Middleton</surname> <given-names>JR</given-names></name> <name><surname>Finch</surname> <given-names>CJ</given-names></name> <name><surname>Killen</surname> <given-names>DE</given-names></name> <name><surname>Zanwar</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Simian virus 40 tumor antigen expression and immunophenotypic profile of AIDS-related non-Hodgkin&#x00027;s lymphoma</article-title>. <source>Virology.</source> (<year>2005</year>) <volume>342</volume>:<fpage>38</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2005.06.053</pub-id><pub-id pub-id-type="pmid">16122775</pub-id></citation></ref>
<ref id="B252">
<label>252.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tognon</surname> <given-names>M</given-names></name> <name><surname>Luppi</surname> <given-names>M</given-names></name> <name><surname>Corallini</surname> <given-names>A</given-names></name> <name><surname>Taronna</surname> <given-names>A</given-names></name> <name><surname>Barozzi</surname> <given-names>P</given-names></name> <name><surname>Rotondo</surname> <given-names>JC</given-names></name> <etal/></person-group>. <article-title>Immunologic evidence of a strong association between non-Hodgkin lymphoma and simian virus 40</article-title>. <source>Cancer</source>. (<year>2015</year>) <volume>121</volume>:<fpage>2618</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.29404</pub-id><pub-id pub-id-type="pmid">25877010</pub-id></citation></ref>
<ref id="B253">
<label>253.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Pietrobon</surname> <given-names>S</given-names></name> <name><surname>Bilancia</surname> <given-names>M</given-names></name> <name><surname>Vinante</surname> <given-names>F</given-names></name> <name><surname>Rigo</surname> <given-names>A</given-names></name> <name><surname>Ferrarini</surname> <given-names>I</given-names></name> <etal/></person-group>. <article-title>High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphoma</article-title>. <source>Cancer Immunol Immunother</source>. (<year>2017</year>) <volume>66</volume>:<fpage>1189</fpage>&#x02013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1007/s00262-017-2008-9</pub-id><pub-id pub-id-type="pmid">28455653</pub-id></citation></ref>
<ref id="B254">
<label>254.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amara</surname> <given-names>K</given-names></name> <name><surname>Trimeche</surname> <given-names>M</given-names></name> <name><surname>Ziadi</surname> <given-names>S</given-names></name> <name><surname>Laatiri</surname> <given-names>A</given-names></name> <name><surname>Hachana</surname> <given-names>M</given-names></name> <name><surname>Sriha</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Presence of simian virus 40 DNA sequences in diffuse large B-cell lymphomas in Tunisia correlates with aberrant promoter hypermethylation of multiple tumor suppressor genes</article-title>. <source>Int J Cancer.</source> (<year>2007</year>) <volume>121</volume>:<fpage>2693</fpage>&#x02013;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.23038</pub-id><pub-id pub-id-type="pmid">17724719</pub-id></citation></ref>
<ref id="B255">
<label>255.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heinsohn</surname> <given-names>S</given-names></name> <name><surname>Scholz</surname> <given-names>R</given-names></name> <name><surname>Kabisch</surname> <given-names>H</given-names></name></person-group>. <article-title>SV40 and p53 as team players in childhood lymphoproliferative disorders</article-title>. <source>Int J Oncol.</source> (<year>2011</year>) <volume>38</volume>:<fpage>1307</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.3892/ijo.2011.967</pub-id><pub-id pub-id-type="pmid">21399869</pub-id></citation></ref>
<ref id="B256">
<label>256.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Restrepo</surname> <given-names>CS</given-names></name> <name><surname>Chen</surname> <given-names>MM</given-names></name> <name><surname>Martinez-Jimenez</surname> <given-names>S</given-names></name> <name><surname>Carrillo</surname> <given-names>J</given-names></name> <name><surname>Restrepo</surname> <given-names>C</given-names></name></person-group>. <article-title>Chest neoplasms with infectious etiologies</article-title>. <source>World J Radiol</source>. (<year>2011</year>) <volume>3</volume>:<fpage>279</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.4329/wjr.v3.i12.279</pub-id><pub-id pub-id-type="pmid">22224176</pub-id></citation></ref>
<ref id="B257">
<label>257.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pass</surname> <given-names>HI</given-names></name> <name><surname>Donington</surname> <given-names>JS</given-names></name> <name><surname>Wu</surname> <given-names>P</given-names></name> <name><surname>Rizzo</surname> <given-names>P</given-names></name> <name><surname>Nishimura</surname> <given-names>M</given-names></name> <name><surname>Kennedy</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences</article-title>. <source>J Thorac Cardiovasc Surg</source>. (<year>1998</year>) <volume>116</volume>:<fpage>854</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-5223(98)00438-3</pub-id><pub-id pub-id-type="pmid">9806392</pub-id></citation></ref>
<ref id="B258">
<label>258.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cristaudo</surname> <given-names>A</given-names></name> <name><surname>Vivaldi</surname> <given-names>A</given-names></name> <name><surname>Sensales</surname> <given-names>G</given-names></name> <name><surname>Guglielmi</surname> <given-names>G</given-names></name> <name><surname>Ciancia</surname> <given-names>E</given-names></name> <name><surname>Elisei</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Molecular biology studies on mesothelioma tumor samples: preliminary data on H-ras, p21, and SV40</article-title>. <source>J Environ Pathol Toxicol Oncol</source>. (<year>1995</year>) <volume>14</volume>:<fpage>29</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="pmid">7473072</pub-id></citation></ref>
<ref id="B259">
<label>259.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>Increasing evidence for involvement of SV40 in human cancer</article-title>. <source>Dis Markers.</source> (<year>2001</year>) <volume>17</volume>:<fpage>167</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1155/2001/857621</pub-id><pub-id pub-id-type="pmid">11790883</pub-id></citation></ref>
<ref id="B260">
<label>260.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vilchez</surname> <given-names>RA</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>SV40 in human brain cancers and non-Hodgkin&#x00027;s lymphoma</article-title>. <source>Oncogene</source>. (<year>2003</year>) <volume>22</volume>:<fpage>5164</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1206547</pub-id><pub-id pub-id-type="pmid">12910253</pub-id></citation></ref>
<ref id="B261">
<label>261.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname> <given-names>F</given-names></name> <name><surname>Koprowski</surname> <given-names>H</given-names></name> <name><surname>Pagano</surname> <given-names>JS</given-names></name> <name><surname>Pont&#x000E9;n</surname> <given-names>J</given-names></name> <name><surname>Ravdin</surname> <given-names>RG</given-names></name></person-group>. <article-title>Autologous and homologous implantation of human cells transformed <italic>in vitro</italic> by simian virus</article-title>. <source>J Natl Cancer Inst.</source> (<year>1964</year>) <volume>32</volume>:<fpage>917</fpage>&#x02013;<lpage>37</lpage>.</citation></ref>
<ref id="B262">
<label>262.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x000F3;pez-R&#x000ED;os</surname> <given-names>F</given-names></name> <name><surname>Illei</surname> <given-names>PB</given-names></name> <name><surname>Rusch</surname> <given-names>V</given-names></name> <name><surname>Ladanyi</surname> <given-names>M</given-names></name></person-group>. <article-title>Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids</article-title>. <source>Lancet</source>. (<year>2004</year>) <volume>364</volume>:<fpage>1157</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(04)17102-X</pub-id><pub-id pub-id-type="pmid">15451223</pub-id></citation></ref>
<ref id="B263">
<label>263.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mayall</surname> <given-names>F</given-names></name> <name><surname>Barratt</surname> <given-names>K</given-names></name> <name><surname>Shanks</surname> <given-names>J</given-names></name></person-group>. <article-title>The detection of Simian virus 40 in mesotheliomas from New Zealand and England using real time FRET probe PCR protocols</article-title>. <source>J Clin Pathol.</source> (<year>2003</year>) <volume>56</volume>:<fpage>728</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1136/jcp.56.10.728</pub-id><pub-id pub-id-type="pmid">14514773</pub-id></citation></ref>
<ref id="B264">
<label>264.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname> <given-names>P</given-names></name> <name><surname>Bocchetta</surname> <given-names>M</given-names></name> <name><surname>Powers</surname> <given-names>A</given-names></name> <name><surname>Foddis</surname> <given-names>R</given-names></name> <name><surname>Stekala</surname> <given-names>E</given-names></name> <name><surname>Pass</surname> <given-names>HI</given-names></name> <etal/></person-group>. <article-title>SV40 and the pathogenesis of mesothelioma</article-title>. <source>Semin Cancer Biol</source>. (<year>2001</year>) <volume>11</volume>:<fpage>63</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1006/scbi.2000.0347</pub-id><pub-id pub-id-type="pmid">11243900</pub-id></citation></ref>
<ref id="B265">
<label>265.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaudino</surname> <given-names>G</given-names></name> <name><surname>Yang</surname> <given-names>H</given-names></name> <name><surname>Carbone</surname> <given-names>M</given-names></name></person-group>. <article-title>HGF/Met signaling is a key player in malignant mesothelioma carcinogenesis</article-title>. <source>Biomedicines</source>. (<year>2014</year>) <volume>2</volume>:<fpage>327</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.3390/biomedicines2040327</pub-id><pub-id pub-id-type="pmid">28548074</pub-id></citation></ref>
<ref id="B266">
<label>266.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Governa</surname> <given-names>M</given-names></name> <name><surname>Amati</surname> <given-names>M</given-names></name> <name><surname>Bellis</surname> <given-names>D</given-names></name> <name><surname>Bichisecchi</surname> <given-names>E</given-names></name> <name><surname>Santarelli</surname> <given-names>L</given-names></name></person-group>. <article-title>Diagnosis of asbestos-related pleuropolmonary diseases</article-title>. Med Lav. (<year>2006</year>) <volume>97</volume>:<fpage>463</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="pmid">17009682</pub-id></citation></ref>
<ref id="B267">
<label>267.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leithner</surname> <given-names>A</given-names></name> <name><surname>Weinhaeusel</surname> <given-names>A</given-names></name> <name><surname>Windhager</surname> <given-names>R</given-names></name> <name><surname>Schlegl</surname> <given-names>R</given-names></name> <name><surname>Waldner</surname> <given-names>P</given-names></name> <name><surname>Lang</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Absence of SV40 in Austrian tumors correlates with low incidence of mesotheliomas</article-title>. <source>Cancer Biol Ther</source>. (<year>2002</year>) <volume>1</volume>:<fpage>375</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4161/cbt.1.4.10</pub-id><pub-id pub-id-type="pmid">12432250</pub-id></citation></ref>
<ref id="B268">
<label>268.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aoe</surname> <given-names>K</given-names></name> <name><surname>Hiraki</surname> <given-names>A</given-names></name> <name><surname>Murakami</surname> <given-names>T</given-names></name> <name><surname>Toyooka</surname> <given-names>S</given-names></name> <name><surname>Shivapurkar</surname> <given-names>N</given-names></name> <name><surname>Gazdar</surname> <given-names>AF</given-names></name> <etal/></person-group>. <article-title>Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan</article-title>. <source>Cancer Sci.</source> (<year>2006</year>) <volume>97</volume>:<fpage>292</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2006.00171.x</pub-id><pub-id pub-id-type="pmid">16630121</pub-id></citation></ref>
<ref id="B269">
<label>269.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Comar</surname> <given-names>M</given-names></name> <name><surname>Zanotta</surname> <given-names>N</given-names></name> <name><surname>Bovenzi</surname> <given-names>M</given-names></name> <name><surname>Campello</surname> <given-names>C</given-names></name></person-group>. <article-title>JCV/BKV and SV40 viral load in lymphoid tissues of young immunocompetent children from an area of north-east Italy</article-title>. <source>J Med Virol.</source> (<year>2010</year>) <volume>82</volume>:<fpage>1236</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1002/jmv.21786</pub-id><pub-id pub-id-type="pmid">20513090</pub-id></citation></ref>
<ref id="B270">
<label>270.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cacciotti</surname> <given-names>P</given-names></name> <name><surname>Strizzi</surname> <given-names>L</given-names></name> <name><surname>Vianale</surname> <given-names>G</given-names></name> <name><surname>Iaccheri</surname> <given-names>L</given-names></name> <name><surname>Libener</surname> <given-names>R</given-names></name> <name><surname>Porta</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>The presence of simian-virus 40 sequences in mesothelioma and mesothelial cells is associated with high levels of vascular endothelial growth factor</article-title>. <source>Am J Respir Cell Mol Biol.</source> (<year>2002</year>) <volume>26</volume>:<fpage>189</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1165/ajrcmb.26.2.4673</pub-id><pub-id pub-id-type="pmid">11804869</pub-id></citation></ref>
<ref id="B271">
<label>271.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Catalano</surname> <given-names>A</given-names></name> <name><surname>Romano</surname> <given-names>M</given-names></name> <name><surname>Martinotti</surname> <given-names>S</given-names></name> <name><surname>Procopio</surname> <given-names>A</given-names></name></person-group>. <article-title>Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen</article-title>. <source>Oncogene</source>. (<year>2002</year>) <volume>21</volume>:<fpage>2896</fpage>&#x02013;<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1205382</pub-id><pub-id pub-id-type="pmid">11973650</pub-id></citation></ref>
<ref id="B272">
<label>272.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Porcu</surname> <given-names>P</given-names></name> <name><surname>Ferber</surname> <given-names>A</given-names></name> <name><surname>Pietrzkowski</surname> <given-names>Z</given-names></name> <name><surname>Roberts</surname> <given-names>CT</given-names></name> <name><surname>Adamo</surname> <given-names>M</given-names></name> <name><surname>LeRoith</surname> <given-names>D</given-names></name> <etal/></person-group>. <article-title>The growth-stimulatory effect of simian virus 40 T antigen requires the interaction of insulinlike growth factor 1 with its receptor</article-title>. <source>Mol Cell Biol.</source> (<year>1992</year>) <volume>12</volume>:<fpage>5069</fpage>&#x02013;<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.12.11.5069</pub-id><pub-id pub-id-type="pmid">1406682</pub-id></citation></ref>
<ref id="B273">
<label>273.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reeve</surname> <given-names>JG</given-names></name> <name><surname>Guada&#x000F1;o</surname> <given-names>A</given-names></name> <name><surname>Xiong</surname> <given-names>J</given-names></name> <name><surname>Morgan</surname> <given-names>J</given-names></name> <name><surname>Bleehen</surname> <given-names>NM</given-names></name></person-group>. <article-title>Diminished expression of insulin-like growth factor (IGF) binding protein-5 and activation of IGF-I-mediated autocrine growth in simian virus 40-transformed human fibroblasts</article-title>. <source>J Biol Chem</source>. (<year>1995</year>) <volume>270</volume>:<fpage>135</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.1.135</pub-id><pub-id pub-id-type="pmid">7529226</pub-id></citation></ref>
<ref id="B274">
<label>274.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Li</surname> <given-names>H</given-names></name> <name><surname>Nomura</surname> <given-names>K</given-names></name> <name><surname>Dofuku</surname> <given-names>R</given-names></name> <name><surname>Kitagawa</surname> <given-names>T</given-names></name></person-group>. <article-title>Cytogenetic analysis of hepatic cell lines derived from SV40-T antigen gene-harboring transgenic mice</article-title>. <source>Cancer Genet Cytogenet</source>. (<year>1991</year>) <volume>55</volume>:<fpage>207</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/0165-4608(91)90079-A</pub-id><pub-id pub-id-type="pmid">1657366</pub-id></citation></ref>
<ref id="B275">
<label>275.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strickler</surname> <given-names>HD</given-names></name> <name><surname>Goedert</surname> <given-names>JJ</given-names></name> <name><surname>Fleming</surname> <given-names>M</given-names></name> <name><surname>Travis</surname> <given-names>WD</given-names></name> <name><surname>Williams</surname> <given-names>AE</given-names></name> <name><surname>Rabkin</surname> <given-names>CS</given-names></name> <etal/></person-group>. <article-title>Simian virus 40 and pleural mesothelioma in humans</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. (<year>1996</year>) <volume>5</volume>:<fpage>473</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="pmid">8781745</pub-id></citation></ref>
<ref id="B276">
<label>276.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strickler</surname> <given-names>HD</given-names></name> <name><surname>International</surname> <given-names>SV40 Working Group</given-names></name></person-group>. <article-title>A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. (<year>2001</year>) <volume>10</volume>:<fpage>523</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="pmid">11352864</pub-id></citation></ref>
<ref id="B277">
<label>277.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engels</surname> <given-names>EA</given-names></name> <name><surname>Sarkar</surname> <given-names>C</given-names></name> <name><surname>Daniel</surname> <given-names>RW</given-names></name> <name><surname>Gravitt</surname> <given-names>PE</given-names></name> <name><surname>Verma</surname> <given-names>K</given-names></name> <name><surname>Quezado</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Absence of simian virus 40 in human brain tumors from northern India</article-title>. <source>Int J Cancer</source>. (<year>2002</year>) <volume>101</volume>:<fpage>348</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.10621</pub-id><pub-id pub-id-type="pmid">12209959</pub-id></citation></ref>
<ref id="B278">
<label>278.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gee</surname> <given-names>GV</given-names></name> <name><surname>Stanifer</surname> <given-names>ML</given-names></name> <name><surname>Christensen</surname> <given-names>BC</given-names></name> <name><surname>Atwood</surname> <given-names>WJ</given-names></name> <name><surname>Ugolini</surname> <given-names>D</given-names></name> <name><surname>Bonassi</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>SV40 associated miRNAs are not detectable in mesotheliomas</article-title>. <source>Br J Cancer.</source> (<year>2010</year>) <volume>103</volume>:<fpage>885</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjc.6605848</pub-id></citation></ref>
<ref id="B279">
<label>279.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manfredi</surname> <given-names>JJ</given-names></name> <name><surname>Dong</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>W</given-names></name> <name><surname>Resnick-Silverman</surname> <given-names>L</given-names></name> <name><surname>Qiao</surname> <given-names>R</given-names></name> <name><surname>Chahinian</surname> <given-names>P</given-names></name> <etal/></person-group>. <article-title>Evidence against a role for SV40 in human mesothelioma</article-title>. <source>Cancer Res.</source> (<year>2005</year>) <volume>65</volume>:<fpage>2602</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-2461</pub-id><pub-id pub-id-type="pmid">15805256</pub-id></citation></ref>
<ref id="B280">
<label>280.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Bononi</surname> <given-names>I</given-names></name> <name><surname>Benassi</surname> <given-names>MS</given-names></name> <name><surname>Picci</surname> <given-names>P</given-names></name> <name><surname>Torreggiani</surname> <given-names>E</given-names></name> <name><surname>Rossini</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Serum antibodies against simian virus 40 large T antigen, the viral oncoprotein, in osteosarcoma patients</article-title>. <source>Front Cell Dev Biol.</source> (<year>2018</year>) <volume>6</volume>:<fpage>64</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2018.00064</pub-id><pub-id pub-id-type="pmid">30013971</pub-id></citation></ref>
<ref id="B281">
<label>281.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Pietrobon</surname> <given-names>S</given-names></name> <name><surname>Masini</surname> <given-names>I</given-names></name> <name><surname>Rotondo</surname> <given-names>JC</given-names></name> <name><surname>Gentile</surname> <given-names>M</given-names></name> <name><surname>Fainardi</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis</article-title>. <source>PLoS ONE</source>. (<year>2014</year>) <volume>9</volume>:<fpage>e110923</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0110923</pub-id><pub-id pub-id-type="pmid">25365364</pub-id></citation></ref>
<ref id="B282">
<label>282.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fainardi</surname> <given-names>E</given-names></name> <name><surname>Bortolotti</surname> <given-names>D</given-names></name> <name><surname>Bolzani</surname> <given-names>S</given-names></name> <name><surname>Castellazzi</surname> <given-names>M</given-names></name> <name><surname>Tamborino</surname> <given-names>C</given-names></name> <name><surname>Roversi</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis</article-title>. <source>Mult Scler.</source> (<year>2016</year>) <volume>22</volume>:<fpage>245</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1177/1352458515590647</pub-id><pub-id pub-id-type="pmid">26084349</pub-id></citation></ref>
<ref id="B283">
<label>283.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rizzo</surname> <given-names>R</given-names></name> <name><surname>Pietrobon</surname> <given-names>S</given-names></name> <name><surname>Mazzoni</surname> <given-names>E</given-names></name> <name><surname>Bortolotti</surname> <given-names>D</given-names></name> <name><surname>Martini</surname> <given-names>F</given-names></name> <name><surname>Castellazzi</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis</article-title>. <source>J Transl Med.</source> (<year>2016</year>) <volume>14</volume>:<fpage>216</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-016-0981-y</pub-id><pub-id pub-id-type="pmid">27443345</pub-id></citation></ref>
<ref id="B284">
<label>284.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Milstone</surname> <given-names>A</given-names></name> <name><surname>Vilchez</surname> <given-names>RA</given-names></name> <name><surname>Geiger</surname> <given-names>X</given-names></name> <name><surname>Fogo</surname> <given-names>AB</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name> <name><surname>Dummer</surname> <given-names>S</given-names></name></person-group>. <article-title>Polyomavirus simian virus 40 infection associated with nephropathy in a lung-transplant recipient</article-title>. <source>Transplantation</source>. (<year>2004</year>) <volume>77</volume>:<fpage>1019</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1097/01.TP.0000119156.52197.CA</pub-id><pub-id pub-id-type="pmid">15087764</pub-id></citation></ref>
<ref id="B285">
<label>285.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>C</given-names></name> <name><surname>Zhang</surname> <given-names>S</given-names></name> <name><surname>Adam</surname> <given-names>E</given-names></name> <name><surname>Paszat</surname> <given-names>L</given-names></name> <name><surname>Butel</surname> <given-names>JS</given-names></name></person-group>. <article-title>SV40 seroprevalence in two Latin American countries involved in field trials of candidate oral poliovaccines</article-title>. <source>J Infect.</source> (<year>2019</year>) <volume>78</volume>:<fpage>476</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2019.04.007</pub-id><pub-id pub-id-type="pmid">30965068</pub-id></citation></ref>
<ref id="B286">
<label>286.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scuda</surname> <given-names>N</given-names></name> <name><surname>Hofmann</surname> <given-names>J</given-names></name> <name><surname>Calvignac-Spencer</surname> <given-names>S</given-names></name> <name><surname>Ruprecht</surname> <given-names>K</given-names></name> <name><surname>Liman</surname> <given-names>P</given-names></name> <name><surname>K&#x000FC;hn</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>A novel human polyomavirus closely related to the African green monkey-derived lymphotropic polyomavirus</article-title>. <source>J Virol.</source> (<year>2011</year>) <volume>85</volume>:<fpage>4586</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02602-10</pub-id><pub-id pub-id-type="pmid">21307194</pub-id></citation></ref>
<ref id="B287">
<label>287.</label>
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>zur Hausen</surname> <given-names>H</given-names></name> <name><surname>Gissmann</surname> <given-names>L</given-names></name></person-group>. <article-title>Lymphotropic papovaviruses isolated from African green monkey and human cells</article-title>. <source>Med Microbiol Immunol.</source> (<year>1979</year>) <volume>167</volume>:<fpage>137</fpage>&#x02013;<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1007/BF02121180</pub-id><pub-id pub-id-type="pmid">226854</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work is supported by funds from the Associazione Italiana per la Ricerca sul Cancro (AIRC) to MT (ID:21617) and to JR (ID:21956). JR is also supported by a postdoctoral fellowship from the Fondazione Umberto Veronesi, Milan, Italy (2019&#x02013;2020).</p>
</fn>
</fn-group>
</back>
</article>